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SCOPE AND THESIS OUTLINE 
 
The aim of the present thesis was to get more insight in a number of aspects dealing with 
acaricide resistance in the two-spotted spider mite, Tetranychus urticae. The problems 
associated with the widespread occurrence of acaricide resistance in this species stimulated us 
to investigate this phenomenon. Out of the wide range of research topics that could have been 
interesting to study, we have chosen to focus on the biochemical and molecular mechanisms 
involved in acaricide resistance. We therefore chose three important groups of acaricides, two 
of which have been used for decades (i.e. pyrethroids and organophosphates) and a recently 
introduced group (tetronic acid derivatives). Next to a number of more fundamental topics, 
we also wanted to study some more practical aspects by trying to determine the acaricide 
resistance status and cross-resistance patterns in this species in several strains collected in the 
field. 
Chapter I provides an overview of the taxonomy, biology and pest status of T. urticae. The 
known mechanisms of resistance to insecticide and acaricides are discussed with emphasis on 
mechanisms conferring resistance in the two-spotted spider mite.  
Pyrethroids are currently widely used insecticides/acaricides and many pest species have 
developed resistance to them. Therefore, the resistance mechanisms responsible for resistance 
to an important pyrethroid acaricide, bifenthrin, in T. urticae were investigated. Chapter II 
focuses on the resistance-associated mutations in the T. urticae para sodium channel, the 
target site of pyrethroids. Sequence characteristics and phylogeny of a partial cDNA fragment 
of the T. urticae sodium channel and its alternative splicing variants are presented. 
Next to pyrethroids, organophosphates still occupy a dominant position as crop protection 
chemicals. Despite the fact that organophosphates are usually not used directly as acaricides, 
spider mites are frequently exposed to them while crops are treated against insect pests. The 
mechanism of resistance to organophosphates in two-spotted spider mite and its consequences 
are presented in Chapter III. Several point mutations in the T. urticae acetylcholinesterase 
conferring resistance to organophosphates and carbamates and also a highly developed 
sensitive monitoring technique based on the PCR-RFLP are discussed.  
To overcome the problem of resistance in spider mites, one of the best approaches is the 
judicious use of new chemistries with novel mode of actions. If it were possible to predict 
likely resistance mechanisms to novel acaricides before they evolve, it might lead to more 
effective management strategies. Spirodiclofen differs from other acaricides in its chemical 
structure and biochemical mode of action. It inhibits lipid biosynthesis, possibly through 
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inhibition of acetyl-CoA carboxylase (ACCase). No field resistance to spirodiclofen has been 
reported up till now. The results of a large number of experiments trying to elucidate 
spirodiclofen resistance, using a strain which has been selected for spirodiclofen resistance in 
the laboratory, are presented in Chapter IV. First, the results of crossing experiments, 
biochemical assays and cDNA sequences in spirodiclofen resistant and susceptible strains are 
discussed, followed by results on the in vitro expression of the spirodiclofen target site, 
ACCase, in insect cell lines and bacteria. Expression of the target genes in model systems can 
be an essential step in elucidating resistance mechanisms at the molecular level, since the 
functionality of reported field mutations can be mimicked by site directed mutagenesis in 
vitro and their effect on acaricide binding can be quantified. 
Results of the survey on the acaricide resistance status in T. urticae populations collected 
from cut roses in greenhouses were presented in Chapter V. Details on the toxicity of 10 
commercially important acaricides on a large number of T. urticae strains, the activities of 
detoxifying enzymes and the presence of resistance-associated point mutations in the 
collected strains are discussed and practical advice is given concerning the future use of some 
of the tested compounds. 
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1 TWO-SPOTTED SPIDER MITE 
 
1.1 Classification 
 
Kingdom: Animalia 
Phylum: Arthropoda 
Subphylum: Chelicerata 
Class: Arachnida 
Subclass: Acari 
Superorder: Acariformes 
Order: Trombidiformes 
Suborder: Prostigmata 
Superfamily: Tetranychoidea 
Family: Tetranychidae 
Subfamily: Tetranychinae 
Genus: Tetranychus 
Species: T. urticae 
(Lindquist et al. 2009) 
 
The subclass of the Acari, or mites and ticks, are a very diverse group of arthropods which 
form the bigger part of the class Arachnida (which also comprises scorpions, spiders and 
harvestman) (Zhang 2003, Lindquist et al. 2009). They have colonized any terrestrial and 
aquatic habitat capable of supporting life. Up till now, approximately 55,000 acarine species 
have been described but the estimated numbers of extant species vary from 500,000 to 
1,000,000. Described acarine species are classified in 5500 genera, 540 families, 124 
superfamilies and 6 orders (Krantz 2009).  
The two-spotted spider mite (TSSM), Tetranychus urticae, is a member of the family 
Tetranychidae or spider mites. Tetranychids are obligatory phytophagous mites and are 
unique in having greatly elongated movable cheliceral stylets which are used to puncture 
individual cells of their host plants (Walter et al. 2009). The family Tetranychidae is a large 
family, including 1250 species belonging to 73 genera. It also is undoubtedly the most 
important family of mites attacking plants (Zhang 2003, Vacante 2010). Well known 
economically important pests belonging to this group are T. urticae, the fruit tree red spider 
mite Panonychus ulmi and the citrus red spider mite Panonychus citri. TSSM is also known 
Chapter I____________________________________________________________________  
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as the red spider mite because of the red/ orange colour of the overwintering form, and as the 
glasshouse spider mite, due to its importance in protected crops (Jeppson et al. 1975, Zhang 
2003). 
The taxonomic placing of T. urticae has been an issue of debate for the past few decades and 
as many as 44 synonymous names are used for this species (Bolland et al. 1998). Although 
interspecific matings have been reported between T. urticae and some closely related species, 
some of which resulted in viable F1 females, F2 eggs cannot hatch  possibly due to a post-
zygotic reproductive barrier (Ben-David et al. 2009). 
1.2 Developmental biology 
The TSSM has five life stages i.e. egg, larva, protonymph, deutonymph and adult. The 
spherical, semi-translucent eggs are often deposited on the underside of leaves. As the embryo 
develops, the eggs become opaque and yellow. Prior to hatching, the red eye spots of the larva 
are visible. The yellowish six-legged larval stage is followed by two yellowish green eight-
legged nymphal stages, the protonymph and deutonymph. Adult females are about 0.5 mm 
long, pale yellow, greenish or straw-coloured, with two characteristic lateral dark green to 
black spots which are the result of an accumulation of food material in the digestive tract 
(summer form). Only female adults overwinter. In autumn, due to shorter photoperiod, lower 
temperatures and declining food supply, they become orange or red and lose their dark body 
spots (non-feeding overwintering form). In spring, females leave their overwintering places, 
start to feed, loose their red colour and start egg deposition. Males are about 0.3 mm long, 
with a narrower, more pointed abdomen. At the end of each active larval and nymphal stage, 
there are quiescent phases called nymphochrysalis (=protochrysalis), deutochrysalis and 
teliochrysalis. During these periods, mites anchor to a leaf or to their webbing, to prepare 
moulting (Crooker 1985).  
Reproduction is arrhenotokous parthenogenesis. Males are haploid and develop from 
unfertilized eggs, whereas females are diploid and develop from fertilized eggs. Unmated 
females give rise only to males, while mated females can produce both female or male 
progeny. The sex ratio is three females: one male (Helle and Sabelis 1985). Male adults 
emerge earlier than females. The males await the emergence of the female adult and often 
help them to free themselves from exuvia. Immediately after emergence, copulation takes 
place (Mitchell 1973, Potter et al. 1976). 
The life cycle of spider mites is driven by temperature, as is the case in most arthropods. 
Table 1.1 provides a summary of the effect of temperature on a number of biological traits of 
TSSM. Females and males have a similar total developmental time at 15 and 20°C, but at 
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higher temperatures males develop faster. The duration of the life stages decreases with 
increasing temperature up to 30°C (Bounfour and Tanigoshi 2001).  
1.3 Host plants and damage 
Among spider mites, T. urticae is the most polyphagous species. It causes significant yield 
losses globally in many cultivated crops, both in the field and greenhouses (Jeppson et al. 
1975). A recent checklist of host plants of TSSM includes more than 1000 species (Bolland et 
al. 1998, Zhang 2003, Migeon and Dorkeld 2010). TSSM is an economically important pest 
in protected vegetable crops, especially in Solanaceae (e.g. tomatoes, eggplant, pepper) and 
Cucurbitaceae (e.g. cucumbers, squashes), and greenhouse ornamentals (e.g. roses, 
chrysanthemum, carnations, azalea). It is also a major pest in annual field crops such as 
maize, soybean and sugar beet, and in perennial cultures like alfalfa, strawberries, grapevines, 
citrus, apples, pears, almonds, plums, maples and elms. 
 
Table 1.1 Developmental duration, sex ratio, life table parameters, longevity and oviposition rates for 
T. urticae at four constant temperatures (mean± SEM) (Bounfour and Tanigoshi 2001) 
Temperature, °C Life stages or parameters 15 20 25 30 
Developmental duration in days     
 egg  10.18±0.28 6.56±0.17 3.06±0.08 2.7±0.08 
 larva  2.52±0.09 1.63±0.07 1.14±0.09 0.75±0.06 
 nymphochrysalis  2.65±0.07 1.32±0.09 0.98±0.07 0.59±0.03 
 protonymph  2.57±0.11 1.36±0.09 1.63±0.11 0.82±0.04 
 deutochrysalis  2.41±0.11 1.37±0.09 1.85±0.12 0.54±0.04 
 deutonymph  2.38±0.06 1.69±0.11 1.97±0.11 0.78±0.09 
 teliochrysalis  2.47±0.07 1.94±0.11 2.22±0.12 0.64±0.04 
 total - female  25.3±0.55 16.0±0.44 13.9±0.37 7.4±0.27 
 total - male  24.9±0.64 15.9±0.49 10.7±0.45 6.0±0.30 
Sex ratio      
 proportion of female 65% 63% 65% 63% 
Life table parameters      
 net reproductive rate R◦ 24.66 80.99 54.86 86.01 
 capacity of increase rc 0.082 0.149 0.174 0.259 
 intrinsic rate of increase rm (day-1) 0.084 0.166 0.188 0.321 
 cohort generation time, Tc (days) 39.28 29.53 22.97 17.19 
 mean generation time T (days) 38.29 26.48 21.25 13.86 
Longevity and oviposition       
 female longevity 22±1.4 26.9±0.8 20.9±1.1 17.1±1.63 
 total eggs per female 38.1±2.9 124.7±4.6 92.8±6.4 121.2±12.4 
 eggs per female per day 1.7±1.08 4.6±0.12 4.4±0.17 7.1±0.18 
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All moving stages of the TSSM feed actively on the lower leaf surface by piercing epidermal 
cells with their cheliceral stylets, after which they consume the protruding cell fluid. The 
upper surface of the leaf develops a characteristic whitish or yellowish speckling. These 
speckles may join and become patches and turn reddish-brown as the damage intensifies. 
Heavy damage results in complete defoliation, and the plant may die prematurely (Devine et 
al. 2001).  
TSSM has been an important agricultural pest since 1900 (van de Vrie et al. 1972). Recently 
dramatic crop losses caused by TSSM have been described in Europe, as exemplified by the 
outbreak in Belgium sugar beet fields in 1996 (Legrand et al. 1997). In heavy infestations the 
crop loss reached to 60 percent (AGRIS 1997, Carbonelle et al. 2007). 
Considering that TSSM becomes more destructive during dry and hot weather conditions, due 
to its increase in feeding activity and reproductive rate (Weidhaas 1979), global warming and 
climate change may lead to an increase in outbreaks and host plant damage and a wider 
geographical distribution. There are already some reports on the northward expansion of 
TSSM distribution area in Western Europe (Carbonelle et al. 2007). 
The control of TSSM is achieved mainly through the use of biological and chemical methods 
in integrated pest management programs. Today biological control, for the bigger part by 
means of predatory phytoseiid mites, is widely used and successful in protected crops. 
However, the use of acaricide based chemical control still is a necessity, especially in field 
crops where biological control has not been adopted yet and for correcting biological control 
failures in protected crops (Zhang 2003, Vacante 2010). 
Managing TSSM and other spider mites is becoming more and more difficult due to the 
decreasing number of registered acaricides and the quick development of resistance to many 
important acaricides.   
 
2 PESTICIDE RESISTANCE 
2.1 Magnitude and definition 
Arthropod pests cause enormous annual losses in crop production worldwide and are able to 
transmit a number of infectious diseases. Pesticides play a key role in their management. 
However, frequent application of pesticides on the same pest population may lead to pesticide 
resistance, one of the most serious obstacles and challenges for effective pest control today. 
Since the first report on resistance development to lime sulphur in 1908 (Melander 1914), 
pesticide resistance in arthropods has occurred and is still occurring with an ever increasing 
frequency, both in numbers of species and pesticides affected. While in the early 1950s 
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resistance was still a relatively rare phenomenon, since the late 1980s, on the contrary, fully 
susceptible insect populations are becoming hard to find. The database on arthropod pesticide 
resistance (http://www.pesticideresistance.org) indicates that currently over 570 species of 
insects and mites have developed resistance to one or more insecticides and acaricides, often 
belonging to the major classes of active ingredients (Whalon et al. 2010). Pesticide resistance 
poses serious economic and public health problems because it compromises agricultural 
production and causes outbreaks of vector-borne diseases. It also results in an increased 
pesticide use, higher environmental contamination and disruption of wildlife and natural 
enemies, leading to disturbances in ecosystems (Georghiou 1986).  
Pesticide resistance has been defined as “the inherited ability in a target population to tolerate 
doses of toxicant that would prove lethal to a majority of individuals in a normal population 
of that species” (National Research Council 1986). Tabashnik et al. (2009) defined resistance 
as “a heritable decrease in susceptibility of a population to a toxin caused by exposure of the 
population to the toxin”. These definitions do not imply loss of economic efficacy in the field, 
yet another definition provided by Whalon and McGaughey (1998) states that resistance “is a 
microevolutionary process of genetic adaptation in response to pesticides that can result in 
unique and often more difficult management challenges”.  
Arthropods commonly exhibit different levels of resistance to a range of insecticides. A 
situation where resistance to a pesticide by a pest population results in resistance to a second 
pesticide or group of pesticides without having been exposed to them is called cross-
resistance. In this phenomenon a single gene or mechanism confers resistance to more than 
one pesticide. When two or more different resistance mechanisms (each affecting different 
groups of chemicals) are involved in the same individual or pest population, it is called 
multiple resistance (Georghiou 1986, Stenersen 2004). Biochemical tests are required to 
determine whether or not a mechanism is conferring cross-resistance to the tested insecticides 
or several mechanisms are conferring multiple-resistance (Perez et al. 2009).  
2.2 Resistance mechanisms 
Although there are thousands of arthropod pest species and a wide variety of pesticides, the 
number of processes known to cause resistance to pesticides is limited to a very few types. 
These mechanisms involve either the reduction of the effective dose of the pesticide that 
reaches the target site (pharmacokinetically derived resistance) or the modification of the 
target site itself (pharmacodynamically derived resistance) or a combination of the two. Well 
demonstrated mechanisms such as behavioural avoidance, reduced penetration through the 
cuticle, enhanced excretion, sequestration and detoxification all contribute to decrease the 
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dose of the pesticide that finally reaches the target site. Alternatively, target site 
modifications, will contribute to render a dose of pesticide ineffective through reduced 
sensitivity of the target site by point mutations or by reducing or increasing the quantity of 
target site (Feyereisen 1995). These two types of resistance mechanisms are generally referred 
to as metabolic resistance (increased pesticide detoxification) and target site insensitivity 
(alterations to the pesticide target site). In both, several biochemical mechanisms are 
involved. Other mechanisms are generally considered to play a minor role or to arise only 
under very specialized conditions (Denholm and Devine 2001). Depending on the mechanism 
involved, three general types of genetic changes can result in resistance: a gene may be 
amplified, the expression of a gene may be altered, or a structural alteration in a gene 
encoding target site proteins or detoxifying enzymes can result in resistance (Scott 1995). 
2.2.1 Metabolic resistance  
Metabolic resistance can be caused by interference with three major enzyme systems: 
cytochrome P450 mono-oxygenases (P450s), esterases, and glutathione S-transferases 
(GSTs). These enzymes act by actively degrading the pesticide to non-toxic products, or by 
binding rapidly to the pesticide (sequestration), combined with very low degradation activity. 
Metabolically resistant strains possess enzymes that are quantitatively and/or qualitatively 
different from the enzymes of the susceptible strains (Hemingway et al. 1998). 
Cytochrome P450 enzymes are best known for their mono-oxygenase activity, catalyzing the 
transfer of one atom of molecular oxygen to a substrate and reducing the other to water. 
P450s catalyse a variety of detoxification reactions in virtually all living organisms and can 
potentially confer resistance to most chemical classes. Biochemical changes in P450 structure 
or activity can lead to changes in insecticide activation or inactivation. To date, in a few 
instances gene amplification contributes to P450-mediated resistance (Wondji et al. 2009, 
Puinean et al. 2010), but other molecular mutations (structural, up- or down-regulation) are 
frequently involved. The first indirect lines of investigation for this mechanism have been the 
use of mono-oxygenase inhibitors (e.g. piperonyl butoxide, PBO) and the measurement of 
metabolic breakdown of selected model substrates. However, metabolic studies with the 
insecticide itself in the resistant strain are more conclusive. Recently, genomic information 
has been used to search for differences in the P450 gene structures and expression between 
susceptible and resistance strains (Feyereisen 2005, Li et al. 2007, Hollingworth and Dong 
2008). 
Esterases are a large group of enzymes able to hydrolyze ester bonds in the presence of water. 
Many widely used insecticides contain ester bonds, including virtually all organophosphates 
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and carbamates, most pyrethroids, and other compounds belonging to different chemical 
groups (i.e. acequinocyl, spiromesifen, fluacrypyrim and bifenazate). Esterases are frequently 
implicated in insecticide resistance through gene amplification, upregulation, coding sequence 
mutations, or a combination of these mechanisms (Li et al. 2007, Hollingworth and Dong 
2008). The majority of esterases which function by sequestration are overproduced through 
gene amplification. Point mutations within structural genes produce esterases with an 
enhanced capability for increased metabolism.  Finally, mutations in regulatory genes may 
also cause the over-expression of these enzymes resulting in an enhanced capacity for 
metabolizing insecticides (Oakeshott et al. 2005a, Wheelock et al. 2005, Li et al. 2007, 
Hollingworth and Dong 2008). 
Glutathione S-transferases are a diverse family of multifunctional enzymes that enhance the 
conjugation of electrophilic sites of xenobiotics with the thiol group of reduced glutathione 
(GSH), generally resulting in GSH conjugates which are less toxic and more water soluble 
and excretable than the non-GSH conjugated substrates. Increases in the amount of one or 
more GST enzymes have been implicated in resistance to all the major classes of insecticides, 
either as a result of gene amplification or more commonly through increases in transcriptional 
rate, rather than through qualitative changes in individual enzymes. GSTs are also involved in 
other reactions besides conjugation. Dehydrochlorination of DDT to the noninsecticidal 
metabolite DDE is catalyzed by GSTs as a cofactor (Enayati et al. 2005, Ranson and 
Hemingway 2005, Li et al. 2007). GSTs also play a very important role in conferring 
resistance to pyrethroid insecticides in Nilaparvata lugens through detoxifying lipid 
peroxidation products induced by pyrethroids and protecting tissues from oxidative damage 
(Vontas et al. 2001). 
2.2.2 Target site resistance  
A change in the target protein that decreases the pesticide binding or activity results in target 
site resistance. Point mutations leading to alterations of critical amino acids responsible for 
insecticide binding cause the insecticide to be less effective or even ineffective. 
Overproduction of target molecules, as is sometimes recorded for herbicides or drugs, is not 
commonly reported in arthropods. Despite the potential complexity and/or large size of the 
target site receptors or enzymes, a limited number of resistance associated amino acid 
substitutions can cause a sufficient resistance while retaining an adequate physiological 
function of the receptor or enzyme. Hence, identical amino acid substitutions are commonly 
found across diverged taxa (ffrench-Constant et al. 1998, Hollingworth and Dong 2008). 
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Generally, insecticide target molecules are functionally important and therefore knockout 
mutations in target molecules will tend to be lethal. However, there are few reports that the 
insecticide target site is not essential for the insect’s survival and a knockout mutation in a 
target molecule results in insecticide resistance (Baxter et al. 2010). For example, mutations 
resulting in a non-functional cadherin protein are an important mechanism for Cry1Ac 
resistance in some Bt resistant lepidopteran pests (Gahan et al. 2001, Zhao et al. 2010). 
The genes encoding for the historically important targets of conventional insecticides are: Rdl, 
which encodes a γ-aminobutyric acid receptor subunit (RDL) as the target site of cyclodiene 
insecticides; para, which encodes for a voltage-gated sodium channel, target site of DDT and 
pyrethroids; and Ace, which encodes for insect acetylcholinesterase (AChE), target site of 
organophosphorus and carbamate insecticides. An alanine 302 to serine replacement within 
RDL confers resistance to cyclodienes in a wide range of insect species (ffrench-Constant et 
al. 2000). So far, about 26 mutations in sodium channel genes have been found to be 
responsible for pyrethroid resistance in different insect and arachnid pest species (Soderlund 
2005, Dong 2007). Several point mutations in the AChE genes are known to provide 
decreased sensitivity to inhibition of the enzyme by organophosphate and carbamate 
insecticides. Each mutation in the AChE provides a specific resistance pattern, sometimes 
conferring resistance to one insecticide while increasing sensitivity to another (Fournier 
2005). 
2.3 Detecting and characterizing resistance  
Detecting and monitoring resistance and understanding its biochemical and molecular 
mechanisms have a practical use both in resistance management and the search for new 
pesticides. Although several laboratory methods are available for detecting and characterizing 
resistance, bioassays still remain the main component of most resistance monitoring 
programs, certainly where resistance mechanisms have not been identified. Since bioassays 
are resource-intensive, rapid and more incisive biochemical and molecular assays can be used 
in monitoring and also diagnosing the type of resistance mechanism present. A variety of 
biochemical methods have been adopted for unravelling the mechanisms and detection of 
resistance, including electrophoretic or immunological detection of detoxifying enzymes, 
kinetic and end-point assays for quantifying the activity of enzymes or their inhibition by 
insecticides. In cases where the molecular mechanisms of resistance are known and the 
underlying DNA changes identified, DNA-based diagnostics for mutant resistant alleles is an 
available option. Point mutations, deletions, and inversions can all be detected through 
designing allele-specific probes and PCR primers (Denholm and Devine 2001, Hollomon 
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2002, Black and Vontas 2007). Although most of the genes encoding for the targets of 
conventional insecticides have been identified in important pest species, recent advances in 
insect genomics now facilitate the identification of new resistance genes and also (whole 
genome) expression microarray data further unravels complex detoxification pathways 
(Hemingway et al. 2002, ffrench-Constant et al. 2004). The discovery of resistance-associated 
mutations can be also facilitated by new generation  genome/transcriptome sequencing 
technologies (Vontas et al. 2010). 
2.4 Genetics of insecticide resistance  
Resistance is a heritable trait and under genetic control. In population genetics of resistance 
some aspects are critical for the formulation of resistance management strategies such as the 
expression of resistance (i.e. dominant vs. recessive), whether the resistance is monogenic or 
polygenic, and how many independent origins they have.  
Generally crossing experiments are used to determine whether the resistance is sex-linked or 
autosomal and whether the resistance trait is dominant, recessive or intermediate. Such 
procedures are carried out using crosses between the resistant and susceptible strains in 
reciprocal directions. Bioassays on offspring resulting from backcrosses between F1 progeny 
and the most phenotypically different parent can provide insights in the number of genes 
involved. Economically important cases of insecticide and acaricide resistance have been 
usually due to a single dominant or semi-dominant gene. However, the number of resistance 
genes depends on whether selection acts within or outside of the phenotypic distribution of 
the susceptible population. The doses applied in the field are designed to kill every individual 
(selection outside the normal range of the physiological distribution), whereas repeated 
selection in the laboratory necessitates at least some survivors and uses doses at 80-90% 
mortality (selecting within the normal physiological distribution). Most laboratory strains 
selected continuously from small genetically-uniform populations, show polygenically 
inherited resistance, whereas most resistant field strains show monogenic resistance (Roush 
and McKenzie 1987, ffrench-Constant et al. 2004). Although polygenic resistance in field 
situations may be less common than monogenic resistance, there are some well known cases 
of polygenic resistance. Resistance through a high frequency of major resistance genes in 
field populations may result rather from the very strong selection than from an inherent bias 
in genetic potential. The response observed in the field depends on how the variation is 
screened. The intent of new methods of pesticide application to lower the effective intensity 
of selection may increase the incidence of polygenic resistance (Via 1986, McKenzie 2000). 
Furthermore, when a gradual selection is operating in the range of an existing genetic 
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variation, a series of resistance genes may evolve, and will lead to polygenic resistance 
(Gassmann et al. 2009). 
Insecticide resistance is believed to be the result of the natural selection of pre-existing forms 
that possess genetically controlled mechanisms conferring some degree of resistance. 
Insecticides, at recommended application rates, often are not mutagenic; therefore it is 
supposed that resistance associated mutations occur independently of insecticide application. 
Despite that, the pre-adaptative nature of resistance evolution is a well established hypothesis 
(Crow 1957, Hartley et al. 2006), it was also stated that insecticides might increase mutation 
rates (post-adaptive), especially with regard to amplified resistance genes. However, no 
substantial data have been provided to test this hypothesis (Devonshire and Field 1991, 
ffrench-Constant 2007). Resistance alleles may arise once and spread globally or arise several 
times independently at different locations. Both hypotheses, single or multiple origins, have 
been supported by DNA sequence data flanking the insecticide associated mutations (Andreev 
et al. 1999, Daborn et al. 2002, ffrench-Constant et al. 2004). 
2.5 Selection of resistance genes  
Resistance does not evolve at the same rate for all organisms; it may develop rapidly in one 
species and more slowly in another. The rate at which resistance genes are selected reflects 
the combined influences of many factors which, for convenience, can be classified into factors 
relating to the intrinsic properties of pests and resistance mechanisms within these pests 
(genetic and ecological) and factors relating to the chemical itself and how it is applied 
(operational). Georghiou and Taylor (1986) classified these influencing factors as shown in 
Table 1.2. 
One of the important factors influencing the strength of selection and stability of resistance is 
the relative fitness of susceptible and resistant genotypes. Despite the advantages they confer 
under exposure to insecticides, with few exceptions, resistance genes confer lower fitness than 
their susceptible counterparts. This could lead to counterselection when insecticides are not 
applied. Continued selection may improve fitness through coadaptation of the resistant 
genome, i.e., the integration of resistance genes with other modifier loci that ameliorate 
fitness costs, resulting in more stable resistance (Georghiou and Taylor 1986, Denholm and 
Devine 2001). The fitness estimates have to be obtained for resistant and susceptible 
genotypes as functions of stage in the life cycle and concentrations of pesticides and it is 
necessary to check for a variety of other environmental and genetic factors such as 
temperature, season, physiological state, population density, and genetic background 
(Georghiou and Taylor 1986). In many cases the strength of the selection pressure of 
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insecticides is far greater than the counterbalancing selection imposed by fitness costs 
(Gassmann et al. 2009). 
 
Table 1.2 Known or suggested factors influencing the selection of resistance to insecticides in field 
populations (Georghiou and Taylor 1986) 
 
A. Genetic 
a. Frequency of R alleles 
b. Number of R alleles 
c. Dominance of R alleles 
d. Penetrance, expressivity, 
interactions of R alleles 
e. Past selection by other 
chemicals 
f. Extent of integration of R 
genome with fitness factors 
 
B. Biological/Ecological 
1. Biotic 
a. Generation turnover 
b. Offspring per generation 
c. Monogamy/polygamy, 
parthenogenesis 
2. Behavioural/Ecological 
a. Isolation, mobility, migration 
b. Monophagy/polyphagy 
c. Fortuitous survival, refugia 
 
C. Operational 
 1. The chemical 
a. Chemical nature of pesticide 
b. Relationship to earlier-used 
chemicals 
c. Persistence of residues, 
formulation 
 2. The application 
a. Application threshold 
b. Selection threshold 
c. Life stage(s) selected 
d. Mode of application 
e. Space-limited selection 
f. Alternating selection 
 
2.6 Managing insecticide resistance in arthropods 
The aim of insecticide resistance management (IRM) is to reduce the deleterious impact of 
resistance on pest management through the implementation of strategies for overcoming 
resistance to currently used compounds or preventing its development to existing or new 
compounds. Resistance management tactics should be aimed at reducing allele frequencies, 
reducing dominance, and minimizing the fitness of resistance genotypes. Between the factors 
influencing resistance selection, only operational factors can be manipulated. There are 
several practical, economic, and political constraints on the choice of possible IRM tactics 
(Leeper et al. 1986, Denholm and Rowland 1992). Different tactics have yet been suggested, 
such as the use of insecticide mixtures or high doses, and alternation of insecticides, while 
keeping in mind the mode of action of the compounds. However, all strategies depend first 
and foremost on methods to reduce the selection pressure of the insecticide on the target pests. 
In theory, resistance development can be delayed either by reducing the mortality of 
susceptible homozygotes or by overpowering resistant insects before they become too 
common. The first can be achieved by decreasing overall exposure or by lowering application 
rates. Simulations performed based on this theory do not usually predict significant delays. 
The second can be applied using doses of insecticides that are at least high enough to kill 
heterozygotes, but this theory is only applicable when heterozygotes are not highly resistant 
and the resistant genes are rare. Susceptible migrants also are essential to dilute resistance 
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among any individuals that survived the high dose (Roush and McKenzie 1987, Denholm and 
Rowland 1992).  
On cotton in Israel and southwestern USA, a dramatic reduction in the number of insecticide 
applications was achieved after implementing resistance management programs for Bemisia 
tabaci based on a combination of increased chemical diversity, voluntary or mandatory 
restrictions on the use of key insecticides, and integration of non-chemical pest-management 
options (Denholm et al. 1998). In the Australian cotton industry, a large-scale IRM strategy 
was introduced in 1983, when pyrethroid resistance in H. armigera resulted in unsatisfactory 
control in the field. The program was primarily based on insecticide rotation and resulted in 
the delay of the rate of pyrethroid resistance evolution but not in its prevention (Andow et al. 
2008). 
 
3 ACARICIDE RESISTANCE IN THE TWO-SPOTTED SPIDER MITE 
Resistance of mites and ticks to pesticides is a widespread and growing problem. The 
intensive use of acaricides has resulted in a rapid selection of resistant populations - more 
than 70 mite and tick species have now shown resistance to the chemicals used for their 
control, summing up to 1102 documented resistance cases in the Arthropod Pesticide 
Resistance Database (APRD) (Whalon et al. 2010). T. urticae has developed resistance to 
over 91 different acaricides and can be considered as the most resistant species among all 
arthropod pests. A high level of resistance can develop as fast as one to four years after 
introduction of a new chemical. This resistance is often accompanied with a high degree of 
cross-resistance. The high reproductive potential, their extremely short life cycle and 
arrhenotokous reproduction, combined with the frequent acaricide applications usually 
required to maintain the population below economic threshold, facilitates rapid resistance 
build-up. Its ability to develop resistance to nearly all acaricides used for its control and its 
global distribution, make it one of the most notorious agricultural pests in the world (Cranham 
and Helle 1985, Croft and van de Baan 1988).  
3.1 Effect of arrhenotoky on TSSM resistance 
The arrhenotokous reproduction is a special feature which can help in accelerating resistance 
evolution no matter whether it is dominant or recessive (Croft and van de Baan 1988). 
Because of male haploidy, the situation occurs that mutations are immediately expressed in 
the male, without respect to whether they are dominant or recessive. These characteristics can 
be added quickly to the population through natural selection (Helle and Overmeer 1973, 
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Denholm et al. 1998). Therefore the potential for development of genetic resistance to 
insecticides and acaricides in TSSM can be greatly enhanced by this method of reproduction. 
The resistance development rate is much lower in diploid populations than haplodiploid 
populations when the resistance trait is recessive or partially recessive (Denholm et al. 1998). 
However, this theory was based on the assumption that R males and RR females are equally 
tolerant to pesticides. Using simulations considering between-sex differences in pesticide 
tolerance, Carriere (2003) concluded that resistance evolves at a slower rate in haplodiploid 
populations, if resistant diploid females are more tolerant to a pesticide than resistant haploid 
males. For resistant strains of TSSM, this author reported a ratio of male to female tolerance 
of 0.002 to 0.85 against the tested acaricides such as dicofol, oxydemeton-methyl and 
propargite.  
3.2 Acaricide chemistry and mode of action  
Acaricides, which are chemical compounds used to control Acari, belong to different 
chemical groups, with different modes of action (Figure 1.1). Among the oldest recorded are 
sulfur, lime sulfur and petroleum oils. Dinitrophenol was the first synthetic organic 
compound, widely used between 1930 and 1950. From 1940 on, a large number of acaricides 
belonging to different chemical categories, such as dithiocarbamates, diphenyl carbinols, 
organochlorines, the sulfur-bridged, organotins, formamidines, organophosphates, 
carbamates, pyrethroids, benzoylphenylureas, abamectin, tetronic acid derivatives and other 
substances were developed, registered and commercialized (Knowles 1997, Vacante 2010). 
Historically, comparable to insecticides and antihelmintics, the vast majority of acaricides 
were neurotoxic compounds, such as organophosphates, pyrethroids and avermectins (Lees 
and Bowman 2007). A number of these neurotoxins are not used anymore at the moment and 
have been taken out of the market. More recently, several new and structurally diverse 
acaricides were developed which inhibit mitochondrial respiration. These include acaricides 
belonging to a wide range of chemistries: pyridazines, pyrazoles, quinazolines, 
naphthoquinones, pyrroles, thioureas and pyrimidines. Other compounds, like 
benzoylphenylureas, tetrazines, tetronic acids and oxazolines, effectively affect growth and 
development (Dekeyser and Downer 1994, Dekeyser 2005, Lees and Bowman 2007). 
Based on the biological mode of action, acaricides can be divided into three classes: 
chemicals that are primarily toxic to eggs (ovicides), those showing high toxicity to larvae 
(larvicides), and others having toxicity to all motile stages. 
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Figure 1.1 Chemical structure of some acaricides, DDT (a), dicofol (b), carbaryl (c), methomyl (d), 
chlorpyrifos (e), pirimiphos-methyl (f), dimethoate (g), azinphos-methyl (h), phosmet (i), bifenthrin 
(j), fluvalinate (k), fenpropathrin (l), spirodiclofen (m) 
(a) 
(c) 
(d) 
(e) 
(f) 
(g) 
(h) 
(i) 
(b) 
(j) 
(k) 
(m) 
(l) 
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3.3 Resistance mechanisms in the T. urticae 
Cranham and Helle (1985), Knowles (1997), Van Leeuwen et al. (2009) and more recently 
Van Leeuwen et al. (2010a) have reviewed acaricide resistance in spider mites. 
Organophosphates and carbamates (acetylcholinesterase inhibitors) on one hand and 
pyrethroids on the other hand were widely used insecticides/ acaricides and in this thesis 
major emphasis is placed on those, together with the new class of tetronic acids. 
3.3.1 Resistance to acetylcholinesterase inhibitors 
Acetylcholinesterase (AChE; EC 3.1.1.7) is a key enzyme in the insect central nervous system 
(CNS) which terminates nerve impulses by catalyzing the hydrolysis of neurotransmitter 
acetylcholine (Ach) in the synapse. Irreversible inhibitors of AChE like organophosphates and 
carbamates block this enzyme, causing a disruption of the hydrolysis, resulting in over-
excitation of the nervous system and finally death (Menozzi et al. 2004). They phosphorylate 
or carbamoylate the active-site serine leading to inhibition of the enzyme. This results in an 
accumulation of acetylcholine at nerve synapses which in turn leaves the acetylcholine 
receptors permanently open, resulting in the paralysis and death of the insect (Oakeshott et al. 
2005a). 
Metabolic resistance to organophosphate and carbamate insecticides has been associated with 
an elevation in the activity of a number of detoxification systems. Most frequently, resistance 
to these insecticides has been correlated with elevated esterase activity. The esterase-mediated 
metabolic resistance involves degradation or sequestration of the pesticides by mutant or 
overexpressed carboxylesterases (Oakeshott et al. 2005b). Glutathione S-transferases and 
P450 mono-oxygenases have also been frequently associated with OP resistance. However, 
modified AChE has been reported as the main mechanism of resistance since the first report 
of insensitive AChE to organophosphates in T. urticae (Smissaert 1964). Most insects and 
acarines have two AChEs encoded by two genes, but only one is responsible for neural 
acetylcholine hydrolysis and its inhibition causes the death of the organism. It is also this one 
in which one mutation or a combination of mutations are linked to the resistance to 
organophosphate and carbamate insecticides (Fournier 2005, Oakeshott et al. 2005a). 
Increased AChE production was also found to have contributed in resistance (Charpentier and 
Fournier 2001). The role of AChE gene duplication in organophosphate resistance and the 
reduction of the fitness cost associated with the resistant allele have been documented in the 
mosquito Culex pipiens (Labbe et al. 2007).  
Spider mites, like insects, can become resistant to organophosphates and carbamates by 
insensitive AChE (Stumpf et al. 2001) caused by several amino acid substitutions that will be 
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discussed in the chapter 3. Recently, Kwon et al. (2010a) reported that resistance to 
organophosphates has evolved through a combination of mutation accumulation and extensive 
gene duplication which is actively involved in the increasing level of resistance in T. urticae 
field populations. Enhanced detoxification enzyme activity may also be involved in 
organophosphate resistance in spider mites. Enhanced carboxylesterase activity was reported 
to confer organophosphate resistance in two American strains of T. urticae, the Blauvelt strain 
(Matsumura and Voss 1964) and Niagara strain (Herne and Brown 1969). Kwon et al. 
(2010d) reported a significant increase in P450 activity, suggesting that oxidative metabolism 
is likely involved in monocrotophos resistance in the two-spotted spider mite. Ay and 
Yorulmaz (2010) suggested that esterase enzymes may be playing a minor role in chlorpyrifos 
resistance in a laboratory-selected strain of T. urticae, while glutathione S-transferase and 
P450 enzymes had no effect on chlorpyrifos resistance.  
3.3.2 Resistance to sodium channel modulators 
Voltage-gated sodium channels (VGSC) are well known as the primary target of DDT, 
pyrethrins and pyrethroids. They are integral transmembrane proteins responsible for the 
initiation and propagation of action potentials in almost all excitable cells (Soderlund 2005). 
Pyrethroids, one of the most widely used group of insecticides, cause prolonged opening of 
the channels upon binding to VSCGs primarily by inhibiting channel deactivation, thereby 
stabilizing the open configuration of the activation gate. VGSCs also possess at least nine 
independent toxin-binding sites for a variety of neurotoxins and some insecticides such as 
indoxacarb (Silver et al. 2010). Insect’s VGSC are structurally and functionally homologous 
with the α-subunit of mammalian VGSCs, containing 4 internally homologous domains 
(named I–IV) connected by intracellular linkers, with each domain consisting of 6 membrane-
spanning segments (named S1–S6) joined by intracellular or extracellular loops (Figure 1.2) 
(Davies et al. 2007a, Davies et al. 2007b). Although several (at least nine) different sodium 
channel α -subunits have been identified in mammals, it seems that only one gene encodes for 
the sodium channel in Drosophila and presumably in other insect species (Dong 2007). 
VGSC sequence comparisons between susceptible and pyrethroid-resistant insects and mites 
and functional expression of cloned sodium channels in Xenopus laevis oocytes has provided 
convincing evidence that point mutations in insect voltage-sensitive sodium channel genes are 
the primary cause of pyrethroid resistance (Figure 1.2) (Soderlund and Knipple 2003). 
Involvement of an amino acid substitution (phenylalanine to isoleucine) in domain IIIS6 
(F1538I according to Musca domestica numbering), has been documented in pyrethroid 
resistance in T. urticae (Chapter 2). Kwon et al. (2010b) recently proposed that a leucine to 
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valine (L1025V, Musca domestica numbering) mutation may confer sodium channel 
insensitivity to pyrethroids in a fenpropathrin-resistant T. urticae strain from Korea (Figure 
1.2). Besides target site modification, enzyme-mediated metabolic detoxification through 
elevated levels of mono-oxygenases (Yang et al. 2001, Van Leeuwen et al. 2005), esterases 
(Ay and Gürkan 2005, Van Leeuwen and Tirry 2007) and glutathione-S-transferases (Yang et 
al. 2002, Lin et al. 2009) have been found in pyrethroid resistant spider mites. 
 
Figure 1.2 The schematic diagram of the sodium channel protein indicating four homologous domains 
(I–IV), each having six transmembrane segments. The location of amino acid substitutions occurring 
in the para-sodium channel gene of pyrethroid resistant insects, mites and ticks. Mutations that have 
been documented in insects are indicated by squares and described in the upper part of the figure. 
Mutations that have been documented in Acari are indicated by circles and described below. Open 
squares and circles indicate mutations that have been functionally characterized and confirmed to 
reduce the sodium channel sensitivity to pyrethroids (Adapted from Van Leeuwen T, Vontas J, 
Tsagkarakou A, Dermauw W, Tirry L. 2010. Acaricide resistance mechanisms in the two-spotted 
spider mite Tetranychus urticae and other important Acari: A review. Insect Biochemistry and 
Molecular Biology 40: 563-572).  
 
 
3.3.2 Resistance to acetyl-coenzyme A carboxylase inhibitors 
Inhibitors of acetyl-coenzyme A carboxylase (ACCase), the enzyme responsible for the fatty 
acid biosynthesis, are effective pharmaceuticals, herbicides, fungicides and insecticides. Three 
classes of herbicides including aryloxyphenoxypropionates, cyclohexanediones and 
phenylpyrazolines, target ACCase and have a specific graminicide activity (Muehlebach et al. 
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2007). Based on the IRAC mode of action classification (version 6.3, July 2009) tetronic and 
tetramic acid derivative insecticides such as spirodiclofen, spiromesifen and spirotetramat 
interfere with lipid biosynthesis by inhibiting ACCase. Soraphen A, an inhibitor of ACCase, 
has demonstrated strong promise as a broad-spectrum fungicide against various plant 
pathogenic fungi (Shen et al. 2004). 
ACCase (E.C. 6.4.1.2) is composed of a biotin carboxyl carrier (BCC), biotin carboxylase 
(BC), and carboxyl transferase (CT), and catalyses the synthesis of malonyl-coenzyme A 
which is the substrate required for fat synthesis (Incledon and Hall 1997). Two distinct types 
of this enzyme, a heteromeric and a homomeric, are found in nature. The heteromeric form is 
composed out of four distinct subunits, BCC, BC and two α and β subunits of CT, and usually 
is present in prokaryotes. In contrast, the homomeric form is composed of a large polypeptide 
carrying all functional domains (Sasaki and Nagano 2004). Most plants have both forms, the 
heteromeric form in plastids and the homomeric form in the cytosol. Poaceae (grasses) are an 
exception, since they have the homomeric form in both cytosol and plastids (Figure 1.2). 
Addition of a transit peptide (TP) at the N-terminal end of plastidic and mitochondrial 
homomeric isoform of ACCase (Figure 1.3) likely enables this isoform to be directed to 
chloroplasts and mitochondria (Delye 2005). 
Frequent use of ACCase-inhibiting herbicides has resulted in the development of resistance in 
at least 35 grass species worldwide (Wenger and Niderman 2007). Mechanisms of this 
resistance can be divided in two ACCase-related and metabolism-based mechanisms. In most 
cases, mutations within the CT domain of homomeric plastidic ACCase are involved in 
altered sensitivity to ACCase inhibitors. An L1781I was the first identified resistance 
endowing mutation in the ACCase of resistant grass weeds. Since then, seven other resistance 
substitutions have been identified in ACCase of various grass species (W1999C, W2027C, 
I2041N, I2041V, D2078G, C2088A and G2096A). Of these mutations, L1781I is the most 
common. However, depending on the weed species and type of applied herbicide, particular 
mutations result in high-level to quite low-level resistance (Powles and Yu 2010). 
Metabolism-based resistance involves detoxifying enzymes such as cytochrome P450 mono-
oxygenases, glutathione-S-transferases and glucosyltransferases (Delye 2005, Wenger and 
Niderman 2007). It has been found that a mutation in the BC domain of yeast ACCase renders 
the enzyme resistant to soraphen A (Shen et al. 2004). 
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Figure 1.3 ACCase isoforms in plants. TP, transit peptide; ACC functional domains: BCC, biotin 
carboxyl-carrier; BC, biotin carboxylase; CT, carboxyl transferase. Note that the TP could be 
cleaved after the plastidic ACCase isoform has been imported into the chloroplast (Adapted from 
Delye C. 2005. Weed resistance to acetyl coenzyme A carboxylase inhibitors: an update. Weed 
Science 53: 728-746). 
 
3.4 Cross/multi-resistance in acaricide-resistant T. urticae strains 
Selection for resistance to an acaricide may lead to cross-resistance to others of the same class 
or even other chemical classes (Nauen et al. 2001). Development of cross and/or multi-
resistance to acaricides is a commonly found problem in spider mites on several crops (Van 
Leeuwen et al. 2004, Osakabe et al. 2009). Adequate control of spider mites was impossible 
in 1966 in the Aalsmeer, The Netherlands, because of resistance to organophosphates, 
tetradifon, chlorobenzilate and dicofol. Even 7 years after interrupting the treatments, a high 
proportion of the population was still resistant to dicofol and tetradifon (Overmeer et al. 
1975). Kono (1985) reported that a Japanese dicofol-resistant T. urticae strain showed cross-
resistance to organophosphates and structurally dicofol-resembling acaricides. A dicofol-
resistant T. urticae strain showed positive cross-resistance to amitraz, bromopropylate, and 
chlorobenzilate (Fergusson-Kolmes et al. 1991). Cross-resistance between METI 
(mitochondrial electron transport inhibitor) acaricides is common and can occur very rapidly 
(Stumpf and Nauen 2001, Van Pottelberge et al. 2009a). A strain of T. urticae, collected from 
hops in England with a short history of tebufenpyrad exposure, exhibited high levels of 
resistance to four METI acaricides (tebufenpyrad, pyridaben, fenazaquin and fenpyroximate). 
Similar patterns of resistance inheritance were found and suggested a common mechanism of 
resistance to all the METI acaricides (Devine et al. 2001). However, genetic analysis of a 
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Belgian field strain exhibiting different levels of resistance by Van Pottelberge et al. (2009a) 
revealed differences in the mode of inheritance to these four METI acaricides. 
Cross-resistance was detected in a chlorfenapyr laboratory selected strain to amitraz, 
bifenthrin, bromopropylate, clofentezine and dimethoate (Van Leeuwen et al. 2004). A field-
collected strain from Belgium with resistance to bifenthrin, dicofol and fenbutatin oxide 
showed cross-resistance with clofentezine, dimethoate, chlorfenapyr, bromopropylate, 
amitraz, flucycloxuron and azocyclotin (Van Leeuwen et al. 2005). Nicastro et al. (2010) 
found a significant correlation between the resistance frequencies for milbemectin and 
abamectin in 25 field populations of T. urticae, and concluded there was a positive cross-
resistance for these acaricides. In Australia, clofentezine resistance conferred high levels of 
cross-resistance to hexythiazox (Herron et al. 1993). An etoxazole resistant population 
collected from rose greenhouses in Korea and further selected exhibited resistance to 
acequinocyl, emamectin benzoates, milbemectin, amitraz and pyridaben (Lee et al. 2004). 
Some mutations in the mitochondrial cytb gene can confer cross-resistance between 
bifenazate and acequinocyl, although not all bifenazate resistance-associated mutations 
resulted in acequinocyl cross-resistance (Van Nieuwenhuyse et al. 2009).  
Negative cross-resistance, i.e. the fact that resistance to one compound causes greater 
susceptibility to another, has been reported in some T. urticae resistant strains. Negative 
cross-resistance to chlorpyrifos in a dicofol resistant strain was linked to increased oxidative 
activation of chlorpyrifos (Hatano et al. 1992). In a strain collected from apple orchards in 
New Zealand, it was demonstrated that increasing azinphos-methyl (an organophosphate) 
resistance conferred an increase in fenvalerate (a pyrethroid) susceptibility (Chapman and 
Penman 1979). The etoxazole resistant strain from Korea, which was selected further (Lee et 
al. 2004) showed negative cross resistance to bifenazate. 
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IDENTIFICATION OF PYRETHROID RESISTANCE ASSOCIATED 
MUTATIONS IN THE PARA SODIUM CHANNEL OF THE TWO-SPOTTED 
SPIDER MITE TETRANYCHUS URTICAE (ACARI: TETRANYCHIDAE) 
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1 INTRODUCTION 
 
Tetranychus urticae Koch is an economically important phytophagous and polyphagous mite 
with a worldwide distribution. The species has been heavily exposed to insecticides and 
acaricides, and insecticide-resistant populations have been reported in more than 40 countries 
in both greenhouses and open field crops (Georghiou and Lagunes-Tejeda 1991, Stumpf and 
Nauen 2001, Van Leeuwen et al. 2008). The rapid development of resistance in T. urticae is 
favoured by its high reproductive potential, extremely short life cycle and arrhenotokous 
reproduction. In greenhouses resistance develops even faster due to the relative isolation of 
the mite populations and the extended growing season (Cranham and Helle 1985).  
The pyrethroid bifenthrin, an interesting development in pyrethroid chemistry after the initial 
success of allethrin synthesis, as a result of the replacement of 3-phenoxybenzyl alcohol by 3-
phenylbenzyl alcohol and the introduction of a methyl group at position 2 (Khambay and 
Jewess 2005), is particularly active against mites and has been used extensively for T. urticae 
control in several countries. Bifenthrin resistance was first detected by Farnham et al. (1992),  
in T. urticae  collected from an apple orchard in New York. A number of resistance case 
reports followed, such as the field-caught populations from cotton in New South Wales 
(Resistance Ratio (RR) up to 109 fold (Herron et al. 2001)), the laboratory strains originating 
from cotton plants in Turkey (RR up to 650 fold, Ay and Gürkan 2005) and a strain isolated 
from a greenhouse nursery at Ghent University (RR > 1850 fold, Van Leeuwen et al., 2005). 
Insecticide resistance in insects and mites has been attributed to increased rates of insecticide 
detoxification or mutations in the target sites (Bloomquist 1996, Zlotkin 1999, Soderlund and 
Knipple 2003, Li et al. 2007). Metabolic resistance to pyrethroids has been associated with 
P450 oxidation (Bergé et al. 1998) and carboxylesterase (COE)-mediated hydrolytic 
degradation (Wheelock et al. 2005). Glutathione S-transferases (GST) have been also shown 
to contribute to the resistant phenotype (Vontas et al. 2001). The majority of T. urticae 
resistance reports implicate COE hydrolysis in pyrethroid detoxification (Ay and Gürkan 
2005, Van Leeuwen et al. 2005, Van Leeuwen and Tirry 2007). Increased mono-oxygenase 
(MO) activities were also detected in a pyrethroid resistant strain from Belgium (Van 
Leeuwen et al. 2005). A small number of conserved voltage gated sodium channel (VGSC) 
resistance mutations have also been reported to confer target site insensitivity to pyrethroids. 
Most mutations have been found in the transmembrane segments 4 to 6 of the domain II (IIS4-
IIS6) region of this large membrane protein, and include changes at residues such as M918 in 
the IIS4-IIS5 linker, L925, T929 and L932 in IIS5 and L1014 in IIS6 (Figure 1.2) (Soderlund 
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and Knipple 2003, Davies et al. 2008). A resistance mutation, F1538I, has also been reported 
within the S6 transmembrane segment of domain III, which is predicted to form part of the 
pyrethroid binding site, based on a recent computer modelling study of pyrethroid/sodium 
channel interactions (O'Reilly et al. 2006). This mutation has been confirmed to confer strong 
insensitivity to a number of pyrethroids by functional assays (He et al. 1999, Tan et al. 2005).  
Target-site resistance has been also associated with sodium channel alternate transcriptional 
variation and/or post transcriptional modifications in some species (Tan et al. 2002b, Du et al. 
2006), although the possible broader role of such changes in other species remains unclear. 
In this chapter the resistance mechanism responsible for high levels of bifenthrin resistance in 
two T. urticae strains from Greece was investigated. Also, cDNA sequences which encode a 
large part of the T. urticae para sodium channel were isolated and identified mutations were 
associated with the resistance phenotype. 
 
2 Materials and Methods 
2.1 Strains  
The pyrethroid susceptible strain SAMB was initially collected on Sambucus nigra (L) in the 
Netherlands and obtained from the Centre de Biologie et de Gestion des Populations, 
Montpellier France. The German susceptible strain GSS was obtained from Bayer 
CropScience.  
Two pyrethroid resistant T. urticae strains were used in this study. The ATHRos-Bf strain was 
isolated from a heavily sprayed rose plant greenhouse in 2007 near Athens, and the CREVeg-
Bf strain was derived from field populations collected from several vegetable crops from the 
island of Crete in 2006. Before collection, these field strains had been heavily treated with 
several insecticides and acaricides. Both strains were selected with concentrations causing ~ 
70% mortality every two generations, until homogeneity in bioassay response was obtained. 
Mites were maintained on detached bean leaves that were deposited on a piece of moist cotton 
placed on trays filled with water to prevent contamination and reared at 25 ± 2°C, 70 ± 5% 
relative humidity with a photoperiod of 16:8 h (L:D). Under these conditions, a new 
generation was obtained every 2 weeks and mites were transferred to new bean leaves every 
week.  
2.2 Bioassays 
Commercial formulations of bifenthrin 100 g L-1 EC (Talstar, FMC Greece), fluvalinate 240 g 
L-1 SC (Mavrik, Alpha Greece) and of dicofol 35% WP (Kelthane, Protex, Belgium) were 
used. DDT and fenpropathrin were of analytical grade (Chem Service) and formulated by 
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preparing stock solutions in a 3:1 (v/v) mixture of N,N-dimethylformamide and 
alkylarylpolyglycolether (emulsifier) and subsequently diluted with de-ionised water (Van 
Leeuwen et al. 2007). Bean leaves were placed on wet cotton in plastic Petri dishes for 
conducting bioassays. Twenty five adult females were transferred onto a leaf with a fine brush 
inside a 35 mm disc delimitated by insect glue. Individual Petri dishes were then sprayed with 
a precision Potter Spray Tower (Burkard, Rickmansworth, Hertfordshire, UK) (Potter 1952) 
with 1 ml aqueous solutions of insecticide at 1 bar pressure in order to obtain a homogenous 
spray film (2.4 mg ± 0.3 aqueous acaricide deposit cm-2). Four replicates of at least 4 
concentrations causing between 20% and 80% mortality 48 hours after treatment were tested 
with each insecticide. The synergists piperonyl butoxide (PBO) (Sigma-Aldrich, UK), an 
inhibitor of cytochrome P450 mono-oxygenases and carboxylesterases, and S,S,S-tributyl 
phosphorotrithioate (DEF, Sigma, UK), an inhibitor of esterases and glutathione-S-
transferases (GST) were used to investigate the effect of inhibition of detoxifying enzymes on 
bifenthrin resistance. Female mites were sprayed with PBO and DEF at the highest 
concentration causing no mortality (30 mg L-1 and 100 mg L-1 respectively), 4 h prior to 
bifenthrin application as described above. Before use, PBO and DEF were dissolved in a 
mixture of N,N-dimethylformamide and emulsifier W (3:1 by weight) and subsequently 
diluted with de-ionised water (1000-fold). Mites sprayed with synergist only served as control.  
LC50 values and their 95% confidence limits were calculated from probit regression analysis 
(Raymond et al. 1993) based on Finney (1971). Resistance ratios (RR) or synergism ratios 
(SR) were considered to be significantly different from 1 when their 95% confidence limits 
(95% CL) did not include this value. 
For selections, the two resistant strains were exposed to successive applications of bifenthrin 
every ~ 2 generations. Adult females were placed on bean leaf discs and sprayed as described 
above with concentrations causing 70% mortality. The surviving mites were transferred to 
new leaves after 48 hours. 
2.3 Crossing experiments 
To estimate the dominance of the resistance, the SAMB and CREVeg-Bf strains were 
reciprocally crossed to produce hybrid F1 females as described by Van Leeuwen et al. (2004). 
Briefly, 10 female teleiochrysalis of one strain and 30 adult males of the other strain were 
placed together on the upper side of a primary bean leaf on wet cotton in a Petri dish. Directly 
after molting the diploid females were fertilized by the haploid males. After 3 days, fertilized 
females were collected and placed on fresh bean leaves and were allowed to lay eggs for 14 
days. Every day, the egg laying females were collected and placed on a fresh leaf. The 
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resulting F1 females were collected 10 days after hatching and were used after maturation (1–
3 days) in a bioassay with the appropriate concentrations of bifenthrin, as described in 
paragraph 2.2. The following formula was used to calculate the degree of dominance (Stone 
1968). 
31
3122
XX
XXXD −
−−=  
in which X1 is the log of the LC50 of the resistant strain, X2 is the log of the LC50 of the 
heterogenous strain and X3 is the log of the LC50 of the susceptible strain. This formula will 
result in a value of -1 if resistance is fully recessive, a value of 0 if there is no dominance, and 
a value of +1 if resistance is fully dominant.  
2.4 Biochemical assays 
COE, GST and MO activities of mass homogenates of female mites were determined on a 
SpectraMax M2e microplate reader (Molecular Devices, UK). COE activities were 
determined with the substrates α-naphthyl acetate, p-nitrophenyl acetate (pNPA) and the more 
specific 1-naphthyl 2,2-dimethylbutyrates, as detailed in Van Leeuwen et al. (2005) and 
Rauch and Nauen (2002). GST activities were measured with the substrates 1-chloro-2,4 
dinitrobenzene (CDNB) and monochlorobimane as detailed in Stumpf and Nauen (2002). The 
O-deethylation of 7-ethoxy-4-trifluoromethylcoumarin (7-EFC) by T. urticae P450 mono-
oxygenases was measured according to Van Leeuwen et al. (2005). The protein concentration 
in the enzyme source was determined according to Bradford (1976) using bovine serum 
albumin as a standard, to normalise activities for protein concentration. All enzymatic assays 
were repeated at least 3 times. The mean activity values were compared between resistant and 
each of the susceptible strains, by one-way analysis of variance (ANOVA) using the SPSS 
statistical software version 13.0 (LSTM, UK). 
2.5 Extraction of gDNA and RNA, cDNA synthesis, cloning, and sequencing 
Total RNA was extracted from mass homogenates of T. urticae mites using TRI reagent 
(Sigma-Aldrich, Belgium) according to the manufacturer’s instructions. The RNA was treated 
with DNase RQ1 (Promega, USA) to remove genomic DNA and 2 µg RNA for each sample 
was reverse transcribed into cDNA by using the High Fidelity cDNA synthesis kit (Roche, 
Belgium) and random hexamer primers. Genomic DNA (gDNA) was extracted using the 
DNeasy Kit (Qiagen, Germany) following the manufacturer’s protocol. A number of 
degenerate primers (Table 2.1) designed against conserved coding sequences of Acari sodium 
channel genes in domains II, III and IV, were used to PCR amplify partial sequences of the T. 
urticae para sodium channel gene.  
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Amplifications from approximately 40 ng gDNA or 0.5 µl cDNA were performed in 1x Taq 
reaction buffer (Promega, Greece) with a final concentration of 2 mM MgCl2 and 0.5 µM each 
primer, and cycling conditions 94 oC for 5 min, then 30 cycles of 50 oC for 30 s, 72 oC for 2 
min, 95 oC for 15 s, followed by a final cycle of 72 oC for 5 min. On the basis of partial 
domain II and IV sequences that were obtained with primer pairs aIIS3-F1/aIIS5-R6 and 
aIIIS5-F2/ aIVS6-R3 (Table 2.1), a single pair of specific primers (GAP2F and GAP2R) were 
designed to amplify the entire fragment using a long PCR approach (Expand Long Range Kit, 
Roche, Belgium) with cDNA as template. Fragments were purified with QIAEX II (Qiagen, 
the Netherlands) and sequenced by primer walking. To ensure allele representations, 
fragments were also cloned into the pGEM-T vector (Promega, the Netherlands). PCR 
fragments and plasmids were sequenced by Agowa Sequencing Service (Germany). Sequence 
data was analyzed using BIOEDIT 7.0.1 (Hall 1999). 
 
Table 2.1. Primers used for the amplification of the domain IIS4-IVS6 of the T. urticae para sodium 
channel gene. 
 
Primers Sequence (5’ – 3’) 
aIIS3-F1 GAAGGNTGGAAYATNTTYGA 
aIIS5-R6 ATCCAYTCKCCRCAHARMACHCGRAA 
aIIIS5-F2 CATCTTCAAYGTRYTRYTGGT 
aIVS6-R3 TGCCARATYTCRTAGTACAT 
aIVS6-F3 TGCTGTTYGCSYTNGCYATG 
aIIS4-F4 TTYAARYTDGCMAARTCDTGG 
aIIS5-F5 GGMGARTGGATMSARTCBATGTGG 
aIIS5-F6 TAYTTCACVAAYGYBTGGTGYTGG 
aIIS6-R1 CYTCTKSWANYTTNTTKGTRT 
aIIIS6-R2 GAKCCCATYTTYTTCATNGC 
aIIIS3-R4 ATVACRAARTCVAGCCARCACCA 
aIIIS4-R5 TTGAAGATGGCNGGNATNGCTTG 
GAP2F ATCGTGGCCCACTCTTAACC 
GAP2R GACCCACAATCTGACACTTCG 
KdrR1 TCTTCCGTCATCAACATCTCC 
KdrR2 GTTTCTTCCAGGCAACATGG 
SGF3B TAAAGAACGTCCCTGGTTGG 
SGR6 GCCAAAAATGATGAAAAATACG 
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2.6 Phylogenetic analysis 
A phylogenetic analysis was performed as in Davies et al. (2007a) using the para sodium 
channel sequences of 17 arthropod (5 Arachnida and 12 Insecta) species. Amino acid 
sequences were aligned by CLUSTAL W (Thompson et al. 1994) as implemented in BIOEDIT 
7.0.1. Ambiguously aligned parts were omitted from the analysis by making use of GBLOCKS 
0.91b (Castresana 2000), using default block parameters except for changing “allowed gap 
positions” to “with half”. Model selection was done with PROTTEST 1.4 (Abascal et al. 2005). 
According to the Akaike information criterion the WAG + I + G + F model was optimum for 
phylogenetic analysis with amino acid alignments and a Bayesian inference (BI) was used. 
(Mr. Bayes ver. 3.1.2, (Huelsenbeck and Ronquist 2001)). Four chains ran for 100,000 
generations and tree sampling was carried out every 100 generations. The first 250 out of 
1000 trees were discarded as burn-in and the remaining 750 were used to calculate Bayesian 
posterior probabilities. 
 
3  RESULTS  
3.1 Characterization of bifenthrin resistance in the resistant strains 
The ATHRo-Bf and CREVeg-Bf strains exhibited high levels of resistance to bifenthrin (RR, 
2495 and 1026, respectively), compared to the susceptible SAMB strain (Table 2.2). ATHRo-
Bf and CREVeg-Bf had high levels of cross resistance to another halogenated pyrethroid, 
fluvalinate (RR 1251 and 968, respectively), but lower levels of cross resistance to 
fenpropathrin (RR 86 and 47) and the organochlorine dichlorodiphenyltrichloromethyl-
methane (DDT) (RR 6.76 and 2.33). Cross resistance to dicofol was high in ATHRos-Bf 
strain (200-fold resistance) but only twofold in CREVeg-Bf. 
Inhibitors of COE, GSTs and P450 MO only slightly synergized bifenthrin toxicity in the 
ATHRos-Bf strain (Table 2.3), whilst COE and GST activities with several substrates were 
not statistically different (P > 0.01) in the resistant strains compared to the susceptible ones 
(Table 2.4). P450 activities with the substrate 7-ethoxy-4-trifluoromethylcoumarin was 
statistically significantly elevated (P < 0.01) in the ATHRos-Bf and the CREVeg-Bf 
compared to GSS (nine and six fold, respectively) and the SAMB (three and twofold, 
respectively).  
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Table 2.2 Concentration probit mortality data of several acaricides on the T. urticae strains  
 
Treatment na
 
LC50 b
 
Slope ±  SE x 2 c
 
df RR50d
 
       
SAMB       
Bifenthrin 317       9 (6 – 12) 1.88 ± 0.29 5.05 3  
Fluvalinate 266     26 (13 – 39) 1.58 ± 0.30 3.61 2  
Fenpropathrin 342     44 (36 – 54) 2.62 ± 0.27 0.09 2  
Dicofol 568     10 (9 – 11) 5.10 ± 0.45 13 7  
DDT 487 2940 (1975 – 4386) 3.10 ± 0.77 15*** 2  
       
GSS       
Bifenthrin 257       13 (4.38 – 41) 1.79 ± 0.92 18*** 2      1.49 (0.68 – 32) 
Fluvalinate 225       55 (16 – 190) 2.49 ± 1.86 40*** 2 2.05 (0.59 – 7.10) 
Fenpropathrin 238       63 (49 – 82) 3.45 ± 0.57 5 2 1.43 (1.04 – 1.97) 
Dicofol 534       15 (13 – 18) 5.62 ± 1.03 25*** 6 1.54 (1.14 – 2.09) 
DDT 305   6994 (5927 – 8059) 3.62 ± 0.52 0.50 2 2.38 (1.40 – 4.03) 
       
CREVeg-Bf       
Bifenthrin 356   9162 (7014 – 11242) 2.13 ± 0.30 3.02 2 1026 (807 – 1304) 
Fluvalinate 351 26072 (12626 – 54421) 1.22 ± 0.38 7.83* 2 968 (614 – 1524) 
Fenpropathrin 368   2078 (1749 – 2497) 3.19 ± 0.38 1.44 2        47 (37 – 60) 
Dicofol 598       25 (21 – 30) 4.33 ± 0.83 26*** 7 2.56 (1.95 – 3.37) 
DDT 432   6851 (5165 – 9072) 3.47 ± 0.83 13** 3 2.33 (1.29 – 4.21) 
       
ATHRos-Bf       
Bifenthrin 400 22269 (17285 – 33211) 2.02 ± 0.31 2.20 2 2495 (1905- 3266) 
Fluvalinate 283 33711 (22237– 132277) 0.98 ± 0.17 4.27 2 1251 (949 – 1649) 
Fenpropathrin 308   3786 (3050 – 4400) 3.34 ± 0.78 3.92 2         86 (75 – 97) 
Dicofol 516   2212 (1996 – 2456) 3.61 ± 0.36 9.95 7 225 (189 – 267) 
DDT 472 19893 (12358 – 32022) 4.17 ± 1.44 47.84*** 3 6.76 (2.81 – 16) 
 
a number of mites tested 
b LC, lethal concentration expressed in mg L -1 
c Chi-square testing linearity, * P < 0.05, ** P < 0.01, *** P < 0.001 
d RR, resistance ratio = LC/LC SAMB 
  
Table 2.3 Effect of pre-exposure to S,S,S-tributyl phosphorotrithioate (DEF) and piperonyl butoxide (PBO) on mortality  
as a result of bifenthrin treatment 
 
Treatment na
 
LC50b
 
Slope ±  SE χ2 c
 
df RR50d
 
SR50e
 
        
SAMB        
Bifenthrin 317         9 (6 - 12) 1.88 ±  0.29    5.05 3 - - 
Bifenthrin + DEF 262   3.17 (2.09 - 5.3) 1.42 ±  0.23    5.68 3 - 2.82 (2.15 - 3.69) 
Bifenthrin + PBO 252   4.37 (0.03 - 545) 2.13 ±  3.9 214*** 2 - 2.04 (0.04 - 7.48) 
        
CREVeg-Bf        
Bifenthrin 356  9162 (7014 - 11242) 2.13 ± 0.30     3.02 2 1026 (807 - 1304) - 
Bifenthrin + DEF 464 12441 (8941 - 17469) 1.81 ± 0.39     6.27* 2 3928 (2840 - 5432) 0.76 (0.62 - 0.92)  
Bifenthrin + PBO 365  6950 (5562 - 8479) 1.93 ± 0.26     1.89 2 1590 (28 - 90514) 1.36 (1.00 - 1.84)  
        
ATHRos-Bf        
Bifenthrin 400 22269 (17285 - 33211) 2.02 ± 0.31     2.20 2 2495 (1905 - 3266) - 
Bifenthrin + DEF 299   8473 (7283 - 9871) 2.87 ± 0.38     1.86 2 2675 (2107 - 3395) 2.63 (2.07 - 3.33) 
Bifenthrin + PBO 306   8458 (7243 - 10017) 2.87 ± 0.37     3.10 2 1934 (344 - 110255) 2.63 (2.07 - 3.36) 
 
a number of mites tested 
bLC, lethal concentration expressed in mg L-1  
cChi-square testing linearity, * P < 0.05, ** P < 0.01, *** P < 0.001 
dRR, resistance ratio = LC/LCSAMB 
eSR, synergism ratio = LC observed in absence of synergist / LC observed in presence of synergist 
  
 
 
Table 2.4 Resistance ratios and detoxifying enzyme activities in the two susceptible SAMB and GSS and the two resistant CREVeg-Bf and ATHRos-Bf 
strains. 
 
 Bifenthrin   Mean esterase activity       Mean GSTs activity  Mean P450 activity 
Strain  
RR 
 α-Naphthyl-
acetatea
 p-NPAb
 
1-Naphthyl-2,2 
dimethylbutyratea
 CDNBc
 
Monochlorobimaned
 
 7-EFCe
 
SAMB   131 ±  60 2.91 ± 0.57 1465 ± 173 1.30 ± 0.20 67122 ± 2812  248 ± 20 
GSS      1.49 (0.68 - 32)  120 ±  66 2.91 ± 1.2 1099 ± 269 1.28 ± 0.83 88902 ± 48105    92 ± 12 
CREVeg-Bf 1026 (807 - 1304)  315 ±  174 5.02 ± 0.36 1181 ± 293 0.99 ± 0.14 69068 ± 67155  564 ± 25 
ATHRos-Bf 2495 (1905 - 3266)  167 ±  38 4.97 ± 2.77 1251 ± 267 0.92 ± 0.28 151712 ± 89427  844 ± 24 
 
anmole α naphthol/min/mg protein 
bµmole/min/mg 
cµmole glutathione conjugated/min/mg protein  
d relative fluorescent units/min/mg protein 
epmol 7-hydroxycoumarin/(30min)/mg protein  
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3.2 Cloning of the T. urticae voltage gated sodium channel gene (domains II-IV) 
A 3324 bp fragment encoding an 1108 amino acid sequence of the T. urticae para sodium 
channel across domains II, III and IV (IIS4-IVS6, see Figure 2.1) was amplified from T. 
urticae cDNA using a degenerate primer and long-PCR strategy. Sequences were deposited in 
GenBank under the accession numbers FJ906804-FJ906811. 
The T. urticae sodium channel gene fragment showed highest similarity to other species of the 
same subphylum: 56 % with the other Acariformes mite Sarcoptes scabiei, 51.7% and 48.9% 
with the two Parasitiformes Boophilus microplus and Varroa destructor and 49.4% with the 
scorpion Mesobuthus martensii.  
                                                         IIS5     
M. domestica   VFKLAKSWPT LNLLISIMGR TMGALGNLTF VLCIIIFIFA VMGMQLFGKN YIDHKDRFKD  960   
B. microplus   .......... .........K .I........ ..G....... .......... .EES.HK...  99    
S. scabiei     .......... .........K .I.D...... ..V....... .......... .TEES--.GG  159   
T. urticae     ---------. .....T...K .L.D...... ..A..V.... ........A. .SKKVYL.PN  51    
                                        IIS6 
M. domestica   HELPRWNFTD FMHSFMIVFR VLCGEWIESM WDCMYVGDVS CIPFFLATVV IGNLVVLNLF  1020  
B. microplus   NMV.....V. .......... .......Q.. ....W.SGWP .......... ...L......  159   
S. scabiei     K.I.....K. .......... .......... ....R.SGAA .V........ ...L......  219   
T. urticae     A.I.....K. .......... .......... .S..L.CGFV .V.......I ..HL.M....  111   
 
M. domestica   LALLLSNFGS SSLSAPTADN -DTNKIAEAF NRIARFKNWV KRNIADCFKL IRNKLTNQIS  1079  
B. microplus   ......S..A .N..QANP.S G..K.LQ..I D.FH.ASR.I .S.SMKL..S F.R.PR...G  219   
S. scabiei     ......S..A .N.....SES A..K.LQ... D.FS.GGK.I .HRTLSLL.R MSP.TR...R  279   
T. urticae     ......S..A .N..S..SES A..K.LQ... D.FG.AHK.L .NR.LTGL.Q L.S.TR...R  171   
 
M. domestica   D--QPSEH-- --GDNELELG ----HDEIMG DG---LIKKG MKG------- ----------  1109  
B. microplus   .--.TTDIRG GGAGE...AD PGVAGEVVLL ..RVPMRDRK PQH------- ----------  260   
S. scabiei     .--.ICD.S- -ISYE.MLKT ----SNK.DQ TSEII.VENE KNQ------- ----------  314   
T. urticae     .TA.WPGRGG ASSGGMVGRS MMLGSESVLD E.DIIMMDGL NASGLIRDKK LLAAAAYGET  231   
 
M. domestica   ---------- ---------- ---------- ---------- ---------- ---ETQLEVA  1116  
B. microplus   ---------- ---------- ---------- ---------- ---------- ---NND...V  267   
S. scabiei     ---------- ---------- ---------- ---------- ---------- ---QISPTIS  321   
T. urticae     VVGPDGLEYS LTESGKVTLK SSAQTVLNSV KLSQAVKDLS SDKLILTESA LIEKLSPS.T  291   
 
M. domestica   IGDGMEFTIH GD---MKNNK PKKSKFINNT TMIGNSINHQ DNRLEHELNH RG--------  1165  
B. microplus   V...LDIA.Q ..GKAV.MKL KNN..PVM.S VWV.PM.EPK NKQ..KDNKE KEKEAQGNKV  327   
S. scabiei     .PNANNMKAS TILPNVNLEM VHLIQNQ.DL NK.NGTNSQT KSIINRKESN DAQ-------  374   
T. urticae     NHSDEGNRL. ..VSTVN..N VNDRSTSL.N .NFN..L.SN NLLVSASTIN NNNVNKVKPS  351   
 
M. domestica   LSIQD----- ---------- ---------- ---------- --------DD TASINSYGSH  1182  
B. microplus   YPQK.----- ---------- ---------- ---------- --------E. .L.EK.AS.P  344   
S. scabiei     I.RKN----- ---------- ---------- ---------- --------SM NVNFE.DLTR  391   
T. urticae     .HDANGCSPF PLDDNHHHHH LVQQQPHGGD YHGESGYYGS SESQQHLVNN NV.N.NDS.A  411   
 
                                                                            
M. domestica   K------NRP FKDESHKGS- AETIEGEEKR DVSKEDLG-- ---------- ----LDEELD  1219  
B. microplus   .EKVLLG.K. S..L.NSSLY LGNNLE...K .A......-- ---------- ----TK.GEE  388   
S. scabiei     .IS-MDTEII V...KFSSLD SN..Q..SRS ..I.S----- ---------- ----------  425   
T. urticae     QQSSSLSVT. SHHLN.PS.H PTAHHYNASQ LSKVHPA.GP VPISFQHSYS SLNR.APSPL  471   
                                                                            
M. domestica   EEAEG----D EGQLDGDIII HAQNDDEIID DYPADCFPDS YYKKFPILA- GDEDSPFWQG  1274  
B. microplus   APT.EPINP. TEDV.T.KLE T.TS-.I..P EM....C..W C.TR.AFACF F..NKI...R  447   
S. scabiei     ---------- ---IEVNGKL D.ATA.VV.N E..SE.W.EP M.QYC.WCL- --DETT..AR  469   
T. urticae     NHFN.PGEDV M.EEMNANKM VTVTA.VN.N .H.D..L.EY W.HR..CCL- --.ETA..IK  528   
 
                                 IIIS1                               IIIS2 
M. domestica   WGNLRLKTFQ LIENKYFETA VITMILMSSL ALALEDVHLP DRPVMQDILY YMDRIFTVIF  1334  
B. microplus   YKIV.T.AYA .V.H.....I .VVL..T... .......N.K ...TLKAV.T ...KT.....  507   
S. scabiei     .KTI.S.CYK IV.H.....L ...L..I..M .......NFK KD.LFMEY.N .V.KF..I..  529   
T. urticae     .REV.S.CYK .V.D.....L ...L..I..M T......N.K E..WLEYS.K .I.QF..I..  588   
 
 
                                         IIIS3                        IIIS4 
M. domestica   FLEMLIKWLA LGFKVYFTNA WCWLDFVIVM LSLINLVAVW SGLNDIAVFR SMRTLRALRP  1394  
B. microplus   .F..ML.... F...K..... .........L V.FF.MAVAM M.YGR.PA.K T.........  567   
S. scabiei     IC........ F..YG....V .......... V.IM.IIVGI A..GN.PA.K T.........  589   
T. urticae     TC...L..F. Y...S..S.. ......I... V....FTVGQ L.FSN.PA.K T.........  648   
                                                  ******************************   
Figure 2.1 
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                                     IIIS5 
M. domestica   LRAVSRWEGM KVVVNALVQA IPSIFNVLLV CLIFWLIFAI MGVQLFAGKY FKCKDGNDTV  1454  
B. microplus   ...M..L... R......... ..A....... ........S. ....ML...F YR.V...G.R  627   
S. scabiei     ...L..LD.. R......I.. ..A....... ........S. ......L..F YQ.I.AKTKI  649   
T. urticae     ...M..L... R......I.. ..A....... .......... .........F SY.R.R.TEE  708   
 
               ******** 
M. domestica   -LSHEIIPNR NACKSENYT- -WENSAMNFD HVGNAYLCLF QVATFKGWIQ IMNDAIDSRE  1511  
B. microplus   -.NSTHV... K..EAN.F.- -.D.PMI... N.L....A.. ........TD ..DN.....G  684   
S. scabiei     R.NASYV..K E..EAR.H.I -.Y.PPI... N.L....A.. ........TD ...N....KQ  708   
T. urticae     KSDPNE.E.K TI.DQH.E.L E.YTPMV... N.F.G..S.. ........TI ..DH......  768   
                    
           IIIS6       
M. domestica   -VDKQPIRET NIYMYLYFVF FIIFGSFFTL NLFIGVIIDN FNEQKKKAGG SLEMFMTEDQ  1570  
B. microplus   GKED..EY.A .......... .......... .......... .......... ..........  744   
S. scabiei     EL.E..EK.V .L........ .......... ...T....E. .......... ..........  768   
T. urticae     -.HQ..VY.N S.L....... .......... .......... .......G.. .R..L.....  827   
 
 
                                               IVS1 
M. domestica   KKYYNAMKKM GSKKPLKAIP RPRWRPQAIV FEIVTDKKFD IIIMLFIGLN MFTMTLDRYD  1630  
B. microplus   .......... .....A.... ...FKL..M. .DLT.N.M.. MA..I..V.. .TV.A..H.K  804   
S. scabiei     .......... .....M.... ...FKL.... .DVT.N.... M......A.. ..I.SM.E.R  828   
T. urticae     ...L...... .....M.... ...FKL...I .D...N.... ML.....M.. ..V.S..H.Q  887   
 
                               IVS2                               IVS3 
M. domestica   ASEAYNNVLD KLNGIFVVIF SGECLLKIFA LRYHYFKEPW NLFDVVVVIL SILGLVLSDI  1690  
B. microplus   Q.RLFESI.E R..IF.IAV. TA........ ..W...R... .M..F..... ....T..K.L  864   
S. scabiei     QNPTVSII.E R..LF.IA.. TA........ ..W....... .V..F..... ....VL.R..  888   
T. urticae     ..AFMEHI.E MC.LF.IAV. TA..M..... ..F...R... .V..F.I... ..ASSA.K.F  947   
 
                                     IVS4                              IVS5 
M. domestica   IEKYFVSPTL LRVVRVAKVG RVLRLVKGAK GIRTLLFALA MSLPALFNIC LLLFLVMFIF  1750  
B. microplus   .AA....... ......V... .........R .......... .......... .........Y  924   
S. scabiei     .A........ ......V... .........R .......... .......... ......I..Y  948   
T. urticae     V.N.LI.... ......V.I. .........R .......... .......... .........Y  1007  
 
 
M. domestica   AIFGMSFFMH VKEKSGINAV YNFKTFGQSM ILLFQMSTSA GWDGVLDAII NEEDCDPPDN  1810  
B. microplus   .......... ..HRY.VDEN F..E...... ......C... ......A..M D.H..NR.TD  984   
S. scabiei     .........N ..QRY..DET F..S..SR.F .......... ...H..A..M D.N..T.TGP  1008  
T. urticae     .........N ..QRY.LDET F..G..FR.F ......C... ......A..M D.SK.EKDSE  1067  
 
                                                                      IVS6 
M. domestica   DKGYPGNCGS ---------- ---------- ---------- ATVGITFLLS YLVISFLIVI  1840  
B. microplus   ESE--....K ---------- ---------- ---------- RGIAVAY.V. ..I....VI.  1012  
S. scabiei     ESE--.D..T KESLYRSWIL FDYFVSNNHQ HVHRNHTRKI KGIA.A..V. ..I.....I.  1066  
T. urticae     VSD------- ---------- ---------- -------CGS KKIA.AY.VT ..I....VIV  1093  
 
 
M. domestica   NMYIAVILEN YSQATEDVQE GLTDDDYDMY YEIWQQFDPE GTQYIRYDQL SEFLDVLEPP  1900  
B. microplus   .......... .......... .......... .........K ....VA.SN. TN.VNA..E.  1072  
S. scabiei     .......... ....A...H. .......... .....K...K ...F.S.H.. .D.VHA..E.  1126  
T. urticae     .......... .....----- ---------- ---------- ---------- ----------  1108  
 
Figure 2.1 Continued Alignment of the deduced amino acid sequence of T. urticae sodium channel 
(FJ906808) with susceptible M. domestica (U38813), S. scabiei (DQ077148) and Boophilus 
(=Rhipicephalus) microplus (AF134216). Dots represent identical residues, and dashes indicate gaps 
introduced to obtain optimal alignment. Numbers on the right indicate the amino acid positions in each 
protein. The IIS5 to IVS6 transmenbrane segments are highlighted. Arrows indicate the position of the 
two mutations found only in the two resistant T. urticae strains. Stars indicate the location of the 
transcript variants in T. urticae. Here the transcript variant v2 corresponding to the exon k is 
presented. 
 
 
The overall similarity to insect species (subphylum Hexapoda) was slightly lower (for 
example 47.7 % for Musca domestica) and against all species the greatest similarities (57.7% 
to 96.3%) were found in the transmembrane segments of domains II, III, IV as well as the 
intracellular linker connecting domains III and IV (91%). The T. urticae sequence also 
contains the conserved residues of the channel selectivity filter from the P-loop regions of 
domains II-IV, including residues referred to as the ‘DEKA motif’, which is important for 
Chapter II___________________________________________________________________ 
 
 38 
determining sodium selectivity (these are E76, K754 and A1047 in Figure 2.1) (Heinemann et 
al. 1992). In contrast, much greater variation was observed in the cytoplasmic linker between 
domain II and III (similarity 25%), due to the differences in both sequence and length of this 
highly divergent region (422 residues in T. urticae compared to 256 and 270 in S. scabiei and 
M. domestica respectively, Figure 2.1). 
The phylogenetic relationship of the T. urticae voltage gated sodium channel with Insecta and 
Arachnida sequences is presented in an unrooted phylogenetic tree in Figure 2.2 As the 
cytoplasmic loop between domain II and domain III varies extensively in length and sequence 
amongst species, we excluded this region from the phylogenetic analyses. The overall 
topology of the tree shows that voltage gated sodium channel from Insecta form a more 
homogenous group compared to those of the Arachnida. The voltage gated sodium channel of 
the Arachnida is most divergent, as within group distances are equivalent to those between 
Arachnida and Insecta species (Figure 2.2). 
 
 
 
 
 
 
Figure 2.2 Phylogenetic tree of insect and 
arachnid species voltage-gated sodium channel 
cDNAs. Sequences were aligned and a 
bootstrapped unrooted tree was constructed as 
described in the materials and methods. 
Bootstrap values are indicated on branches.  
 
 
 
3.3 Identification of mutations within the sodium channel gene of T. urticae  
The cloned region contains the majority of mutation sites previously implicated in conferring 
target site resistance to pyrethroids across a range of insect and mite species (Davies et al. 
2007b). Residues associated with the susceptible phenotype were present at most of these 
positions in both the resistant and susceptible T. urticae strains analysed, including M918, 
T929, L925 and L1014 (numbering according to M. domestica). An interesting exception is 
the presence of methionine at residue 1016 in T. urticae, as this is normally a valine in all 
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other known insect and mite sequences, and replacement of this valine by methionine has 
been identified as a possible resistance mutation in Aedes aegypti mosquito populations from 
Central America (Saavedra-Rodriguez et al. 2007). The M1016 is present in all the T. urticae 
strains tested here, so although not associated solely with the resistant phenotype, it may 
nevertheless contribute towards the general reduced sensitivity of this species for most 
pyrethroids (Khambay and Jewess 2005).  
Comparison of the cDNA sequences between the resistant and susceptible T. urticae strains 
revealed a total of 29 nucleotide substitutions. Most of these were silent, although 7 were 
found to result in amino acid replacements, and of these 2 were found in both ATHRos-Bf and 
CREVeg-Bf resistant strains but not in the susceptible SAMB and GSS strains. The first, a 
phenylalanine (TTC) to isoleucine (ATC) replacement at amino acid 1538 (M. domestica 
numbering) is located within domain III segment 6 (IIIS6) and has been previously reported in 
the southern cattle tick B. microplus (He et al. 1999). The role of this mutation has been 
established by site directed mutagenesis and functional expression studies in Xenopus laevis 
oocytes (Tan et al. 2005) and shown to confer high levels of insensitivity to a number of 
pyrethroids (Tan et al. 2005). The second is an alanine (GCT) to aspartic acid (GAT) 
substitution at amino acid residue 467 of the T. urticae sequence (Figure 2.1). This residue 
corresponds to the amino acid D1215 in housefly, which is located in the intracellular linker 
between domains II and III and has not been previously reported to be associated with 
resistance in any species. The remaining 5 amino acid replacements are found only in the 
resistance strain CREVeg-Bf. Following the numbering of T. urticae in Figure 2.1, these 
amino acid changes are L151V, G178S, A182G, G189D and S253T and are all found within 
the II/III linker, a highly variable region.  
3.4 Splicing variants  
The sequence alignment of several cDNA clones from the resistant and susceptible strains 
revealed the presence of a variable region overlapping segments S3-S4 of domain III with 
three variants (v1, v2 and v3 Figure 2.3). The two variants (v1 and v2) differed from each 
other in 14 /40 amino acids (35%) and correspond to the mutually exclusive k/l exon pair 
already identified in insects (Davies et al. 2007b, Dong 2007). A larger variant (v3) containing 
both v1 and v2 sequences was observed in some rare plasmids. In order to investigate the 
frequency of these variants in resistant and susceptible strains, we analyzed a larger number of 
colonies with the 3.3 kb insert. We therefore amplified the region around the two variants  
(primers SGF3b and SGR6) with a colony-PCR based method, followed by a DraI 
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(Fermentas) restriction digest to distinguish between colonies with the transcript v1 or v2 (l or 
k respectively) or v1 + v2 transcript variant. This digest generates fragments of 465+108+103 
or 573 +103, or 465+231+103 bp for the v1 (exon trancript l), v2 (exon transcript k) or v3 
(exons k+l) respectively. The v2 transcript (Figure 2.3) was found at a frequency of 63% and 
the v1 transcript was present in 36% of the plasmids analyzed, whereas the v3 was present in 
only 1%. No association between splicing variant frequencies and resistance phenotype was 
observed, as the before-mentioned frequencies were not significantly different between the 
resistant and susceptible strains. 
In order to investigate any possible association between putative resistance point mutations 
identified and transcript variants, we sequenced several plasmids containing the 3.3 kb 
fragment with the internal primers KdrR1 and KdrR2. Sequencing reads with these primers 
covered both the mutation-regions and transcript variants. The phenylalanine with isoleucine 
and the alanine with aspartic acid replacements were absent from all the 10 colonies of the 
susceptible strains. They were found together in all the 10 colonies from the resistant strains 
(five of each strain) independently of the transcript v1 or v2.  
3.5 Inheritance of resistance  
Reciprocal crosses of CREVeg × SAMB were performed in order to examine the degree of 
dominance. Crossing female CREVeg-Bf with male SAMB resulted in 100% male offspring 
indicating cytoplasmic incompatibility, since in the arrhenotokous reproduction mode of T. 
urticae unfertilised eggs result in male progeny. SAMB was strongly infected by Wolbachia 
as determined by PCR with universal wsp primers (Zhou et al. 1998), while infection could 
not be detected in CREVeg-Bf, suggesting that interference in reproduction by this 
endosymbiont is one possible explanation of the observed incompatibility (results not shown). 
The dominance was hence calculated by the mortality response of the female offsprings of the 
cross f SAMB × m CREVeg-Bf. In Table 2.5, the pesticide concentrations giving 50% 
mortality (LC50s) of the two parental strains and F1 females are presented. The resistance was 
almost fully recessive with degree of dominance D = -0.57. 
  
 
Figure 2.3 The three transcript variants (v1, v2, v3) in T. urticae VGSC corresponding to the mutually exclusive exons k and l found in insects. 
 
 
Table 2.5 Mortality data of the F1 progeny 
 
Strain na
 
LC50b
 
Slope ± SE χ2 c
 
df RR50d
 
SAMB 565    11 (12 - 14) 3.19 ±  0.27     5.46 4 - 
CREVeg-Bf 540 3397 (2733 - 4219) 4.35 ±  0.91   16.44*** 3 311 (218 - 442) 
F1 SAMB × CREVeg-Bf 329    37 (29 - 47) 1.46 ±  0.18     1.70 5 3.38 (2.92 - 3.92) 
 
anumber of mites tested 
bLC, lethal concentration expressed in mg L-1  
cChi-square testing linearity, * P < 0.05, ** P < 0.01, *** P < 0.001 
dRR, resistance ratio = LC/LCSAMB 
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4 DISCUSSION 
 
We have investigated pyrethroid resistance in two strains of T. urticae from Greece (ATHRos-
Bf and CREVeg-Bf ) exhibiting strong resistance to bifenthrin (2495- and 1026-fold) and 
fluvalinate (867- and 1132-fold). Combined bioassays (cross resistance pattern), biochemical 
and synergistic data indicated that enhanced detoxification was not a major component of 
resistance, suggesting target-site resistance as the main mechanism. A 3.3-kb cDNA fragment 
(domains II-IV) of the T. urticae para sodium channel gene was obtained by a degenerate 
PCR strategy. A comparison of the sequences between susceptible and resistant mites revealed 
two changes that were found only in the resistant strains: a phenylalanine to isoleucine 
substitution (equivalent to F1538I) in domain IIIS6 and an alanine to aspartic acid substitution 
(equivalent to A1215D) within the II/III intracellular linker region. The F1538I mutation 
seems to be the most important in determining the resistance phenotype because 1) this same 
mutation has previously been identified in several pyrethroid-resistant strains of the southern 
cattle tick B. microplus (He et al. 1999); 2) it has been shown to confer strong insensitivity to 
a range of pyrethroids when functionally expressed in an in vitro assay system (Tan et al. 
2005); 3) F1538 is one of several aromatic residues in the IIIS6 helix that form part of a 
putative hydrophobic binding site for pyrethroids in a computer-generated 3D model of the 
housefly sodium channel (O'Reilly et al. 2006, Davies et al. 2008). In this model, which is 
based on crystal structures of closely-related potassium channels, a high-affinity site for 
pyrethroid binding is formed during channel activation as the IIS4-S5 linker is pulled closer to 
the IIS5 and IIIS6 helices, with the bound pyrethroid then acting as a molecular ‘wedge’ to 
hold the channel in its open conformation and thereby delaying channel de-activation. F1538 
is one of several aromatic residues that are predicted to interact with the alcohol groups of 
double-ring cyclic pyrethroids and so it is not surprising that mutations at this residue will 
destabilise this high affinity binding to give resistance (O'Reilly et al. 2006, Davies et al. 
2008), although the exact nature of these interactions and the reason(s) why that certain 
pyrethroids (e.g. bifenthrin and fluvalinate) are more affected than others (e.g. fenpropathrin) 
are not clear at present, but are likely to reflect other sequence differences between the insect 
and mite sodium channel within the proposed binding site (O'Reilly et al. 2006) and can be 
explored in more detail by continued site-directed mutagenesis and expression studies of 
insect/mite sodium channels in Xenopus oocytes (Tan et al. 2005). 
At this stage, it is not possible to predict whether the second substitution (A1215D) is likely to 
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be contributing to the resistance phenotype. This residue lies within the domain II-III 
intracellular linker which is one of the most variable regions of the protein amongst species 
and the role of this region in determining channel structure and function is currently not 
known. It is of course possible that this is a simple polymorphism that happened to be present 
in the resistance allele when F1538I was selected, and so makes no contribution towards 
resistance.  Likewise, the five amino acid replacements (L151V, G178S, A182G G189D and 
S253T) found only in the resistant strain from Crete (CREVeg-Bf) are similarly located in the 
highly variable region of the domain II/III linker and so may also be polymorphisms that are 
related to the origin of the strain rather than to the resistant phenotype. Nevertheless, the 
possibility that these mutations also contribute to the resistance, in line with I/II linker 
mutations of the cockroach channel (Tan et al. 2002a) can not be excluded completely. 
Finally, the possibility of the occurrence of additional mutation(s) outside the IIS4-IVS6 gene 
region analysed in this study, associated or contributing to the resistance phenotype can not be 
discounted. 
In contrast to previous studies (Van Leeuwen et al. 2005), biochemical and bioassay 
(synergistic) data indicated that detoxifying enzymes are probably not the primary resistance 
component in the ATHRo-Bf and the CREVeg-Bf strains. However, the overexpression of 
P450s in both resistant strains, and notably (up to 9 fold) in the ATHRo-Bf with the highest 
resistance levels requires further investigation, as it is possible (but not clear, given that the in 
vivo data with PBO do not support this hypothesis) that the P450 based detoxification 
supplements the main target site resistance mechanism.  
The putative 1108 amino acid sequence isolated in this study had highest similarities to the 
remarkably heterogeneous class Arachnida and less than 50% compared to the class Insecta. 
The distinct sequence characteristics and variation of the T. urticae sodium channel gene 
compared to insects might be related to the pharmacologically different response of this mite 
to several pyrethroids in comparison to insects (Khambay and Jewess 2005). 
Alternative splicing is a major mechanism by which sodium channels increase their functional 
diversity in several species, including the physiological response to pyrethroid insecticides 
(Tan et al. 2002b, Davies et al. 2007a). Three alternative splicing variants were identified in 
this study. Two of them differed dramatically in sequence variation and correspond to the 
mutually exclusive k/l exon pair already identified in insects. A larger variant that includes 
both k and l exons was also observed in some rare plasmids and probably results from 
incomplete RNA processing. The frequency of variants was not different between resistant 
and susceptible strains and the occurrence of resistant mutations was not affected by the 
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transcript variation. The functional importance of this transcript variation in T. urticae (if any) 
remains to be investigated. 
Mortality data with bifenthrin in the F1 progeny from crosses between SAMB and CREVeg-
Bf indicated that the mode of inheritance of the target insensitivity-based bifenthrin resistance 
was almost completely recessive, consistent with studies of this mechanism in other species 
(Halliday and Georghiou 1985, Sayyed et al. 2005). The resistance in a B. microplus strain 
with the F1538I mutation displayed various levels of incomplete dominance to pyrethroids, 
although this was probably a maternal effect due to additional mechanism(s) involved in 
pyrethroid resistance (Aguilar-Tipacamú et al. 2008). In T. urticae it was not possible to detect 
the involvement of such maternal effects since one of our reciprocal crosses resulted only in 
male offspring due to possible Wolbachia mediated reproductive incompatibility (Breeuwer 
1997).  
The recessive mode of inheritance means that the trait will be mainly expressed in 
homozygous individuals. Therefore, the ability to detect heterozygotes is of paramount 
importance for the early detection of resistance and the application of resistance management 
strategies. 
In conclusion, we characterized the pyrethroid resistance mechanism in two T. urticae strains 
isolated from Greece. The substitution F1538I in III6 of the voltage gated sodium channel, 
one of the most highly effective resistance loci for synthetic pyrethroids, has been found for 
the first time in an agricultural pest. The mutation appears to be a prime target for developing 
a DNA-based screening method for pyrethroid resistance in field populations of T. urticae. 
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1 INTRODUCTION 
 
Organophosphates (OPs), and, to a lesser extent, carbamates (CARB), are both chemical 
groups used to control the two-spotted spider mite T. urticae, an economically important 
agricultural pest with a wide range of host plants and geographic distribution. They act by 
inhibiting acetylcholinesterase (EC 3.1.1.7, AChE), a key enzyme in the nervous system of 
both vertebrates and invertebrates.  
Since the first reported cases of OP resistance in the late 40’s (Helle 1962), T. urticae has 
developed resistance towards almost every acaricide used for its control. Within the OP 
family, cross-resistance is a general rule in T. urticae (Voss and Matsumura 1964, Cranham 
1974, Brun et al. 1983, Tsagkarakou et al. 1996, Herron et al. 1998, Stumpf et al. 2001, Van 
Leeuwen et al. 2005). This can result from enhanced detoxification (Voss and Matsumura 
1964, Van Leeuwen et al. 2005) and/or target site insensitivity. The insensitivity of T. urticae 
AChE towards OPs was first reported in 1964 (Smissaert 1964) suggesting the presence of 
some modifications at the active site of the enzyme (Voss and Matsumura 1964). Since then, 
AChE insensitivity to OPs has been demonstrated in various strains of T. urticae from the 
Netherlands, Germany, USA, New Zealand, Israel, Egypt, Greece and Japan (Zahavi and 
Tahori 1970, Helle 1984, Cranham and Helle 1985, Eldin 1990, Stumpf et al. 2001, 
Tsagkarakou et al. 2002, Anazawa et al. 2003). 
Many insects and ticks have at least two genes, termed ace-1 and ace-2, encoding for AChE1 
and AChE2, respectively. These genes correspond to the Drosophila paralogous and 
orthologous genes (Weill et al. 2002). In the dipteran order of the Cyclorrhapha (true flies), 
only the ace-2 gene is present (Huchard et al. 2006). In insects that have both genes, the main 
synaptic function is encoded by ace-1 (Weill et al. 2002, Weill et al. 2003). In this gene, seven 
point mutations associated with resistance to OPs and CARBs have been reported, resulting in 
the following amino acid substitutions: G119S, A201S, F290V, G227A, S331F, and 
F331W/C; numbering based on Torpedo californica AChE nomenclature (Massoulié et al. 
1992, Anazawa et al. 2003, Nabeshima et al. 2003, Weill et al. 2003, Li and Han 2004, 
Nabeshima et al. 2004, Baek et al. 2005, Cassanelli et al. 2006, Alout et al. 2007b, Alout et al. 
2007a). However, only G119S, F290V, S331F and F331W were demonstrated to confer 
insensitivity by means of in vitro experiments. In true flies, one or a combination of mutations 
in the ace-2 gene, including substitutions F78S, I129V/T, V150L, G227A/V, F290Y, G328A 
and G396S conferred in vitro insensitivity to OP insecticides (Mutero et al. 1994, Walsh et al. 
2001, Vontas et al. 2002, Menozzi et al. 2004, Aiki et al. 2005, Magana et al. 2008).  
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Although biochemical evidence of AChE insensitivity in T. urticae was already revealed in 
1964 by Smissaert (1964), the exploration of the molecular basis of AChE1 insensitivity in 
Tetranychidae started only quite recently. Among phytophagous mites, ace-1 gene sequences 
encoding for the enzyme AChE1 have been determined in two tetranychid species, i.e. T. 
urticae and T. kanzawai (Anazawa et al. 2003, Aiki et al. 2005). The comparison of the 
AChE1 amino acid sequence from susceptible and OP resistant T. urticae from Japan revealed 
the presence of a F331C substitution (Anazawa et al. 2003). In OP resistant T. kanzawai a 
tryptophan was detected at position 331 (W331) (Aiki et al. 2005). In a first part of this 
chapter the presence of mutations in the ACHE1 of several OP- and CARB-resistant T. 
urticae strains was examined. 
Bifenazate, a hydrazine derivative with acaricidal activity, was discovered in 1990 by 
Uniroyal Chemical and commercialised in 1999 (Dekeyser et al. 1994, 2003, Grosscurt and 
Avella 2005). It was thought to be a neurotoxin, acting on the post-synaptic GABA-receptor 
in the insect/mite nervous system (Dekeyser 2005). However, a different mode of action as a 
mitochondrial Qo inhibitor has recently been proposed mainly based on genetic and cross-
resistance evidence (Van Leeuwen et al. 2008, Van Nieuwenhuyse et al. 2009). In addition, 
while investigating possible detoxification routes, Van Leeuwen et al. (2006a) discovered the 
pro-acaricide nature of bifenazate, i.e. it must be metabolized first in order to become toxic. 
They proposed an activation pathway where hydrolysis of the ester bond by a S,S,S-tributyl 
phosphorotrithioate (DEF) sensitive esterase is the first step.  
Bifenazate mainly shows excellent activity against many phytophagous mite species including 
T. urticae, providing quick knockdown through contact activity and long residual control 
(four weeks) (Ochiai et al. 2007). Bifenazate can be included in integrated management 
programs because of its low toxicity to predatory mites (Ochiai et al. 2007). 
The current trend in pesticide development is to release less broad-spectrum and more 
specific pesticides like bifenazate, in order to avoid negative effects on non-target organisms, 
while still providing effective control of the target pest. However, the two-spotted spider mite 
is typically not the only arthropod pest in fields and greenhouses. Consequently, growers can 
encounter a range of insect and mite pests simultaneously (Warnock and Cloyd 2005). 
Therefore, mixtures of different pesticides are used to manage the diversity of arthropod pests 
present in a crop (Bynum et al. 1997). Although there are concerns associated with pesticide 
mixtures such as enhanced resistance to one or more pesticides, phytotoxicity and pesticide 
incompatibility and antagonism (Warnock and Cloyd 2005), they are widely used. 
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Recently, it was reported that OP and CARB insecticides can interfere with bifenazate 
toxicity (Van Leeuwen et al. 2007). Experiments in which a susceptible reference strain of T. 
urticae was pre-treated with sublethal doses of OPs and CARBs, revealed a clear antagonistic 
effect on bifenazate toxicity. It was argued that antagonism could compromise bifenazate 
efficacy under field conditions. This antagonism may be explained by the proposed esterase-
mediated activation pathway of the bifenazate carboxylester bond (Van Leeuwen et al. 2007). 
Although OP and CARB compounds target acetylcholinesterase (AChE), they can also inhibit 
general hydrolytic esterase activity (Gunning et al. 1999), and hence interfere with bifenazate 
activation and toxicity. 
So, in the second part of this chapter, the risk of antagonism between bifenazate and OPs and 
CARBs in mixtures was estimated, using two OP resistant strains, in contrast to the pre-
treatment experiments previously reported (Van Leeuwen et al. 2007). OPs and CARBs are 
ineffective against these mites, allowing high uptake and inhibition of the general esterase 
activity without inhibiting AChE. Since many strains worldwide have developed resistance to 
OPs, the aim of this study was to evaluate whether these resistant strains pose a threat to 
antagonism based control failure of bifenazate, when OPs or CARBs are mixed with 
bifenazate to control other pests. 
 
2 MATERIALS AND METHODS  
2.1  Strain characteristics  
In this study we characterized three laboratory T. urticae strains which have been commonly 
used as reference strains (SAMB, GSS and LS-VL) and three resistant strains maintained in 
the laboratory under continuous OP selection (OP strains: WI, MR-VL and ATHRos-Pm). 
SAMB and GSS were both maintained in the laboratory without treatment since 1965. SAMB 
was initially collected on Sambucus nigra (L) in the Netherlands and obtained from the 
Centre de Biologie et de Gestion des Populations, Montpellier, France. GSS was obtained 
from Bayer CropScience (Monheim, Germany) and was originally collected from an 
unknown host in Germany. LS-VL was collected in 2000 from roses in a garden near Ghent, 
Belgium (Van Leeuwen et al. 2004) and since then it had been maintained in the laboratory 
without treatment.  
The historical German resistant strain WI has a well studied target site resistance to OPs and 
CARBs (Stumpf et al. 2001). It was obtained from Bayer CropScience where it has been 
maintained in the laboratory under biannual selection with the OP oxydemeton-methyl since 
1954 (Nauen et al. 2001). Biochemical characterization has shown that the main resistance 
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mechanism was an altered acetylcholinesterase with a 110-fold and 340-fold lower sensitivity 
to inhibition by chlorpyrifos oxon and ethyl paraoxon, respectively (Stumpf et al. 2001). 
The OP strains MR-VL (from Belgium) and ATHRos-Pm (from Greece) were more recently 
collected from fields on which failure of all insecticide treatments, including OPs, was 
claimed by the farmers. MR-VL was collected in 2003 from a greenhouse nursery where 
poplar cuttings, beans and ornamentals were grown, while ATHRos-Pm was collected in 2007 
on roses in a greenhouse near Athens. Both strains developed resistance to many acaricides 
currently used to control spider mites (Van Leeuwen et al. 2005, Tsagkarakou et al. 2009b). 
ATHRos-Pm was maintained in the laboratory under pirimiphos-methyl selection every two 
generations with concentrations causing ~ 80% mortality before its characterization after eight 
selections.  
All mites were reared continuously on potted kidney bean plants, Phaseolus vulgaris L. cv. 
“Prelude”, in a climatically controlled room at 26 °C + 1°C, 50-60 % RH and 16/8 h (L/D) 
photoperiod.  
2.2 Chemicals 
Commercial formulations of pirimiphos-methyl 500 g L-1 EC (Actellic, Syngenta, UK), 
dimethoate 400 g L-1 EC (Dimethoate, Lapafarm, Greece), chlorpyrifos 480 g L-1 EC 
(Dursban Dow Agrosciences, USA), bifenazate 240 g L-1 SC (Floramite, Crompton Crop 
Protection, UK), azinphosmethyl 500 g L-1 WP (Guthion, Bayer CropScience, Germany), 
phosmet 700 g L-1 WP (Imidan, Gowan Company, USA), carbaryl 500 g L-1 WP (Sevin, 
Southern Agricultural Insecticides, USA) and methomyl 200 g L-1 SL (Alpha, Greece) were 
used.  
2.3 Bioassays 
Toxicity bioassays using 6 strains and 4 compounds (pirimiphos-methyl, chlorpyrifos, 
dimethoate and methomyl) were conducted on detached bean leaves with a precision Potter 
Spray Tower (Burkard, Rickmansworth, Hertfordshire, UK (Potter 1952)) as described by 
Tsagkarakou et al (2009b). LC50 values and 95% confidence limits were calculated by the 
log-probit program (Raymond et al. 1993) based on Finney (Finney 1971). Resistance ratios 
at the LC50 (RR50) were considered to be significantly different from 1 when their 95% 
confidence limits did not include this value. 
To evaluate antagonistic effects of OPs and CARBs on bifenazate toxicity, first, toxicity of 
the OP and CARB insecticides (methomyl, azinphosmethyl, phosmet and carbaryl) to the WI 
and MR-VL strains was assessed using a dose-screening test (between 50-2000 mg active 
ingredient (a.i.) L-1). Second, mixtures were prepared by adding a constant dose of 100 mg a.i. 
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L-1 (when LC10 is higher than 100 mg a.i. L-1) or LC10 of OP and CARB insecticides to 
varying concentrations (125, 250, 500, 1000 mg a.i. L-1) of bifenazate. Also a water treatment 
as control, a 125 mg a.i. L-1 bifenazate and 100 mg a.i. L-1 or LC10 of the OP and CARB alone 
were used. Each treatment was replicated at least 3 times. Mortality, defined by the inability 
of mites to move when prodded by a camel-hair pencil, was scored every 24 hours for 5 
consecutive days after treatment. 
2.4 Acetylcholinesterase activity and inhibition studies 
For determining the AChE1 activity, 1000 adult females were mass homogenized in 1 ml 
extraction buffer containing 10 mM Tris, pH 7.0, 1 M NaCl and 0.4% Triton X-100. The 
supernatant obtained after centrifugation (10000 g, 4°C, 10 min) was used as the enzyme 
source. The reaction was conducted in 1ml substrate-reagent solution containing 30-50 µg of 
protein, 5,5’-dithio-bis (2-nitrobenzoic acid) (DTNB) and acetylthiocholine (AcSCh) each in 
a final concentration of 0.5mM. The mean activity values were compared between strains by 
one-way analysis of variance (ANOVA) using the SPSS statistical software version 13.0 
(LSTM, UK). Residual AChE1 activities were measured with increasing concentrations of the 
analytical grade inhibitors chlorpyrifos-oxon (varying between 10-9 M to 10-3 Μ), paraoxon 
(10-9 M - 10-3 Μ), carbaryl (10-10 M - 10-3 Μ), pirimiphos methyl (10-7 M - 10-3 Μ) and 
omethoate (10-7 M - 10-3 Μ). Briefly, the enzyme source was incubated for 10 min with the 
inhibitor solution at a given concentration before adding the substrate-reagent solution. 
Residual activity was estimated by kinetically measuring the variation in optical density at 
412 nm with a spectrophotometer (M2e, Molecular Device, UK). Blanks without homogenate 
or substrate were used to correct for non-enzymatic activity. Enzyme inhibition was expressed 
as the mean percentage of activity remaining at different inhibitor concentrations and the 
inhibitor concentration inducing 50% inhibition (IC50) was determined using the Microcal 
Origin 6.0 data analysis program. 
2.5 Detoxifying enzyme assays 
The in vitro activity of cytochrome P450 mono-oxygenases was quantified by measuring the 
O-deethylation of 7-ethoxy-4-trifluoromethylcoumarin (7-EFC) and esterase activity was 
measured with the substrate 4-nitrophenylacetate (4-NPA), as outlined by Van Leeuwen et al. 
(2005). Glutathione-S-tranferase (GST) activity was measured with substrates 1-chloro-2,4-
dinitrobenzene (CDNB) and  monochlorobimane as described by Van Pottelberge et al. 
(2009b). Enzyme activities were compared by analysis of variance (ANOVA) and significant 
differences were assessed using Tukey’s method (S-Plus 8.0 for Windows, Insightful Corp) 
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2.6 Extraction of DNA and RNA, cDNA synthesis, cloning, and sequencing  
Total DNA was extracted from mass homogenates as described by Van Leeuwen et al. 
(2008). Total RNA was extracted from mass homogenates of T. urticae mites using TRI 
reagent (Sigma-Aldrich, Belgium) according to the manufacturer’s instructions. The RNA 
was treated with DNase RQ1 (Promega, Madison, WI) to remove genomic DNA. Two µg 
total RNA for each sample was reverse transcribed into cDNA by using the High Fidelity 
cDNA synthesis kit (Roche, Belgium) and random hexamer primers. Primers (Table 3.1) were 
designed based on the published sequence of T. urticae AChE1 (AY188448). For cDNA 
amplification, a long PCR was performed using Acetrur F and Acetrur R primers (Expand 
Long Range Kit, Roche, Belgium), according to the manufacturer’s instructions. 2.5 kb 
fragments were purified with QIAEX II (Qiagen), cloned into the pGEM-T vector (Promega), 
and sequenced with primer walking. To ensure allele representations, three clones were 
sequenced for each strain. Plasmids were sequenced by Agowa Sequencing Service (Berlin). 
Sequence data were analyzed using BioEdit 7.0.1. (Hall 1999). 
 
Table 3.1 Primers used for the amplification of the Tetranychus urticae AChE1. 
Primers  Sequence (5’ – 3’) 
Acetrur F AAAGGGAGAAGGCAAAAGTGT 
Acetrur R TGCTCATGTTCAGTTGATCG 
AcETuSeqF1 AATGCCACCTCATTTTCAGG 
AcETuSeqF2 TATCACGCAACGTTTTCAGC 
AcETuSeqF3 ATGAAGATCCCGAGGTTTCC 
AcETuSeqF4 TGGGAGTTATTCATGGTGAGG 
AcETuSeqR1 CATGAATCGATGGGCTTAGG 
AcETuSeqR2 AGCTGATTCACCGAAAATGG 
AcETuSeqR3 AACTGCTTCTTGGGCTAAAGG 
AcETuSeqR4 CAGTGTACTCAGGCCACACG 
AchEDISCF2 AAGCAATCGTGATGAGGGGCCCTATT 
AchEDISCR2 CTAAAGGACTCAGATGGGGATAAAT 
 
2.7 Three-dimensional modelling  
The modelled three-dimensional structure (3D) of T. urticae AChE1 was created by 
automated homology modelling as described by Weill et al. (2004). The structural templates 
used were AChE from Torpedo californica (PDB: 1EA5) (Sussman et al. 1991) and 
Drosophila melanogaster (PDB: 1DX4) (Harel et al. 2000). The alpha-carbon skeleton of the 
modelled 3D structure of AChE1 was superimposed on that of the AChE of T. californica. 
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RMS deviation is 1.1 Å on 532 carbon atoms (from Dali pairwise comparison webserver 
[http://ekhidna.biocenter.helsinki.fi/dali_lite/start]). 
2.8 Diagnostic PCR-RFLP for W331 
Two primers were designed (AcheDISCF2, AcheDISCR2, Table 3.1) around position 331 
that amplified a 137 bp fragment using genomic DNA as template. Amplifications from 
approximately 40 ng gDNA were performed in 1xTaq reaction buffer (Invitrogen) with a final 
concentration of 1.5 mM MgCl2 and 0.5 µM of each primer, with cycling conditions 94 oC for 
3 min, 35 cycles of 94 oC for 15 s, 55 oC for 30 s, 72 oC for 40 s, followed by 72 oC for 2 min. 
A restriction digest using 10 µl PCR product was performed in a total volume of 30 µl using 
Bgl I according to the manufacturer’s instructions (Fermentas). Approximately 20µl was 
loaded onto a 3% agarose gel and after 1.5 hours at 50V the separated restriction fragments 
were visualized by ethidium bromide staining. 
 
3 RESULTS 
3.1 Resistance characteristics of the T. urticae strains  
Among the reference strains, variable levels of sensitivity were found (Table 3.2). LS-VL 
proved to be the most susceptible to all insecticides tested: LC50 of pirimiphos methyl, 
chlorpyrifos, methomyl and dimethoate were 16, 11, 28 and 8 mg L-1, respectively. Therefore 
this strain was used as a susceptible reference to calculate the RR50 of the other strains. 
SAMB exhibited a 31 and 29- fold resistance to chlorpyrifos and dimethoate, respectively. 
GSS was 21 and 1411- fold more resistant to pirimiphos-methyl and dimethoate, respectively.  
The OP strains ATHRos-Pm, MR-VL and WI were resistant to all insecticides tested, with 
RR50 of at least 8.4 (Table 3.2). Among the three OP strains, the highest levels of resistance to 
pirimiphos methyl (RR50 = 43), dimethoate (RR50 = 4164) and methomyl (RR50 = 333) were 
exhibited by ATHRos-Pm, and the weaker levels by WI (RR = 8.9, 137 and 8.4 to pirimiphos-
methyl, dimethoate and methomyl, respectively). For chlorpyrifos, the resistance ratio was 
higher in the WI and MR-VL strain (RR50 = 421 and 586, respectively). 
3.2 Biochemical characterization of the AChE1 enzyme  
AChE1 activity was highest in SAMB strain (63 ± 11 mOD/min/mg protein), followed by 
MR-VL strain (37 ± 1 mOD/min/mg protein) (P < 0.01) (Table 3.3). The four other strains 
showed lower activities, which did not differ significantly from each other. 
As is shown by the IC50 values (Table 3.3), AChE1 from the OP strains WI, MR-VL and 
ATHRos-Pm were much less sensitive to inhibition by pirimiphos methyl, chlorpyrifos oxon, 
paraoxon and carbaryl than the three reference strains. WI and MR-VL were less sensitive to 
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inhibition by omethoate than LS-VL and SAMB (omethoate was not tested for AChE1 from 
GSS and ATHRos-Pm strains and no comparison is possible). AChE1 from SAMB and LS-VL 
were more sensitive to inhibition by chlorpyrifos-oxon but less sensitive to inhibition by 
carbaryl than the AChE1 from GSS. For paraoxon, IC50 values for SAMB and GSS were very 
similar and lower than that of LS-VL. Among the OP strains, IC50 values were similar for the 
OPs and the CARBs tested. 
 
Table 3.2 Toxicity data of the OP selected and the reference Tetranychus urticae strains treated with 
several OP and one CARB insecticides.  
 
Treatment na LCb50 Slope ±  SE χ2c df RR50d  
LS-VL        
Pirimiphos methyl 522        16 (12 – 21) 2.66 ± 0.39 11* 4  
Chlorpyrifos 435        11 (4.8 – 24) 0.98 ± 0.27 14*** 3  
Methomyl 435        28 (14 – 57) 1.20 ± 0.30 24*** 4  
Dimethoate 214          8 (2 – 29) 0.88 ± 0.27 12** 3  
SAMB       
Pirimiphos methyl  254        18 (16 – 21) 4.50 ± 0.14    0.4 1 1.1 (0.8 – 1.7) 
Chlorpyrifos 315      333 (173 - 646) 2.75 ±1.17 16*** 2 31 (15 – 64) 
Methomyl 378        40 (9.34 – 167) 2.48 ± 1.36 52*** 2 1.4 (0.4 – 5.4) 
Dimethoate 226      226 (182 - 282) 4.97 ± 0.14   5 2 29 (17 – 47) 
GSS       
Pirimiphos methyl  577      332 (166 - 665) 6.56 ± 6.85 135*** 2 21 (3.9 – 113) 
Chlorpyrifos 328        63 (19 – 215) 5.67 ± 7.05 136*** 2 5.8 (0.4-79) 
Methomyl 279        50 (26 – 94) 2.11 ± 0.50 6.7* 2 1.8 (1.0 – 3.2) 
Dimethoate 281 11164 (7418 - 16836) 3.80 ± 1.43 8.8* 2 1411 (686 – 2904) 
WI       
Pirimiphos methyl 463     142 (96 – 209) 4.70 ± 1.81 37*** 3 8.9 (4.4 – 18) 
Chlorpyrifos 424   4584 (2786 – 7530) 3.93 ± 1.23 28*** 3 421 (196 – 907) 
Methomyl 373     236 (151 – 373)  3.86 ± 1.26 17*** 3 8.4 (4.2 – 17) 
Dimethoate 394   1502 (915 – 2467) 2.24 ± 0.64 18*** 3 137 (84 – 224) 
MR-VL       
Pirimiphos methyl 329     314 (266 – 374) 3.75 ± 0.41 3.9 3 20 (14 – 28) 
Chlorpyrifos 392   6386 (4261 – 9567) 4.05 ± 1.08 21*** 3 586 (302 – 1137) 
Methomyl 419   3759 (3178 – 4370) 3.08 ± 0.32 4.2 3 134 (95 – 189) 
Dimethoate 334   5878 (2218 – 15579) 3.16 ± 2.02 59*** 3 743 (223 – 2465) 
ATHRos-Pm       
Pirimiphos methyl  337     685 (497 – 944) 2.81 ± 0.73 12** 3 43 (28 - 66) 
Chlorpyrifos 366     895 (624 - 1289) 2.62 ±0.57 9.4* 3 78 (39 - 156) 
Methomyl 301   9338 (4421 - 19649) 3.11 ± 0.95 16*** 2 333 (136 - 818) 
Dimethoate 319 32950 (23977 - 45249) 6.09 ± 3.28 8.5*** 1 4164 (1728 – 10036) 
a n, number of mites tested 
b LC, lethal concentration expressed in mg L-1  
c χ2, Chi-square testing linearity, * P < 0.05, ** P < 0.01, *** P < 0.001 
d RR, resistance ratio = LC/LCLS-VL 
Confidence Intervals of LC
50
 and RR
50
 are given in parenthesis 
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3.3 Comparison of the AChE1 sequence of the reference and the OP selected strains  
Using specific primers and long PCR strategy, the cDNA sequence of a 2.5 kb fragment was 
determined in the six strains (GenBank accession nos. GQ461336-GQ461353). This fragment 
contains an open reading frame encoding for an AChE1 precursor of 687 amino acid residues. 
Three cDNA clones were sequenced from each strain resulting in a total of 18 clones which 
revealed 88 variable nucleotide sites including inter- and intra-strain polymorphisms. Forty 
four of these resulted in amino acid substitutions. By comparing these substitutions in the 
AChE1 primary sequence from the different strains, we identified six mutations in the OP 
strains that were not present in the reference strains. Only four of them were present in the 
mature protein (numbering based on Torpedo californica AChE nomenclature, Massoulié et 
al. 1992): 1) at position 201, an alanine residue (GCT) is replaced by a serine (TCT) (A201S) 
in the three clones of the OP resistant strain ATHRos-Pm, 2) at position 280, a threonine 
residue (ACA) is replaced by an alanine (GCA) (T280A) in all the three OP strains except for 
one clone of the ATHRos-Pm strain, 3) at position 328, a glycine (GGA) is replaced by an 
alanine (GCA) (G328A) in the ATHRos-Pm and MR-VL strains and 4) at position 331, a 
phenylalanine (TTT) is replaced by a tryptophan (TGG) (F331W) in all clones of the three OP 
resistant strains. Interestingly, the F331 residue is replaced by a tyrosine (TAT) (F331Y) in 
two clones of reference strains (one in SAMB and one in GSS strain). Moreover, two amino 
acid substitutions, a valine (GTT) to isoleucine (ATT) at position 7 (V7I) and a glycine (GGC) 
to serine (AGC) at position 119 (G119S) were found specifically in the reference strain 
SAMB (Table 3.4). 
3.4 Three-dimensional modelling  
The positions of the mutations in the structural model of T. urticae AChE1 are shown in 
Figure 3.1. The active site of cholinesterases is subdivided into functional groups important for 
the hydrolysing process: the catalytic triad (S200, E327 and H440), the peripheral anionic site 
(D72, Y121, W279 and Y334), the choline binding site (W84, Y130, Y330 and F331), the acyl 
binding pocket (F288 and F290) and the oxyanion hole (G118, G119, A201) (Gibney et al. 
1990, Sussman et al. 1991, Harel et al. 1992, Ordentlich et al. 1993, Vellom et al. 1993). 
Among the two substitutions specifically found in the susceptible strain SAMB the first one, 
V7I, is located in the extremity of the N-terminal of the enzyme structure and may not 
influence the catalytic properties of AChE1. The second substitution, G119S, is located in the 
active site that belongs to the oxyanion hole and affects an important residue close to the 
catalytic serine residue (S200) thus it may modify the catalytic properties of the enzyme.   
  
Table 3.3 Specific activities and IC50 of various OP and CARB inhibitors on AChE1 extracted from OP selected and reference Tetranychus urticae strains 
 
 IC50 (M) 
 
Strain 
 
AChE activity 
mOD/min/mg 
 
Pirimiphos methyl 
 
Chlorpyrifos-oxon 
 
Paraoxon 
 
Carbaryl 
 
Omethoate 
LS-VL 22 ± 1.5 a 3.7 ± 0.7 x 10-4 7.0 ± 2 x 10-8 4.3 ± 1.2 x 10-6 6.0 ± 1.8 x 10-6 7.4 ± 2.7 x 10-6 
SAMB  63 ± 11 b 2.7 ± 0.4 x 10-4 2.5 ± 0.3 x 10-8 1.0 ± 0.4 x 10-7 8.7 ± 4.3 x 10-6 5.2 ± 3.4 x 10-6 
GSS 24  ± 4 a 3.8 ± 1.2 x 10-4 1.8 ± 0.2 x 10-7 1.2 ± 0.1 x 10-7 8.2 ± 3.8 x 10-7  
WI  23 ± 2 a > 10-3 1.8 ± 0.6 x 10-6 8.0 ± 3 x 10-4 7.6 ± 4.2 x 10-5 2.3 ± 1.5 x 10-4 
MR-VL 37 ± 1 c > 10-3 1.1 ± 0.9 x 10-6 4.3 ± 1.8 x 10-4 4.4 ± 2.2 x 10-4 8.7 ± 5.2 x 10-4 
ATHRos-Pm 26 ± 6 a > 10-3 1.0 ± 0.5 x 10-6 2.5 ± 0.3 x 10-4 6.2 ± 3.2 x 10-4  
 
  
 
Table 3.4 Amino acid polymorphism between reference laboratory and OP selected strains of Tetranychus urticae.  
Numbers refer to the position in mature AChE1 of Torpedo californica (Massoulié et al. 1992). Numbers in brackets 
refer to the position in T. urticae AChE1 precursor. 
 
 Position 
Strains-Clones 
(genbank accession) 7 (115) 119 (228)  201 (309) 280 (391) 328 (436) 331 (439) 
LS-VL-1 (GQ461336) V (GTT) G (GGC) A (GCT) T (ACA) G (GGA) F (TTT) 
LS-VL-2 (GQ461337) V G A T G F 
LS-VL-3 (GQ461338) V G A T G F 
SAMB-1 (GQ461342) I (ATT) S (AGC) A T G Y (TAT) 
SAMB-2 (GQ461343) I S A T G F 
SAMB-3 (GQ461344) I S A T G F 
GSS-1 (GQ461348) V G A T G F 
GSS-2 (GQ461349) V G A T G Y 
GSS-3 (GQ461350) V G A T G F 
WI-1 (GQ4613451) V G A A(GCA) G W (TGG) 
WI-2 (GQ461352) V G A A  G W  
WI-3 (GQ461353) V G A A G W 
ATHRos-Pm-1 (GQ461345) V G S (TCT) A  A (GCA) W  
ATHRos-Pm-2 (GQ461346) V G S A A W 
ATHRos-Pm-3 (GQ461347) V G S T A W 
MR-VL-1 (GQ461339) V G A A A W 
MR-VL-2 (GQ461340) V G A A A W 
MR-VL-3 (GQ461341) V G A A A W 
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The T280A mutation was found in all OP strains and the structural model reveals its position 
on the surface of the enzyme near the gorge entrance. However, the T280 residue is not 
involved in the catalytic process and was never shown to confer AChE insensitivity (neither 
AChE1 nor AChE2). Hence, this mutation might be neutral. In contrast, the F331W mutation 
that is also found in all OP strains is at a residue which is conserved among AChE1 from both 
vertebrates and invertebrates, and is a component of the choline-binding site involved in the 
catalytic process. Thus, it is probably responsible, at least partially, for the modification of the 
catalytic properties of T. urticae AChE1 in the three OP resistant strains. In addition to the 
F331W, a G328A substitution was found in the ATHRos-Pm and the MR-VL strains. This 
position is not located in the active site but is in the same α-helix as the 331 position. 
Therefore this substitution may indirectly influence the catalytic process. In the ATHRos-Pm 
strain only, besides the 3 above substitutions (T280A, G328A and F331W), also the A201S 
substitution was detected. This substitution is close to the catalytic serine (S200), therefore it 
may modify some of the biochemical properties of the enzyme. 
3.5 Diagnostic PCR-RFLP for W331 
We have developed a PCR-RFLP assay, based on primer induced mutagenesis that directly 
revealed the presence of W at codon 331. Three (CAA to GGC in MR-VL and ATHRos-Pm) 
or two (GAA to GGC in LS-VL, GSS, SAMB and WI) mutations were introduced by the 
forward primer by site directed mutagenesis, resulting in the generation of a Bgl I restriction 
site (5’-GCCNNNNNGGC), specifically in the PCR product of the resistant allele carrying 
W331. Digestion of the PCR products (137 bp) with Bgl I, consequently allowed for the 
discrimination between the resistance-associated W331 and the F or Y 331 alleles (Figure 3). 
The PCR-RFLP assay with male (haploid) T. urticae displays two different patterns: one with 
two fragments (112 bp and 25 bp) in 331W males and one with one fragment (137 bp), the 
original PCR product, in F331 or Y331 males (Figure 3.2). When pooled DNA from F331 and 
W331 males was used as template, a third pattern with three fragments (137 bp, 112 bp and 25 
bp) was obtained, suggesting that the assay can be used to detect heterozygous females (Figure 
3.2). The fragment of 25 bp is not detected as it is too small to be visualized by electrophoresis 
in a routine agarose gel. It is important to keep in mind that sequence conservation and the 
presence of other resistant alleles should be confirmed by sequencing in any future studies of 
T. urticae of other geographic origins before this diagnostic test is used, as it will not identify 
the C331 allele previously suggested to be associated with OP resistance in a Japanese T. 
urticae strain by Anazawa et al. (2003).  
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Figure 3.1 Three dimensional structure model of Tetranychus urticae AChE1. The backbone of the 
enzyme structure is rendered as green ribbon with secondary structure. The catalytic triad (S200, 
E327 and H440) appears as van der Waals red spheres. The different amino acid substitutions are 
shown as van der Waals coloured spheres. The view points to the entrance of the catalytic gorge. 
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Figure 3.2 Diagnostic PCR-RFLP for 331W after primer induced mutagenesis.  
Lane 1: uncut PCR product 
Lane 2: PCR was performed on plasmid DNA containing GSS 331 Y clone 
Lane 3: PCR on plasmid DNA containing LS-VL 331F clone 
Lane 4: PCR on plasmid DNA containing clone WI 331W clone 
Lane 5: PCR was performed on DNA extracted from a single male of strain MR-VL (containing 331W) 
Lane 6: PCR on pooled plasmids DNA containing clones GSS and WI strains 
Lane 7: PCR on pooled g DNA from two males from GSS and MR-VL strains 
Lane 8: PCR product on pooled mites GSS 
Lane 9: PCR products on pooled mites form LS-VL 
The PCR-RFLP assay on heterozygote females (F,Y331/W331) is expected to display pattern of lanes 6 and 7 
whereas patterns of lanes 1,2,3,8, and 9 are expected from homozygote (F or Y331) females and lanes 4,5 from 
homozygote (W331) females.  
Lane 10: MR DNA ladder (Invitrogen, Belgium). 
137bp 
112bp 
  1     2       3        4          5           6 7  8    9     10 
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3.6 Effects of mixtures of bifenazate with OP and CARB insecticides 
Both the WI and MR-VL strains were resistant to chlorpyrifos, carbaryl, phosmet and 
azinphosmethyl, and the estimated LC10 exceeded 100 mg a.i. L-1 (data not shown). Only 
methomyl was toxic to the WI strain, and the LC10 (50 mg L-1) was selected for mixing with 
bifenazate. A concentration of 100 mg a.i. L-1 was used in the mixtures with all other 
compounds, since this concentration did not cause mortality in both strains. 
Mixing chlorpyrifos with bifenazate decreased bifenazate toxicity in the WI strain. Mortality 
remained low even five days after treatment with the highest bifenazate concentrations (500 
and 1000 mg a.i. L-1) (Figure 3.3a). The maximum mortality obtained by a mixture after 5 
days was 16.2%. A similar effect was also observed in the MR-VL strain during two DAT. 
However, three days after exposure mortality increased, and after five days reached 44.5% at 
125 mg a.i. L-1 and 94% at 250 mg a.i. L-1 (Figure 3.3b). Since the antagonistic effect of 
chlorpyrifos was most prominent in WI strain, other OPs and CARBs were tested only on this 
strain. Methomyl induced a significant antagonistic effect (α<0.05) one DAT, which 
disappeared two DAT (Table 3.5). Azinphos methyl, phosmet, carbaryl and methomyl did not 
have an impact on bifenazate toxicity. 
Quantitative analyses of the enzyme activities of three tested strains are presented in Table 
3.6. No significant difference was observed in P450 O-deethylation activity measured with 7- 
EFC. In contrast, a significant difference in esterase activity was found between strains. The 
activity in MR-VL strain was 1.81-fold higher in comparison to that in the WI strain. GST 
activity measured with CDNB and MCB also were significantly higher in MR-VL strain in 
comparison to GSS and WI.  
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Figure 3.3 Control percentage of Tetranychus urticae strain WI (a) and strain MR-VL (b) with 
chlorpyrifos, different doses of bifenazate and their mixture (mean values + SEM).  
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Table 3.5 Percent mortality (mean± SEM) of Tetranychus urticae strain WI with four OPs and 
CARBs, different doses of bifenazate and their mixture. 
 
  1 DAT 2 DAT 3 DAT 4 DAT 5 DAT 
methomyl (50 mg a.i. L-1)      
Control (water) 0 3.1±1.2 6.2±2.7 11.3±3.1 21.7±4.6 
50 mg L-1 methomyl 17.3±8.2 22.1±9.9 30.8±12.5 37.5±9.8 46.2±7.9 
125 mg L-1 bifenazate 95.7±6.3 100 100 100 100 
125 mg L-1 bifenazate + methomyl 75±10.6 99.1±0.7 100 100 100 
250 mg L-1 bifenazate + methomyl 77.7±7.9 93.6±4.4 100 100 100 
500 mg L-1 bifenazate + methomyl 91.5±2.4 100 100 100 100 
1000 mg L-1 bifenazate+ methomyl 100 100 100 100 100 
azinphosmethyl (100 mg a.i. L-1)           
Control (water) 2.1±1.2 5.3±2.6 10.6±3.3 18.1±4.5 27.66±7.6
100 mg L-1 azinphosmethyl 1±0.7 3±1.1 5±1.6 12±1.7 16±2.3 
125 mg L-1 bifenazate 98±1.7 100 100 100 100 
125 mg L-1 bifenazate + azinphos methyl 99.1±0.7 100 100 100 100 
250 mg L-1 bifenazate + azinphos methyl 99.3±0.8 100 100 100 100 
500 mg L-1 bifenazate + azinphos methyl 99.1±1.1 100 100 100 100 
1000 mg L-1 bifenazate + azinphos methyl 100 100 100 100 100 
phosmet (100 mg a.i. L-1)      
Control (water) 0 1.4±0.8 12.4±1.4 15.9±1.1 17.9±2.1 
100 mg L-1 phosmet 0.9±1.3 0.9±1.3 5.5±1.4 7.3±2 9.1±1.8 
125 mg L-1 bifenazate 100 100 100 100 100 
125 mg L-1 bifenazate + phosmet 99.1±0.8 100 100 100 100 
250 mg L-1 bifenazate + phosmet 97.4±0.9 100 100 100 100 
500 mg L-1 bifenazate + phosmet 99.1±0.9 100 100 100 100 
1000 mg L-1 bifenazate + phosmet 100 100 100 100 100 
carbaryl (100 mg a.i. L-1)           
Control (water) 0 4±1.1 12.6±3.3 14.3±3.4 20.6±1.5 
100 mg L-1 carbaryl 0 4±.7 10.7±2.4 16±1.9 22.7±2.6 
125 mg L-1 bifenazate 100 100 100 100 100 
125 mg L-1 bifenazate + carbaryl 99.4±1 100 100 100 100 
250 mg L-1 bifenazate + carbaryl 98.6±0.7 100 100 100 100 
500 mg L-1 bifenazate + carbaryl 100 100 100 100 100 
1000 mg L-1 bifenazate + carbaryl 100 100 100 100 100 
DAT, day(s) after treatment 
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Table 3.6 Detoxification enzyme activities in different strains of Tetranychus urticae (mean ± SEM) 
Strain P450 mono-oxygenases   Esterases Glutathione-S-transferases 
 O-de-ethylation of EFCA 
 
4-NPA activityB CDNB conjugationC MCB conjugationD 
GSS 225.5 (± 34.2)a  107.2 (± 5.8)b 694.3 (± 17.3)b 805.4 (± 70.3)b 
WI 214.5 (± 23.4)a  88.0 (± 2.5)b 595.2 (± 14.4)c 1398.0 (± 144.6)a 
MR-VL 215.7 (± 96.8)a  159.2 (± 6.9)a 870.9 (± 17.0)a 1695.5 (± 39.5)a 
Means (± SEM) within the same column followed by the same letter are not significantly different 
(Tukey method, α = 0.05). 
 
A pmol 7-hydroxy-4-trifluoromethylcoumarin (30min)-1 mg-1 protein (± SEM) 
B nmol 4-nitrophenol min-1 mg-1 protein (± SEM) 
C nmol glutathione conjugated min-1 mg-1 protein (± SEM)  
D relative fluorescence units (RFU) µg-1 protein (± SEM) 
 
4 DISCUSSION 
Since the development of OP resistance in T. urticae in the late 1960s, the use of these 
compounds to control spider mites has largely been abandoned in many parts of the world. 
However, OPs and CARBs which account for more than 35 % of the total global insecticide 
sales (McCaffery and Nauen 2006) are still amongst the most widely used insecticides to 
control a broad range of arthropod pests of agricultural importance. This keeps spider mites 
like T. urticae under continuous selection pressure in many field and greenhouse crops. This is 
why OP resistance in T. urticae remains a not to be neglected economic factor. 
In an attempt to investigate the molecular basis of OP resistance and its relationship to the 
observed phenotype, a study was set up to elucidate the characteristics of resistance in 3 three 
reference laboratory strains (LS-VL, SAMB and GSS) and three OP resistant strains of T. 
urticae which were continuously kept under OP selection: a strain that historically developed 
OP resistance in the 1960s (WI) and 2 recently collected field strains (ATHRos-Pm from 
Greece and MR-VL from Belgium). Toxicity bioassays on the OP resistant strains revealed 
varying but high levels of resistance to most of the tested insecticides (Table 3.2). The WI 
strain proved to be more resistant to chlorpyrifos whereas the recently collected strains MR-
VL and ATHRos-Pm were particularly resistant to dimethoate. Compared to the reference 
strains, the biochemical experiments confirmed the presence of a more insensitive AChE1 in 
all OP resistant strains (Table 3.3). The high variation found between LC50s of OP resistant 
strains was not reflected in a high variation between IC50s.  Thus, an insensitive AChE1 is 
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probably not the only mechanism involved in the observed resistant phenotype and other 
mechanisms such as metabolic mediated resistance (carboxylesterase, gluthathione-S-
transferase or P450 mono-oxygenase-activity) are likely also involved.  
Target site insensitivity as a mechanism of OP resistance in T. urticae was the first case ever 
reported, and provided a proof of principle for resistance development in arthropods in the 
early 1960s (Smissaert 1964, Voss and Matsumura 1964). In this study, the amino acid 
sequence of AChE1 in three reference strains SAMB, GSS, LS-VL and three OP resistant 
strains (WI, MR-VL and ATHRos-Pm) was determined. Also four amino acid substitutions in 
the mature AChE1 that are present in one or more resistant strains and absent in the 
susceptible ones were identified.  
Two substitutions (F331W and T280A) were consistently present in all three OP strains. The 
position of the T280A substitution in the AChE1 structural model indicates that this mutation 
does not seem to be responsible for the modification of the biochemical properties of AChE1 
(Figure 3.1). This is further supported by the facts that this residue is not conserved among 
species and that both resistant and susceptible strains of T. urticae from Japan have a 
threonine at position 280 (Anazawa et al. 2003). In contrast, the phenylalanine 331 residue is 
involved in substrate guidance and in the hydrolyzing process by interacting with the catalytic 
histidine (H440) (Millard et al. 1999). A substitution at this position could lead to the 
modification of the catalytic properties of AChE1 (i.e. by altering catalytic efficiency and/or 
inhibitor sensitivity). In T. urticae from Japan, a F331C substitution was found to be 
associated with OP resistance (Anazawa et al. 2003). In T. kanzawai, a species closely related 
to T. urticae, a tryptophan at position 331 has been detected in resistant strains (Aiki et al. 
2005). The F331W substitution has also been shown to be responsible for AChE1 insensitivity 
to OP insecticides in the mosquito Culex tritaeniorhynchus by functional characterization after 
site directed mutagenesis and in vitro expression (Nabeshima et al. 2004, Oh et al. 2006). In 
addition, in the aphid species Aphis gossypii and Myzus persicae, a S331F was shown to 
confer insensitivity to AChE1, especially to the CARB pirimicarb (Nabeshima et al. 2003, 
Andrews et al. 2004, Benting and Nauen 2004). More recently, the same substitution was 
associated with OP resistance in the B and Q biotype of Bemisia tabaci from Israel and Greece 
(Alon et al. 2008, Tsagkarakou et al. 2009a). In conclusion, the 331 position in AChE1 has 
been associated with OP-resistance in many species, and the functional expression has clearly 
illustrated the effect of the substitutions on AChE1 sensitivity. Hence, the F331W substitution 
is most probably the major factor in many OP resistant spider mite strains. This is further 
emphasized by the fact that the WI-strain which developed resistance in the 1960s, and the 
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recently collected strains from geographically distant regions (MR-VL and ATHPros-Pm) 
carry this same F331W substitution. 
An allele with a F331Y substitution was sequenced in one clone of the reference strains 
(SAMB and GSS strain). The F331Y substitution may play a role in the carbaryl sensitivity 
since AChE1 of the GSS strain is more sensitive to carbaryl than the AChE1 of SAMB strain. 
Genotyping of single mites displayed that in GSS the F331Y is predominant whereas in the 
SAMB strain the F331 is predominant (Tsagkarakou and Van Leeuwen unpublished data). 
However, it is not known how this substitution influences the catalytic parameters of AChE1 
in these two strains. 
In the recently collected strains ATHRos-Pm and MR-VL strains, another substitution, 
G328A, was found in addition to F331W and T280A. The position 328 in the T. urticae 
AChE1 model suggests that this substitution may indirectly influence the catalytic process by 
affecting position 331 (located in the same α-helix). However, when we compared AChE1 
sensitivity of the MR-VL and ATHRos-Pm strains to that of the WI strain, the additional 
G328A substitution does not seem to alter the sensitivity to the tested insecticides, except for 
carbaryl. This substitution has been also found in the AChE2 of Ceratitis capitata (Magana et 
al. 2008), D. melanogaster (Menozzi et al. 2004) and Musca domestica (Walsh et al. 2001). 
Site directed mutagenesis followed by in vitro expression of D. melanogaster and M. 
domestica AChE2 showed that this mutation conferred insensitivity to chlorpyrifos-oxon, 
omethoate, malaoxon, methamidophos, paraoxon, methyl-paraoxon, and pirimicarb but 
increased the sensitivity to coumaphos and carbaryl (Walsh et al. 2001, Menozzi et al. 2004). 
In the ATHRos-Pm strain a fourth substitution (A201S) was found in addition to T280A, 
G328A and F331W. The proximity of this position to the catalytic serine (S200) may lead to 
some modifications in AChE1 biochemical properties. However, when IC50 values were 
compared between MR-VL and ATHRos-Pm strains (differing only by the presence of the 
A201S), no effect on AChE1 sensitivity toward the tested inhibitors was detected. This 
mutation was also found in other arthropod species, such as a resistant clone of A. gossypii 
(Andrews et al. 2004, Li and Han 2004) and a resistant strain of Plutella xylostella (Baek et al. 
2005, Lee et al. 2007). In A. gossypii the A201S substitution was always found in tandem with 
S331F and in P. xylostella in tandem with G227A. In both cases it was suggested that its 
presence increases resistance levels, playing a supplementary role to the main mutations 
(Andrews et al. 2004, Baek et al. 2005, Lee et al. 2007). In A. gossypii it was shown that 
AChE1 from insects carrying both mutations possess a better substrate affinity than that 
carrying the S331F mutation alone. The role of A201S mutation in resistance was 
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characterized by site directed mutagenesis in AChE1 of Culex tritaeniorhynchus (Oh et al. 
2007), but no functional expression of recombinant A201S AChE1 of A. gossypii or P. 
xylostella has been performed until now.  
Among the two substitutions specifically found in the reference SAMB strain (i.e. V7I and 
G119S), only G119S is located in the active site. This substitution is known to be responsible 
for AChE1 insensitivity (Weill et al. 2002) or reduced AChE1 activity in mosquitoes 
(Bourguet et al. 1996, Alout et al. 2008). The 119 position is close to the catalytic serine 
(S200) and the G-to-S substitution would reduce the accessibility to inhibitors and substrates 
by steric hindrance. Recombinant Culex pipiens G119S AChE1 was similarly or more 
resistant than the recombinant F331W AChE1 to most of the OPs and CARBs tested, 
including chlorpyrifos-oxon and paraoxon (Alout et al. 2007a). SAMB exhibited moderate 
levels of resistance towards chlorpyrifos and dimethoate and the involvement of an AChE 
mutation in resistance cannot be ruled out. However the biochemical data do not support the 
involvement of G119S mutation in resistance towards the insecticides tested in this study, 
which is in line with previous reports on Tetranychidae (Anazawa et al. 2003, Aiki et al. 
2005). Moreover, the AChE1 specific activity of the SAMB strain is higher than that of all 
other strains. However, before any sound conclusions can be made about the role of this 
mutation in T. urticae OP resistance, the frequency of this mutation should be determined by 
genotyping single mites of different strains, combined with a functional analysis of this 
mutation. 
Although it is presumed that the F331W substitution reported in this study is essential in 
determining the insensitivity of AChE1 towards the OP and the CARB, the A201S and G328A 
mutations might have been selected by exposure to other unknown OPs in the population’s 
history. These substitutions may confer an advantage to other inhibitors. Different mutated 
AChE1 could cause a strong insensitivity to specific insecticides since a good relationship has 
been found between the highest insensitivities and the insecticide(s) used locally in mosquito 
control programs (Alout and Weill 2008). Thus it is possible that in T. urticae also different 
mutations are selected and maintained in the populations, each one conferring advantage 
against particular OP or CARB insecticides. Alternatively, substitutions A201S and G328A 
might be selected to reduce a possible fitness cost associated with the F331W substitution in 
T. urticae. Valuable information on the importance of the different substitutions in the 
development and maintenance of an OP-resistant phenotype could be obtained by following 
their dynamics with molecular diagnostic tests under different OP spraying protocols, aimed at 
controlling other arthropod pests in the field. The development of such a diagnostic test was 
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illustrated for F331W mutation, since it was consistently present in recently resistant spider 
mite strains from different geographical regions, as well as in a strain that developed 
resistance in the late 1960s.  
Different mutations and their combinations can result in varying levels of resistance to many 
OP and CARB insecticides (Mutero et al. 1994). Some of them have essentially an additive 
effect, both in terms of reducing the sensitivity of the enzyme to inhibition by the insecticide 
as well as in terms of increasing the stability of the enzyme and its ability to turn over 
acetylcholine (Shi et al. 2004). Functional analysis should be performed to test the influence 
of each mutation (alone or in combination) in OP and CARB insensitivity and in the specific 
activity of the recombinant mutated AChE1 in T. urticae. 
Recently, Van Leeuwen et al. (2007) revealed that OP and CARB insecticides, when applied 
prior to bifenazate, antagonised bifenazate toxicity. This antagonistic effect occurred at very 
low, non-toxic concentrations of the antagonists in an OP susceptible strain, and was 
correlated with a decrease in general esterase activity towards model substrates, as p-
nitrophenyl acetate. However, the presence of low concentrations of OPs and CARBs applied 
before bifenazate treatment on OP susceptible strains is not realistic for field conditions.  
In this study we tested whether mixtures (not simultaneous applications) of OP and CARB 
compounds with bifenazate, when applied on OP resistant strains, which can tolerate higher 
doses of OP and CARB insecticides, are a major risk for bifenazate control failure due to 
antagonism. Based on percent mortality, mixtures of bifenazate and chlorpyrifos revealed an 
immediate and high antagonism in both strains (Figure 3.3). In these experiments, bifenazate 
was not toxic, even at concentrations exceeding 10 times the recommended field rate (96 mg 
a.i. L-1). The effect was more long-lasting in the WI strain, compared to the MR-VL strain, in 
which antagonism decreased two DAT. Possibly, the detoxifying capacity of the MR-VL 
strain resulted in degradation of the internalised OP and CARB insecticides, hence 
counteracting in time the observed antagonism. When the OP concentration within the body 
decreases, inhibition of the general hydrolytic esterase activity decreases and bifenazate 
activation by esterases can reoccur in time. This theory is supported by enzymatic assays 
revealing differences in esterase activity between strains (Table 3.5). A higher esterase 
activity in the MR-VL strain may also be associated with a more rapid recuperation of 
esterase inhibition (Wheelock et al. 2005).    
With the exception of chlorpyrifos, all other tested chemicals did not cause any antagonism 
when mixed with bifenazate. This is in contrast with a previous study in which pre-treatment 
of mites with all tested OPs (acephate, chlorpyrifos, dichlorvos, dimethoate, ethion, 
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monocrotophos, paraoxon, profenofos and trichlorfon) and CARBs (carbaryl and oxamyl) 
antagonised bifenazate toxicity with ratios between 2.8 to 169 (Van Leeuwen et al. 2007). It is 
possible that inhibition of esterase activity is not initiated after treatment with OPs (Gunning 
et al. 1999), while bifenazate exerts quick knockdown activity. In our experiments bifenazate 
intoxication (paralysis) occurred rapidly in the first few hours after treatment, thereby limiting 
further OP and CARB uptake through tarsal contact. The difference in antagonistic effect 
between chlorpyrifos and the other insecticides may be related to differences in speed of 
penetration and rate of conversion to the active oxon-form.  
Several studies evaluating the effect of mixing pesticides for control of T. urticae have 
reported improved control (Bynum et al. 1997) or in a control which was not negatively 
affected by mixture (Cloyd et al. 2007). It can be concluded that mixing OP and CARB 
insecticides with bifenazate in some cases can completely inhibit bifenazate efficacy. 
However, the antagonistic effect depends on the OP and CARB type, as well as on the mite 
strain. As has become clear from this study, OP resistant mites are a greater risk for 
antagonism-based control failure, since they survive OP treatments targeting other pests, 
while the OP insecticides compromise bifenazate activation. In practice, greenhouse 
experiments should be conducted before recommending a specific mixture to growers.
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1 INTRODUCTION 
Spirodiclofen is a persistent non-systemic selective acaricide which chemically belongs to the 
group of spirocyclic tetronic acid derivatives. It was discovered by Bayer CropScience and 
was first registered in 2002 with the trade name Envidor® (Bretschneider et al. 2007).  It has 
been commercialized for the control of economically important phytophagous mite species 
including T. urticae, Panonychus ulmi, Panonychus citri, Aculus schlechtendali, 
Phyllocoptruta oleivora and Brevipalpus phoenicis (Rauch and Nauen 2002). Spirodiclofen 
has no neurotoxic activity, but mainly acts on mite development, hereby eliciting unique 
symptoms of poisoning in spider mites, like flabby legs, immatures which are trapped in the 
quiescent stage and inhibition of molting. Spirodiclofen is active against all developmental 
stages but shows the highest acute toxicity to eggs and immature stages. Treated immature 
mobile stages die in the subsequent quiescent stage. Female adults prove to be less susceptible 
and it takes a few days after treatment before they die. This may be due to the fact that these 
females are unable to deposit eggs, causing a high and lethal number of accumulated eggs in 
their body.  Also, fertility is highly affected. It was observed that a treatment with 200 mg L-1 
spirodiclofen significantly decreased the lipid content in female adults of T. urticae, 
suggesting an interference with lipid biosynthesis (Wachendorff et al. 2002). This interference 
seemed to be based on a selective and potent inhibition of acetyl-CoA carboxylase (ACCase). 
ACCase (E.C. 6.4.1.2) is a member of the biotin-dependent enzyme family which, in short, 
catalyses the synthesis of malonyl-coenzyme A which is the substrate required for fat 
synthesis (Incledon and Hall 1997).  
Fatty acids are important molecules in biological systems. They are key building blocks for 
the synthesis of the phospholipids, important components of the cell membrane. They act as 
hormones and as sources of metabolic energy that can be mobilized to meet the energy 
requirements of the insect. They constitute a large part of the lipids of the cuticular wax layer 
that protects terrestrial arthropods from desiccation. Many of the sex pheromones synthesized 
by insects are derived from fatty acids as well as some compounds within defensive secretions 
such as quinones, phenols, and carboxylic acids (Klowden 2007, Hanin et al. 2008). Due to 
their involvement in many processes, the biosynthesis of fatty acids is a promising target for 
the development of novel chemotherapeutics. For instance, the enzymes involved in fatty acid 
biosynthesis provide excellent targets for the design of novel antibiotics (Campbell and 
Cronan 2001), therapeutics (Tong 2005) and pesticides (Wenger and Niderman 2007).  
ACCase catalyzes the first committed step in the fatty acid biosynthetic pathway in all 
animals, plants, and bacteria, i.e. the carboxylation of acetyl-CoA to produce malonyl-CoA. 
Chapter IV__________________________________________________________________ 
 74 
This generally involves two separate reactions and depends on the tightly-bound cofactor 
(prosthetic group) biotin (Figure 4.1). The first reaction involves the ATP-dependent 
carboxylation of the biotin moiety of the biotin carboxyl carrier protein (BCC), catalyzed by 
the biotin carboxylase (BC). In the second reaction, the activated carboxyl group is transferred 
from the biotin moiety to acetyl-CoA, thereby generating malonyl-CoA. This reaction is 
catalyzed by carboxyltransferase (CT) (Barber et al. 2005). Malonyl-CoA is used for de novo 
fatty acid biosynthesis as well as in fatty acid elongation. 
 
 
In prokaryotes, as well as in the chloroplasts of many plants, ACCase is a multi-subunit 
enzyme consisting of BC, BCC, and CT as separate proteins. In contrast, in most 
eurokaryotes, ACCase is a large (>200 kD), multi-domain enzyme containing all three of 
these components within a single polypeptide chain (a BC, BCC and CT domain). The active 
form of animal ACCase is a linear polymer with a molecular weight of about 8000 kD, made 
up of 10-20 protomers, which are dimers of the enzyme (Tong 2005).  
In humans and other mammals as well as in birds and fish and some other animals there are 
two isoforms of the ACCase, while some animal classes appear to have only one ACCase 
gene. Although only one ACCase gene is present in the Drosophila melanogaster genome 
(Pan and Hardie 2002), this gene generates two transcripts through alternative splicing, 
resulting in a normal ACCase and an ACCase with an extended N-terminus (Barber et al. 
2005). 
Again, due to its central role in fatty acid biosynthesis, ACCase would be an excellent target 
for the design of new pesticides. Shutting down the catalytic activities of either BC or CT 
should be sufficient to inhibit the overall reaction of the enzyme. 
Almost all known ACCase inhibitors such as two classes of commercial herbicides, the 
aryloxyphenoxypropionates and the cyclohexanediones, inhibit the CT, while soraphen A, a 
broad-spectrum fungicide, is the only known potent inhibitor of the BC (Weatherly et al. 
2004). In animals, it might be expected that inhibitors could be discovered that disrupt the 
 
Figure 4.1 Reaction mechanisms for ACCase. Biotin carboxylase (BC) catalyses the ATP-dependent 
phosphorylation of bicarbonate and formation of carboxyphosphate-BCCP (biotin carboxyl carrier 
protein). Acetyl-CoA carboxytransferase catalyses the transfer of the carboxyl group from 
carboxybiotin-BCCP to an acetyl-CoA acceptor, resulting in malonyl-CoA (Barber et al. 2005). 
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enzyme polymerization (Tong 2005). The action of aryloxyphenoxypropionates and 
cyclohexanediones on weeds (Delye 2005) and Toxoplasma (Jelenska et al. 2002) indicates 
that, in all these systems, inhibition of ACCase activity leads to a complete inhibition of the 
organism’s growth. 
Despite its economic importance, knowledge about arthropod ACCase structure and 
molecular interactions with inhibitors is lacking. One reason for the scarcity of information is 
the difficulty in obtaining sufficient quantities of pure protein. Eukaryotic ACCase is difficult 
to purify in high enough quantity from endogenous sources, and their size and complexity 
make recombinant expression difficult as well (Weatherly et al. 2004). To fill this gap, efforts 
should be directed towards the expression and purification of recombinant ACCase enzymes 
in high yield, purity, and activity. Joachimiak et al. (1997) established a yeast expression 
system to investigate the wheat ACCases. The mode of action of ACCase inhibiting 
herbicides have been studied using heterologous expression of chimeric ACCase. It was 
shown that some determinants of sensitivity to these herbicides were located on a 400–amino 
acid fragment of wheat plastidic ACCase CT domain (Nikolskaya et al. 1999). There are only 
a few reports of the recombinant expression of a full-length eukaryotic ACCase. Jelenska et 
al. (2002) tried to develop an expression system for Toxoplasma gondii ACCase, but the 
expressed protein was highly proteolysed, the bulk of it lacked bound biotin, and the 
preparation had very low specific activity. Weatherly et al. (2004) succeeded  in the 
expression of enzymatically active fungal (Ustilago maydis) ACCase in Escherichia coli. 
Cheng et al. (2007) developed an efficient protocol to express recombinant human ACCase2, 
human ACCase1, and rat ACCase2 in high yield and activity in baculovirus/Sf9 cell 
expression system. 
The application of acaricides is usually needed to maintain mite populations below economic 
thresholds. However, T. urticae has the ability to rapidly develop resistance after only a few 
applications. To manage resistance development, it is necessary to gather information on the 
genetics, modes and mechanisms of resistance to each compound (Leeper et al. 1986).  
Up till now, most information on resistance against inhibitors of ACCase has been gathered 
from studies on commercially available herbicides belonging to the 
aryloxyphenoxypropionates and the cyclohexanediones, and to a lesser extent, the cyclic 1,3-
diketones (2-aryl-1,3-diones), the latter being structurally related to spirodiclofen (Dekeyser 
2005). Graminicide herbicides targeting ACCase have been widely used for the control of 
annual and perennial grasses in broadleaf crops and even in certain cereals. Resistance to 
ACCase-inhibiting herbicides has developed in at least 35 grass species worldwide (Wenger 
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and Niderman 2007).  Mechanisms of this resistance can be divided in two groups: ACCase-
related and metabolism-based mechanisms. In most cases, mutations within CT domain of 
homomeric plastidic ACCase are involved in altered sensitivity to ACCase inhibitors. 
Metabolism-based resistance involves detoxifying enzymes such as cytochrome P450 mono-
oxygenases, glutathione-S-transferases and glucosyltransferases (Delye 2005, Wenger and 
Niderman 2007).  
The present study reports on a spirodiclofen resistant T. urticae strain that was selected from a 
susceptible T. urticae strain of under laboratory conditions. We determined the resistance 
ratio and the cross-resistance to several important acaricides. Metabolic detoxification was 
studied by using synergists, and by determining the in vitro enzyme activities. The total lipid 
content of the susceptible and resistant female mites was also measured. Possible target site 
modification was investigated by sequencing and analysing the cDNA encoding the ACCase 
from the susceptible and resistant T. urticae strains. To design and screen effective and 
specific new pesticides and to manage resistance to currently used ACCase inhibiting 
pesticides, it will be necessary to study the ACCase structure and function from each pest 
species, because each may show a different sensitivity and a different mechanism of 
resistance to inhibitors. Here, we tried to develop an optimal protocol to express mite (in casu 
T. urticae) recombinant ACCase. The recombinant expression system can be used as the 
foundation for the subsequent site-directed mutagenesis experiments in order to investigate 
the function of specific residues involved in the enzyme activity or inhibitor binding. 
 
2 MATERIALS AND METHODS 
2.1 Acaricides and chemicals  
Commercial formulations of abamectin 18 g L-1 SC (Vertimec®), pyridaben 150 g L-1 SC 
(Sanmite®) and tebufenpyrad 200 g L-1 SC (Pyranica®) were purchased in a store (Fyto 
Vanhulle, Belgium). Formulated acequinocyl 150 g L-1 SC (Kanemite®) and bifenazate 240 g 
L-1 SC (Floramite®) were kindly provided by W. Petersen (Bayer CropScience) and A. 
Grosscurt (Crompton Crop Protection), respectively. Formulated etoxazole 110 g L-1 SC 
(Borneo®), spirodiclofen 240 g L-1 SC (Envidor®), spiromesifen 240 g L-1 SC (Oberon®) and 
the esterase substrate 1-naphthyl 2,2-dimethylbutyrate were provided by R. Nauen (Bayer 
Cropscience). All other chemicals were of analytical grade and purchased from Sigma-
Aldrich (Belgium). 
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2.2 Spider mites 
The reference laboratory susceptible strain (LS-VL) of T. urticae was originally collected in 
October 2000 from roses in a garden near Ghent (Belgium), where pesticides had not been 
used for at least 10 years (Van Leeuwen et al. 2004).   
To select for a spirodiclofen-resistant strain, LS-VL was exposed to successive applications of 
a gradually increasing concentration of spirodiclofen, starting from 10 mg L-1 (approximately 
the LC90 of LS-VL) in January 2007. Roughly 5000 larvae were used to start the selection. 
During the first selection cycles, spirodiclofen was sprayed on larvae living on detached bean 
leaf discs (as described below). Selection pressure was maintained by varying the 
concentration so that 10 to 20 % of the larvae survived for succeeding generations. Once the 
concentration of 500 mg L-1 was reached, subsequent selections with spirodiclofen were done 
on all life stages on bean plants which were sprayed with a hand-pressurised sprayer 
(Birchmeier, Switzerland) until runoff. Selection was stopped in December 2007, when a 
concentration of 5000 mg L-1 was used. The laboratory selected strain was named SR-VP and 
maintained on bean plants sprayed with 5000 mg L-1 spirodiclofen containing the wetting 
agent Citowet at 0.025%. Mites were used in the experiments for the first time in January 
2008.  
The SR-TK strain was a field strain obtained from Bayer CropScience and was maintained 
under selection pressure using 1200 mg L-1 spirodiclofen. The London strain was provided by 
M. Grbic (University of Western Ontario). This strain has been used in the genome 
sequencing project of T. urticae (Grbic et al. 2008) 
(http://bioinformatics.psb.ugent.be/webtools/bogas/users/login). 
Mites of the LS-VL, London, SR-TK and SR-VP strain were reared on potted kidney bean 
(Phaseolus vulgaris L. cv. Prelude) plants in a climatically controlled room at 26 (±0.5)°C, 60 
% RH and 16/8 h L/D photoperiod. 
2.3 Larval and egg bioassays 
For larval and egg bioassays, 20-30 adult females were transferred to the upper side of 9 cm2 
square-cut kidney bean leaf discs on wet cotton wool, and permitted to lay eggs for 6 hours, 
after which they were removed. The plates were then placed in a climatically controlled room 
at 26 (±0.5) °C, 60 % RH and 16/8 h L/D photoperiod. Immediately after removal of the 
adults (egg bioassay) or after hatching of the eggs (larval bioassay), the eggs or larvae were 
sprayed with 0.75 ml spray fluid at 1 bar pressure using a Cornelis spray tower, resulting in 
1.58 ± 0.06 mg aqueous acaricide deposit cm-2 (Van Laecke and Degheele 1993). Four 
replicates of six concentrations of spirodiclofen plus a control (de-ionised water) were tested. 
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Mortality was assessed when adults appeared in the control. Mortality percentages were 
calculated by dividing the number of mites reaching adulthood by the number of total eggs (in 
the egg bioassay) or larvae and nymphochrysalis (in the larval bioassay) counted one day after 
application. In all bioassays, control mortality was lower than 10 %. LC50-values, slopes and 
95% confidence limits were calculated by probit analysis (POLO, LeOra Software, Berkeley, 
USA) (Robertson and Preisler 1992a). Resistance ratios (RR) were calculated by dividing the 
LC50 value of the resistant strain by the LC50-value of the susceptible strain. 
2.4 Screening for cross-resistance  
Cross-resistance between spirodiclofen and eight other commonly used or new acaricides 
were evaluated using the selected resistant (SR-VP) and susceptible (LS-VL) populations. 
The pesticides used were abamectin, acequinocyl, bifenazate, etoxazole, pyridaben, 
tebufenpyrad and spiromesifen. The bioassay used for etoxazole and spiromesifen was similar 
to that described for spirodiclofen in paragraph 2.3 (larval bioassays). For all other acaricides, 
adult females were used. Adulticidal bioassays were conducted using a standard method (Van 
Leeuwen et al. 2004). Mortality was assessed after 2 days. Mites were scored as ‘alive’ if they 
could walk normally after they were prodded with a camel’s hair brush; all others were scored 
as dead including those that had run off the leaf disk. 
2.5 Synergism studies 
In order to check for metabolic resistance by means of synergists, newly hatched larvae were 
sprayed with PBO, DEF or DEM, 3-4 h prior to spirodiclofen application as described in 
paragraph 2.3. These compounds inhibit cytochrome P450 mono-oxygenases, esterases and 
glutathione-S-transferases, respectively. Based on preliminary tests, the doses of PBO, DEF 
and DEM were chosen as the highest dose that caused maximum 5 % larval mortality (200 
mg L-1 PBO, 10 mg L-1 DEF, 200 mg L-1 DEM). Before use, PBO (~90% purity), DEF (98% 
purity) and DEM (97% purity) were dissolved in a mixture of N,N-dimethylformamide and 
emulsifier W (3:1 by weight) and subsequently diluted with de-ionised water (1000-fold). 
Mites sprayed with synergist only served as control. Synergism ratios (SR) and their 
confidence limits were calculated using the formula and statistics of dose ratios (Robertson 
and Preisler 1992b). If the 95% confidence interval includes 1, then the LC50 of the acaricide 
alone is not significantly different from the LC50 of the acaricide + synergist. 
In order to measure the effect of synergists on the inhibitory effect of spirodiclofen on female 
fertility and fecundity, gravid adult female mites of the LS-VL and SR-VP strains were placed 
on leaf discs sprayed with PBO, DEF or DEM. Based on preliminary tests, the doses of 2000 
mg L-1 PBO, 20 mg L-1 DEF, 2000 mg L-1 DEM were chosen. These doses caused maximum 
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5 % mortality and did not inhibit fecundity. After 24 h, living mites were collected and 
transferred to leaf discs that had been sprayed with different concentrations of spirodiclofen or 
with distilled water (control). After 24 h exposure, 4 replicates of 10 mites from each 
spirodiclofen concentration were transferred to unsprayed leaf discs for oviposition. The day 
after, the female mites were removed. The eggs were left to develop to adults, which were 
finally counted.  
Inhibition by spirodiclofen (the difference between the number of offspring from mites from 
leaves treated with distilled water and those treated with spirodiclofen) was expressed as a 
percentage of the number of offspring in mites treated with water. Spirodiclofen 
concentrations inhibiting reproductivity by 50% (IC50-values) for LS-VL were calculated 
using the logistic equation of the fitted curves. The concentration-inhibition data for SR-VP 
were fitted with a second order regression curve. 
2.6 Total lipid content in T. urticae 
For the determination of the total lipid content, procedures based on the method of Van 
Handel (1985) and described previously (Wachendorff et al. 2002) were used. Two hours, 2 
days and 5 days after spirodiclofen treatment, groups of ten living female adults (respectively 
4, 6 and 9 days old) were randomly selected from (untreated) leaf disks with mites that had 
been exposed for 12 h to spirodiclofen (200 mg L-1, 1000 mg L-1) or distilled water (control), 
as described in 2.3. Additionally, groups of 100 adult females were sampled from the LS-VL 
and SR-VP strain and were pre-treated for 12 h with spirodiclofen. Surviving females were 
transferred to a non-sprayed leaf disc and lipid content was measured after two days. A lipid 
standard curve was obtained using corn oil (analytical grade). Data were analysed by 
ANOVA with means separated by Tukey (p < 0.05). If the assumption of normality or 
equality of variance was not met, a non-parametric Kruskal-Wallis test was used. 
2.7 Crossing experiments 
2.7.1 Bioassay – reciprocal crossing LS-VL♀ × SR-VP♂ and SR-VP♀ × LS-VL♂ 
In an attempt to estimate the dominance of the resistance, individuals of the susceptible (LS-
VL) and resistant (SR-VP) strain were reciprocally crossed to produce hybrid F1 females, as 
described previously (Herron and Rophail 1993, Van Leeuwen et al. 2004). This was 
achieved by placing 50 teleiochrysalid females of one strain and 100 adult males of the other 
strain on the upper side of a primary bean leaf on wet cotton wool in a Petridish (2 replicates). 
Directly after moulting the diploid females were fertilised by the haploid males. These 
cultures were left for three days to produce two-day-old cross-fertilized females. From these 
reciprocal-cross-strains, 25 females were transferred to 9 cm2 square-cut bean leaf discs and 
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left to oviposit for 5-6 hours. Four times a day, the egg laying females were collected and 
placed on fresh discs. When larvae hatched, the discs of each of the reciprocal-cross-strains 
were sprayed with several concentrations of spirodiclofen covering the range of 0 to 100 % 
mortality. Each concentration was replicated at least 4 times and a water only sprayed control 
was included daily. The assays were assessed by the protocol of Overmeer (1967), which 
requires male and female progeny to be counted separately. The unsprayed control discs were 
used to calculate the average number of males in the test population (sex-ratio) in order to 
correct the reciprocal-cross assays for the haploid male offspring, which always show the 
genotype of the mother, due to the arrhenotokous method of reproduction (haplodiploidy - 
males result from unfertilised haploid eggs, females result from fertilised diploid eggs).  
The formula of Stone (1968) was used to calculate the degree of dominance (D),  as described 
in Chapter II, 2.3.  
2.7.2 Bioassay–backcrosses (LS-VL×SR-VP)♀×LS-VL♂ and (SR-VP×LS-VL)♀×SR-
VP♂ 
To obtain F2 progeny, teleiochrysalid females of the reciprocal crosses and males were 
allowed to mate in a similar manner as described above. The resulting F2 larvae were treated 
with several concentrations of spirodiclofen, covering the range of 0 to 100 % mortality. 
Mortalities were also corrected for the haploid male offspring. Analysis of the concentration-
mortality data for the F2 females was done to determine whether the resistance to 
spirodiclofen is under the control of one major gene or more than one gene. Single major gene 
inheritance is characterized graphically by a plateau at 50% mortality of the concentration-
mortality lines (Georghiou 1969). The expected responses of the F2 generation for each 
concentration tested can be obtained with the following formula (Georghiou 1969):  
c = (0.5) W(parent 1) + (0.5) W(parent 2) 
where c is the expected mortality at a given concentration and W is the observed mortality of 
the parental types at a given concentration. A χ2 goodness-of-fit analysis was then used to 
determine how well the observed responses fit expected responses.  
2.7.3 Bioassay – haploid F1 progeny of strains LS-VL and SR-VP 
Analogous to Herron (1994), one hundred and fifty teleiochrysalid females were removed 
from the LS-VL and SR-VP cohort cultures and transferred to new detached leaf cultures for 
three days, by which time they were young adults laying haploid eggs. Twenty five females 
from each culture were transferred to 9 cm2 square-cut bean leaf discs and left to oviposit for 
5-6 hours. Four times a day, the egg laying females were collected and placed on fresh discs. 
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Male haploid offspring in the larval stage were subsequently used in a bioassay as described 
above. 
2.7.4 Bioassay–haploid F2 progeny of strains LS-VL♀ × SR-VP♂ and SR-VP♀ × LS-
VL♂    
Haploid reciprocal crosses were initiated as above. Eggs laid by young adult females from the 
reciprocal crosses were allowed to develop to the teleiochrysalid stage. The female 
teleiochrysalids were then transferred to a detached leaf culture for three days where they 
developed into young adults producing haploid progeny. Twenty five females from each 
culture were transferred to 9 cm2 square-cut bean leaf discs and left to oviposit for 5-6 hours. 
Four times a day, the adult females were removed to leave haploid progeny that were used in 
the described bioassay. Similar to the F2 females, the concentration-mortality data for the F2 
males was analysed to determine whether resistance to spirodiclofen was under the control of 
one major gene or more than one gene. 
2.8 Enzymatic assays 
For the determination of the O-deethylation of 7-ethoxy-4-trifluoromethylcoumarin (7-EFC) 
by P450 mono-oxygenases and the esterase activity towards the substrates 4-nitrophenyl 
acetate (4-NPA), 4-nitrophenyl propionate (4-NPP) and 4-nitrophenyl butyrate (4-NPB), 
procedures were used as previously described (Van Leeuwen et al. 2005). To measure the 7-
EFC-O-deethylation activity in larvae, 500 larvae were homogenised. Esterase activity 
detected with the substrate 1-naphthyl 2,2-dimethylbutyrate (Nauen et al. 2003) was measured 
in a similar way as with 1-naphthyl acetate (1-NA), according to Van Leeuwen et al. (2005) 
The final concentration of all the different substrates in the esterase reaction mixtures was 0.3 
mM. 
Glutathion-S-transferase (GST) activity was assayed using 1-chloro-2,4-dinitrobenzene 
(CDNB) as substrate, based on the method of Habig and Jakoby (1981), and also previously 
described (Van Leeuwen et al., 2005). GST activity was also determined using 
monochlorobimane (MCB) as substrate, based on the method of Stumpf and Nauen (2002). 
Thirty fresh adult females were homogenized in 500 µl Tris-HCl buffer (0.05 M, pH 7.5). The 
homogenate was centrifuged for 10 min at 10,000 g and 4 °C. The total reaction volume per 
well of a 96-well microtiter plate was 300 µl, consisting of 50 µl supernatant, 50 µl buffer, 
100 µl MCB (0.9 mM, dissolved in buffer with 1% ethanol) and 100 µl reduced glutathione (9 
mM, dissolved in buffer). The plate was incubated for 20 min at 22°C and fluorescence was 
measured with a Tecan Infinite M200 microtitre plate spectrofluorometer at 465 nm while 
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exciting at 390 nm. The nonenzymatic reaction of MCB without homogenate served as 
control.  
All protein concentrations were measured with a Coomassie protein assay (Perbio Science, 
Belgium). All enzymatic assays were repeated independently at least three times.  
2.9 Separation of esterases by native isoelectric focusing (IEF) 
IEF was performed on extracted proteins from adults and nymphs (mixed protonymphs and 
deutonymphs of variable age) of two spirodiclofen resistant (SR-VP and SR-TK) and two 
susceptible (LS-VL and London) strains as described by Van Leeuwen et al. (2006b). Briefly, 
the enzyme samples (10,000g supernatant, 12 µg protein) with 5 µl IEF marker (Serva Liquid 
Mix, Serva, Germany) were loaded into each well of a Novex pH 3–7 precast gel (Invitrogen, 
USA). IEF gels were run according to the manufacturer’s instructions (1 h at 100 V, 1 h at 
200 V and 30 min at 500 V). The gel was stained for esterase activity with 1-NA as a 
substrate and Fast blue RR (Van Leeuwen et al. 2006b). To visualise the marker, the gel also 
was stained using GelCode Blue Stain Reagent (Pierce, USA) as described by the 
manufaturer. 
2.10 Cloning of a T. urticae cDNA encoding ACCase 
Total RNA was extracted from mass homogenates of T. urticae strains GSS, LS-VL, SR-VP 
and SR-TK using TRI reagent (Sigma-Aldrich, Belgium) according to the manufacturer’s 
instructions. A quantity of 2 µg total RNA for each sample was reverse transcribed into 
cDNA by using the High Fidelity cDNA Synthesis Kit (Roche, Belgium) and anchored-oligo 
(dT) primers. Several conserved regions on the basis of the published ACCase sequences of 
several insect species were used as the targets of six degenerate primers. Different primer 
(Table 4.1) sets and different PCR conditions were tested. However, with a nested PCR 
strategy we succeeded to amplify a part of cDNA encoding ACCase. First the cDNA of LS-
VL strain was amplified with 2 µM each of  TurACCF2 and TurACCR1 degenerate primers 
using Taq polymerase (Invitrogen, USA) at 94°C 30 s, 54°C 30 s, and 72°C 60 s for 35 
cycles. Then the reaction mix was amplified with TurACCF1 and TurACCR1degenerate 
primers in the same conditions. An amplified fragment with 325 bp (5975- 6299 Drosophila 
melanogaster numbering) was gel extracted using the QIAEX II kit (Qiagen, USA), and 
cloned into a pGEM-T vector (Promega, USA) and sequenced by Agowa Sequencing Service 
(Berlin, Germany). Sequence data were analysed using BioEdit 7.0.1 (Hall 1999).  
Using this 325 bp fragment and by examining the annotated ACCase gene retrieved from the 
T. urticae genome database (http://bioinformatics.psb.ugent.be/webtools/bogas/users/login), 
the putative ACCase gene was inferred. For cDNA amplification several primer sets were 
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designed (Table 4.1, from TurACCF3a to TurACCR11; Figure 4.2). One µl of cDNA was 
used as a template for PCR carried out in a Biometra TProfessional Thermocycler (Biometra, 
Germany). PCR reactions were performed in 50 µl containing 2 mM MgCl2, 0.2 µM of each 
primer, 0.2 mM deoxynucleotide triphosphate (dNTP) mix (Invitrogen, USA), 5 µl 10× PCR-
buffer (Invitrogen, USA) and 1 U Taq DNA polymerase (Invitrogen), under the following 
conditions: 2 min at 94 °C, 35 cycles of 20 s at 94 °C, 30 s at 54 °C, 90 s at 72 °C and a final 
extension of 3 min at 72 °C. Long PCRs (>1.5kb) were performed using Expand Long Range 
Kit (Roche, Belgium), according to the manufacturer’s instructions. PCR products were 
subjected to direct sequencing after purification using E.Z.N.A Cycle-Pure Kit (Omega 
Biotek, USA). To search for possible mutations in the T. urticae ACCase, we aligned the 
nucleotide and deduced amino acid sequences of spirodiclofen resistant and susceptible 
strains. 
 
 
Figure 4.2 Location of the primer binding sites for cDNA amplification of T. urticae ACCase 
TuACCF3a 
TuACCF4 
TuACCF5 
TuACCF9 
TuACCR3a 
TuACCF11 
TuACCR4 
TuACCF6
TuACCR5 
TuACCR6 
TuACCF7
TuACCR7
TuACCF8
TuACCR8 
TuACCR9
TuACCR11
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Table 4.1 Primer sequences used for cloning and genotyping 
Primersa Sequences (5´–3´)b 
TurACCF1 TGATIGARGAYRARGGIGAR 
TurACCR1 CCRTTRTTRWICATRATYTG 
TurACCF2 CCDGAIAARGGITTYAARTA 
TurACCF3a ATGAGTGGACCAAATTTATCTTCAC 
TurACCR3a GATGAGGTGGACCCATGAAC 
TurACCF4 CACAAGATCAAGATGCAGCAA 
TurACCR4 GATTCGGGCTGCAATAACAT 
TurACCF5 GTCAATTTGCCTGCTTGTCA 
TurACCR5 ATATCGCGAGCCATCAATTC 
TurACCF6 TTCTGGAAGCGGGTTGTATC 
TurACCR6 TGATGGATGTGACGAAGGAA 
TurACCF7 CCGGGCGTATATTTGCTATG 
TurACCR7 CCTGAAGCAGGATCACGAGT 
TurACCF8 ATGCCTCTCGTTTGAGGAAA 
TurACCR8 GGAGCGTATGAAAGCCAATC 
TurACCF9 CACTGAACAAGGTGCTTGGA 
TurACCR9 TTTTTGGTCCGCATAGAACC 
TuACCF11 TTAACAAAACAACCGATCCTG 
TuACCR11 GATTGTCGAATCACAACTTTGTCC 
Rp49_qpcrF CTTCAAGCGGCATCAGAGC 
Rp49_qpcrR CGCATCTGACCCTTGAACTTC 
ACC_qpcrF TAACAATGGTAACGTGTCGTGCAAT 
ACC_qpcrR ACCTTGTTCAGTGATGCATGTCC 
TuACC-untF3 TTCTATGCCTTTTTGTGTTACCG 
TuACC-untR3 TGGTGACATCTCTGATTTTTATGG 
TuACC-untR2 TCTGCCCGCTACTAACTTTCA 
TurACC-ExpF1 GCGGCCGCAGTGGACCAAATTTATCTTC 
TurACC-ExpR1 TCTAGAAACTTTGACGATCCATTTCCA 
TurAcc-endF ATGAGTGGACCAAATTTATC 
TurAcc-endR TCACTTTGACGATCCATTTCC 
OpIE2R GACAATACAAACTAAGATTTAGTCAG 
pEIAF1 CAACATGAGTGGACCAAATTTATCTTCACA 
pEIAF2 CCCGGGCAACATGAGTGGACCAAAT 
pEIAR1 GCGGCCGCGACAATACAAACTAAGATTTAG 
pUC/M13F CCCAGTCACGACGTTGTAAAACG 
pUC/M13R AGCGGATAACAATTTCACACAGG 
OpIE2R GACAATACAAACTAAGATTTAGTCAG 
pET-ACCF GTCGACAGTGGACCAAATTTATCTTCACAAGATCAAG 
pET-ACCR GCGGCCGCTCAAACTTTGACGATCCATTTCCAACACC 
a The suffixes F and R in primer names indicate forward and reverse primers, respectively. 
b Mixed base code letter used in degenerate primers: R (A+G), S (C+G), Y (C+T), W (A+T), D 
(G+A+T), I (inosine). Mutations are bold. 
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2.11 Quantitative reverse transcription PCR  
Levels of specific mRNA species were measured by comparative quantitative real-time PCR 
amplification using the isolated RNA from pools of 300-400 deutonymphs of each T. urticae 
strain (SR-TK, SR-VP, London). Extracted RNAs were treated with TurboDNAse (Ambion, 
USA) to remove any genomic DNA contamination, and were then used with Superscript III 
reverse transcriptase (Invitrogen, USA) to make first strand cDNA using oligo-dT primers. 
Quantitative reverse transcriptase PCR reactions were performed in triplicate on a 
MiniOpticon Two-Color Real-Time PCR Detection System (BioRad, USA) using 30 ng of 
cDNA, 0.15 µM primers, and GoTaq qPCR Master Mix (Promega, USA). Cycling conditions 
and dissociation curve analyses were performed according to the manufacturer’s instructions. 
To amplify the ACCase gene the primers ACCqpcrF1 and ACCqpcrR1 were used (Table 4.1). 
The ribosomal protein gene Rp49 (Tetur18g03590, 12/07/2010, BOGAS) was used as the 
reference gene to which the level of other transcripts were standardized (for primers see Table 
4.1). Quantification of the transcript level or relative copy number of a gene was conducted 
according to the 2−∆Ct method (Pfaffl 2001). All experiments were repeated three times. 
2.12 Construction of Expression Plasmids 
2.12.1 Construction of vector pMIB-ACC  
In order to amplify the whole coding sequence of ACCase, six primers were designed inside 
the untranslated regions. First cDNA of LS-VL was amplified using TuACC-untF3 and 
TuACC-untR3 primers. Then, by nested PCR the reaction mix was amplified using TuACC-
untF2/ TuACC-untR2 and TuACC-F3a/TuACC-untR2. All long PCRs were performed using 
the Expand Long Range Kit (Roche, Belgium), according to the manufacturer’s instructions. 
The PCR products were cloned using the CloneJET™ PCR Cloning Kit (Fermentas, 
Germany) following the recommendations of the supplier. Escherichia coli DH5α were 
transformed by heat-shock and positive clones were picked and grown overnight. Plasmid 
Mini Kit I (Omega, USA) was used to extract the recombinant plasmids. Recombinant 
plasmids, pACCunt and pACCF3, containing inserts of about 7 kb, were sequenced. The 
ACCase coding region of sequenced and correct recombinant plasmids (pACCF3) was re-
amplified by PCR using TurACC-ExpF1/ TurACC-ExpR1 oligonucleotides to introduce the 
restriction site for NotI and delete the initiation codon, and the XbaI restriction site and delete 
the terminator codon. The PCR fragment was ligated into the vector pMIB/V5-His B 
(Invitrogen, USA) (Appendix 1) after digestion of both ends with NotI –HF and XbaI (New 
England BioLabs), heat shocked in E. coli and correct recombinant pMIB/V5-His clones 
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identified. Plasmid DNA for sequencing and transfection was prepared using an EndoFree 
Plasmid Maxi kit (Qiagen, USA) to avoid possible endotoxin contamination. Since the result 
of the sequencing showed that there was a 39bp insert between NotI site and the (deleted) 
initiation codon, it was decided to first re-clone the appropriate fragment into the CloneJET™ 
vector. In order to do this, first a PCR was performed with TurAcc-endF/ TurAcc-endR 
primers and the double digested (NotI –HF and XbaI) recombinant CloneJET plasmid 
(pACCF3) as template. This reaction mix was used as a template for the next PCR using 
TurACC-ExpF1/ TurACC-ExpR1 primers. The PCR product was ligated into the CloneJET™ 
vector (pJetExp1) and sequenced. The digested pJetExp1 with NotI –HF, XbaI and BglI was 
ligated into the digested (NotI –HF and XbaI) vector pMIB/V5-His B. The result of 
sequencing showed that the cloned gene was not in frame with the N-terminal HBM secretion 
signal and the C-terminal peptide for detection with the V5 or His(C-term) antibodies. To 
make the gene in frame with the N-terminal signal, the recombinant pMIB was digested with 
NotI and then the protruding ends were conversed by Klenow DNA polymerase (Fermentas, 
Germany) to blunt ends and finally recircularized with T4 ligase to finally generate the correct 
construct pMIB-ACC. 
2.12.2 Construction of vector pEIA+ACC21  
Next to the expression plasmid pMIB, we ligated the ACCase in a second expression plasmid, 
pEIA (formerly pIE1/153A) (Lu et al. 1997) (Appendix 2), provided by Kostas Iatrou, 
Institute of Biology, National Centre for Scientific Research Demokritos, Athens, Greece. 
The ACCase coding region was amplified by two PCR reactions. In the first PCR the 
recombinant pMIB plasmid was chosen as template and pEIAF1/ OpIE2R oligonucleotides 
were used to introduce a Kozak sequence (CAAC) and the initiator codon (ATG) immediately 
upstream of the deleted initiation codon. The second PCR using pEIAF2/ pEIAR1 primers 
and the first PCR as template added a restriction site for SmaI upstream of the Kozak 
sequence and NotI restriction site following the V5 epitope and polyhistidine (6xHis) region 
of pMIB and OpIE2 reverse priming site. To keep the possibility of further use of the SacII 
restriction site upstream of the V5 epitope and polyhistidine region in future experiments with 
this vector, we first deleted SacII restriction site of the original pEIA vector using SacII 
digestion and treatment by Klenow fragment and generated pEIA+ vector. The product of the 
second PCR was ligated into the CloneJET™ vector (pJetpEIA7). The digested pJetpEIA7 
with NotI –HF, SmaI and BglI was ligated into the digested (NotI –HF and SmaI) vector 
pEIA+ to generate pEIA+ACC21. The extra digestion with BglI cuts the vector, but not the 
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insert, and assured rare re-ligation of the CloneJET vector and the ACCase insert, making 
cloning into pEIA+ more efficient. 
2.12.3 Construction of recombinant pFastBac and production of recombinant bacmids 
ACCase recombinant baculoviruses were generated using the Bac-to-Bac baculovirus 
expression system (Invitrogen, USA) after subcloning the ACCase coding sequence into the 
pFastBac shuttle vector, according to the Bac-to-Bac® protocol (Invitrogen, USA). The 
digested pJetExp1 (NotI –HF, XbaI and BglI) was ligated in frame into the digested (NotI –HF 
and XbaI) vector pFastBac HT C (Appendix 3) downstream from the polyhedron promoter. A 
positive pFastBac clone (pFast HTC12) was sequenced. The plasmid was recombined into the 
bacmid backbone following the Bac-to-Bac® Baculovirus Expression system 
recommendations (Invitrogen, USA). Briefly, recombinant pFastBac HTC12 was transformed 
into DH10Bac E. coli competent cells containing the bacmid and helper plasmid in a Bac-to-
Bac® Expression system (Invitrogen, USA). The ACCase fragment was transposed to the 
bacmid. Insertion of the foreign gene caused disruption of lac Zα gene, and thus colonies 
containing the recombinant bacmid were white on Luria Bertani (LB) plates in the presence of 
blue-gal, isopropyl-L-thio-b-galactoside, and antibiotics (kanamycin, gentamicin, and 
tetracycline). The recombinant bacmids (bacmids 1 to 5) were purified and analysed by PCR 
amplification using pUC/M13F and pUC/M13R primers to verify the presence and site of 
insertion of ACCase in the bacmid. Recombinant viruses were produced in Sf9 insect cells 
(Invitrogen, USA) and stored at 4°C. A second positive pFastBac clone (pFast HTC17) 
originating from another pJetExp clone (pJetExp32) was also transformed into competent 
DH10Bac cells, and recombinant bacmids (bacmids 12 and 16) were produced.  
2.12.4. Construction of vector pET-ACC  
A PCR (Expand Long Range Kit) fragment was amplified using a positive pFastBac clone 
(pFast HTC12) as template and the primers pET-ACCF to introduce a SalI restriction site and 
primer pET-ACCR to insert a stop codon and a NotI restriction site, immediately upstream 
and downstream the ACCase CDS, respectively. This PCR fragment was cloned into the pJet 
1.2 vector using the CloneJET™ PCR Cloning Kit. Positive clones were checked by colony 
PCR. A positive clone with the correct insert was digested with SalI/NotI and ligated into the 
pETDuet-1 vector (Novagen, USA) (Appendix 4) resulting in pET-ACC. 
2.13 Transfection, virus generation and protein production in Sf9 and High Five cells 
Spodoptera frugiperda Sf9 or Trichoplusia ni High Five cells (Invitrogen, USA) were seeded 
at 1 × 106 per 2 ml of medium (Sf900 II SFM or complete IPL41 with 10 % FBS) in each well 
of a 6-well plate. For each well, Cellfectin (Invitrogen, USA) solution was prepared at 15 µl 
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of Cellfectin per 250 µl of Grace’s Insect Medum or basal IPL41 medium in a clear Falcon 
tube and was incubated at room temperature for 30-45 min. Plasmid DNA of expression 
plasmids (pMIB-ACC or pEIA+ACC21) for transfection of each well was dissolved at 1.5-2.5 
µg per 250 µl of basal IPL41 medium in a clear Falcon tube and incubated on ice. After 
removing the medium from seeded cells, 1 ml of basal IPL41 medium was gently added to 
wash the cells and remove proteins that could interfere with transfection. Then 250 µl of 
Cellfectin solution was added to each 250 µl of plasmid DNA solution in basal IPL41 to make 
the transfection mixture and was incubated on ice for 15 min. The medium was removed from 
seeded cells and replaced with 500 µl of transfection mixture in each well and was rocked 
gently. The 6-well plate was wrapped in a plastic bag to prevent desiccation and was 
incubated at 28ºC for 4-6 hours. After removing the transfection mixture from the cells in 
each well, 2 ml of medium with 50 µg/ml gentamycin was added to each well and rocked 
gently. The plate was wrapped in plastic and incubated at 27ºC. Transfected cells were 
incubated in an incubator for an additional 48, 72, 96 or 120 h and were harvested by 
centrifugation at 3000 g (5 min) for Western blot analysis. 
Recombinant bacmids were transfected into Sf9 insect cells following the the Bac-to-Bac® 
Baculovirus Expression system recommendations (Invitrogen, USA). For each transfection, 
500 ng of recombinant bacmid was used. Transfected cells were incubated in a 27°C 
incubator. Cells showed signs of viral infection after 4 days. Once the cells appeared infected, 
they were harvested and cell culture medium was saved as a master virus stock. The virus titer 
was determined using the BacPak Baculovirus Rapid Titer Kit (Clontech, USA) according to 
the manufacturer’s protocol. The titer of virus stock P1 was 8 × 104 ml-1. Because of the low 
virus titer, it was decided to further propagate the virus to a higher titer by infection of Sf9 
cells in serum-free medium. After a 4-day-incubation, a titer of 5.7 × 108 ml-1 was reached 
(P2). The virus stock P2 (of bacmid 4) was used for expression studies in Sf9 cells. 
Exponentially growing Sf9 cells in suspension culture in serum-free SF-900 II SFM medium 
(300 ml per flask; 2.1 × 106 cells per ml) were infected with baculovirus stock at a multiplicity 
of infection (MOI) of 0.9. At 24 h, 48 h and 72 h after infection, 100 ml of cell suspension 
were harvested by centrifugation at 500 g (10 min). Cell pellets were resuspended in lysis 
buffer (10 mM HEPES pH 7.4, 20 mM KCl, complete EDTA-free protease inhibitors (Roche, 
Belgium); 5 ml per g fresh weight). Cells were broken using a Potter homogenizer (10 × 1000 
rpm) and lysed by sonication for 5 × 20 sec (70% amplitude). The cell lysate was clarified by 
centrifugation (100000 g for 60 min) and the supernatant (soluble proteins) was normalized to 
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a protein concentration of 1.0 mg ml-1 and used further for enzyme activity and Western 
blotting assays. 
2.14 Expression of pET-ACC in E. coli strains 
E. coli strains “Codon Rare” and “BL21 DE3” (Novagen, USA) were heat-shock transformed 
with pET-ACC.  Single colonies of transformed cells were grown in LB medium overnight. 
One ml of overnight culture was diluted into 100 ml LB medium and vigorously shaken at 
37°C for at least 6 hours. Thereafter, 0.25 mM IPTG was added to the medium to 
induce protein synthesis. At 1, 2 and 3 h post-induction, cells were harvested and resuspended 
in SDS-lysis buffer. Cellular debris was pelleted at 10,000g, and supernatant containing 
soluble protein was diluted with an equal volume of NuPAGE LDS sample buffer (Invitrogen, 
USA) and detected by Western blot analysis using anti-His antibodies and streptavidin-HRP. 
2.15 Analysis of transcript levels of recombinant ACCase by RT-PCR 
Harvested cells (by centrifugation for 5 min at 3000g) were subjected to RNA extraction, 
DNase treatment and reverse transcription using the High Fidelity cDNA Synthesis Kit 
(Roche, Belgium). ACCase expression was confirmed by PCR amplification of cDNA using 
TurACCF6 and TurACCR6 (for plasmids) and pUC/M13F and pUC/M13R (for virus 
expression) from transfected cells and non-transfected cells, and virus and mock-infected cells 
(empty virus). The absence of contaminating genomic DNA in the RNA samples was verified 
by running PCR directly without reverse transcription. 
2.16 Stable expression of pMIB-ACC 
Adherent Sf9 or High Five cell monolayers transfected with plasmid DNA pMIB-ACC were 
subjected to selection with 30 and 60 µg/ml blasticidin–HCl, respectively, for 4 weeks.  
2.17 SDS-PAGE and Western blotting 
 Individual plasmid transfected cell pellets were resuspended in 50 µl of lysis buffer [125 mM 
Tris (pH 6.8), 5% β-mercaptoethanol, 2% SDS and 4 M urea] or were disrupted by sonication. 
Cell lysate was centrifuged at 3000 g for 5 min to remove cell debris. Supernatant preparation 
from baculovirus infected Sf9 cells was explained in 2.14. Supernatant from each lysate was 
transferred to a fresh tube to make similar dilutions of total proteins. Protein concentration 
was determined with a commercially available Coomassie protein assay kit (Perbio Science, 
Belgium). Twelve to 20 µg of supernatant was used for SDS-PAGE and Western blot analysis 
to examine protein expression levels. Supernatant from each cell line infected with 
recombinant plasmid or virus and supernatant of uninfected control cells, Sf9 or High Five 
(Invitrogen, USA), were heated at 70°C for 10 min with NuPAGE LDS sample buffer 
(Invitrogen, USA). Total protein samples were separated using 10% Bis-Tris (with MOPS 
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SDS Running Buffer) or 7% Tris-Acetate (with Tris-Acetate SDS Running Buffer) 
polyacrylamide gel electrophoresis (Invitrogen, USA), and then transferred to a PVDF 
membrane. Blotting also was carried out on cellular debris containing insoluble proteins. The 
gels were in parallel stained with Coomassie blue or GelCode Blue Stain Reagent (Pierce, 
USA). Membranes were blocked with 5% non-fat dry milk, and then incubated with Anti-His 
(Qiagen, USA) or Anti-V5 antibodies (Invitrogen, USA) followed by goat-anti-mouse-HRP-
conjugated secondary antibody (Dako Cytomation, Denmark) or with 
Streptavidin−Peroxidase Polymer (Sigma Aldrich, Belgium) according to the manufacturer’s 
instructions (proteins that bind biotin can be visualised using a streptavidin linked 
peroxidase). Immunodetection was achieved by a colorimetric assay using 3,3’-
diaminobenzidine tetrahydrochloride (DAB) (Sigma-Aldrich, Belgium). A precision protein 
standard (SeeBlue® Plus2 Pre-Stained Standard, Invitrogen, USA) was included for 
estimating molecular weight of the protein.  
Western blotting was also used to compare the ACCase protein level in two susceptible and 
two resistant strains of T. urticae. From each strain 500 deutonymphs were aspirated and 
crushed in 100 µL sodium phosphate buffer (0.1M, pH 7.6) supplemented with protease 
inhibitors (Halt protease inhibitor cocktail kit, Pierce, USA) with a motorised Teflon pestle in 
glass tubes. The homogenate was centrifuged at 10000g and 4° C for 10 min. The resulting 
supernatant was diluted to 800 µg protein mL−1 and used as a protein source.  
2.18 ACCase activity assay 
Preliminary assays of ACCase enzymatic activity were carried out by Peter Lümmen (Bayer 
Cropscience, Germany) according to Tanabe et al. (1981) with some modifications. BSA 
solution was made using 0.1 mg ml-1 BSA in HKM assay buffer (100 mM HEPES, pH 7.4, 15 
mM MgCl2 × 6 H20, 15 mM K-citrate). Equal volumes of ATP solution (4 mM ATP in HKM 
buffer) and Acetyl-Co A stock (8 mM in HKM buffer) were mixed (mixture A) prior to the 
assay. Assay mixtures in Micronic glass tubes (Micronic System, The Netherlands) were 
prepared using 100 µl protein solution (= 50 µg protein per assay mix), 36 µl BSA solution, 
30 µl mixture A (ATP, acetyl-CoA), 4 µl DMSO or inhibitor solution in DMSO (10 µM final 
inhibitor concentration) and 30 µl Na-bicarbonate solution (16.7 mM Na-bicarbonate in 10 
mM Tris/HCl, pH 9.0, including 10 µM 14C-bicarbonate as a radioactive tracer). The reaction 
mixtures were incubated for 30 min at 25°C and were then stopped by adding 35 µl 3 M HCl. 
Addition of the acid liberates CO2 from the unreacted bicarbonate, which evaporated into the 
gas phase for 10 min. Reaction mixtures were combined with 5.0 ml of scintillation cocktail 
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and the amount of radioactive malonyl-CoA was measured by liquid scintillation counting. 
Enzymatic rates were calculated using the specific activity of 2.04 GBq mmol-1. 
 
3 RESULTS 
3.1 Spirodiclofen resistance  
The LS-VL strain proved to be very susceptible to spirodiclofen prior to selection (Table 4.2). 
The LC50-value of this strain, derived from log-dose probit-mortality data, was 4.9 mg L-1. In 
addition, the response of LS-VL to spirodiclofen appeared to be very homogeneous (slope of 
probit line = 5.1).  
Artificial selection of the LS-VL strain was carried out as described in 2.2, and resulted in a 
slow increase of the resistance. One month after the final selection (5000 mg spirodiclofen L-
1), the LC50 of spirodiclofen for the laboratory selected SR-VP was 675 mg L-1, which is far 
above the recommended field-application rate for spirodiclofen (50-200 g a.i./1000 L) 
(Wachendorff et al. 2000). Consequently, the resistance ratio was 138, indicating strong 
resistance in the SR-VP strain. A continuous selection pressure of 5000 mg L-1 during the 
next 5 months even doubled the resistance ratio to 274 (Table 4.2). At that time, an LC90-
value of 5931 mg L-1 (95% CI 4234-9564) was obtained. The slope of the concentration-
mortality curve decreased to 2.0, indicating a more heterogeneous response in the laboratory-
selected resistant strain. The LC50 of spirodiclofen for the SR-TK strain, just before it was 
used for RNA extraction, was 441 mg L-1. 
Furthermore, the egg toxicity bioassay data indicated that the eggs of the SR-VP strain, 
contrary to the eggs of LS-VL, remained far more susceptible to spirodiclofen than the larvae. 
LC50s and slopes were respectively 8.7 mg L-1 (95% CI 7.9-9.4) and 5.5 ± 0.3 for LS-VL, and 
17.9  mg L-1 (14.6-21.1) and 2.5 ± 0.2 for SR-VP, resulting in a resistance ratio of only 2.0 
(95% CI 1.8-2.4). The LC90 for SR-VP eggs is only 60 mg L-1 (95% CI 50-76) (results not 
shown).  
3.2 Cross-resistance and synergism studies 
With the laboratory susceptible strain as control, the resistant strain was tested for cross-
resistance to different acaricides. The results are presented in Table 4.2. The SR-VP strain 
exhibited no cross-resistance to abamectine, etoxazole and pyridaben. In the case of 
acequinocyl, bifenazate and tebufenpyrad, the spirodiclofen resistant population presented 
only a slightly higher LC50 than the susceptible population, indicating that this possible 
associated resistance is of minor importance. The resistance ratios for acequinocyl, bifenazate 
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and tebufenpyrad were 3.8, 2.0 and 2.2, respectively. The highest cross-resistance was 
observed with the tetronic acid derivate spiromesifen (RR = 18).  
 
 
Table 4.2 Concentration probit-mortality data of several acaricides on the LS-VL and SR-VP strain 
with calculated resistance ratios (RR) 
 
 LS-VL  SR-VP  
Acaricide 
Life 
stage 
tested 
LC50 (95%CI) 
(mg L-1) 
Slope ± 
SE  
LC50 (95%CI)  
(mg L-1) Slope ± SE RR (95%CI) 
Spirodiclofen larvae 4.9 (4.5-5.3) 5.1 ± 0.2  675 (574-781) a 2.3 ± 0.2 138 (116-165) 
     1343 (1122-1650) b 2.0 ± 0.1 274 (235-322) 
 eggs 8.7 (7.9-9.4) 5.5 ± 0.3  17.9 (14.6-21.1) 2.5 ± 0.2 2.0 (1.8-2.4) 
Abamectine adults 0.40 (0.36-0.45) 5.2 ± 0.7  0.52 (0.46-0.58) 4.4 ± 0.5 1.3 (1.1-1.5) 
Acequinocyl adults 7.7 (6.7-8.9) 4.1 ± 0.4  29.6 (24.3-35.7) 3.6 ± 0.5 3.8 (3.2-4.6) 
Bifenazate adults 1.2 (1.0-1.4) 4.1 ± 0.5  2.4 (1.7-3.1) 2.8 ± 0.2 2.0 (1.6-2.5) 
Etoxazole larvae 0.76 (0.65-0.87) 3.9 ± 0.3  0.61 (0.52-0.69) 4.2 ± 0.3 0.8 (0.7-0.9) 
Pyridaben adults 156 (96-271) 0.8 ± 0.1  135 (84-200) 1.0 ± 0.1 0.9 (0.7-1.1) 
Spiromesifen larvae 0.79 (0.63-0.94) 3.5 ± 0.3  14.5 (9.8-18.9) 2.2 ± 0.2 18 (15-23) 
Tebufenpyrad adults 63.5 (52.3-75.7) 2.4 ± 0.2  137.5 (108.1-165.8) 2.6 ± 0.3 2.2 (1.7-2.7) 
a January, 2008 
b May, 2008        
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The effect of pre-treatment with PBO, DEF and DEM on the toxicity of spirodiclofen is 
presented in Table 4.3. Synergistic effects on the selected resistant strain were tested using 
mites that have been reared under a continuous pressure of 5000 mg spirodiclofen L-1 for 5 
months. PBO and DEF clearly enhanced the toxicity of spirodiclofen to SR-VP by 3.5- and 
3.3-fold, respectively, and decreased the resistance ratio from 275 to 97 and 64 compared to 
LS-VL. DEM did not synergize the toxicity of spirodiclofen to SR-VP at all. However, DEM 
had a small antagonistic effect on the spirodiclofen toxicity to LS-VL, resulting in a 1.5-fold 
reduction of the resistance ratio. 
The effect of spirodiclofen on reproduction after pre-treatment with PBO, DEF and DEM is 
presented in Figure 4.3. Without synergists, the IC50 value for the LS-VL strain was 43.7 mg 
L-1 spirodiclofen. A similar value (42.2 mg L-1) was obtained when the susceptible strain was 
pre-treated with DEM. Pre-treatment with PBO and DEF increased the inhibitory effect of 
spirodiclofen on reproduction. The IC50 values decreased to 10.7 (DEF) and 16.9 mg L-1 
(PBO). It can be noted that the slopes of these curves are less steep than that of the control, 
indicating a less homogeneous response. In SR-VP mites, spirodiclofen could not inhibit the 
reproductive capacity more than 20%, even at highest concentrations, and the IC50 value could 
not be calculated. Pre-treatment with DEM even reduced the inhibitory effect of 
spirodiclofen. However, as observed in LS-VL, the synergistic effect of PBO and DEF 
treatment was clear. To get an estimation of the IC50 values, a regression curve was added. 
The estimated theoretical IC50 values obtained by extrapolation were 8×103 (PBO) and 
59×103 mg L-1 (DEF).  
 
Table 4.3 Effect of pre-exposure to PBO, DEF and DEM on spirodiclofen mortality in the LS-VL and 
SR-VP strains, with synergism ratios (SR) 
 
 LS-VL  SR-VP   
 LC50 (95%CI) (mg L-1) Slope ± SE 
SR a 
(95%CI) 
LC50 (95%CI)  
(mg L-1) Slope ± SE 
SR  
(95%CI) 
RR 
(95%CI) 
- 4.9 
(4.5-5.3) 
5.1 ± 0.2 1 1343 
(1122-1650) 
2.0 ± 0.1 1 275 
(235-322) 
PBO 3.9 
(3.4-4.5) 
3.9 ± 0.2 1.2 
(1.1-1.3) 
380 
(321-449) 
1.9 ± 0.1 3.5 
(3.0-4.1) 
97 
(84-110) 
DEF 6.3 
(5.3-7.1) 
3.7 ± 0.3 0.8 
(0.7-0.9) 
402 
(346-467) 
1.8 ± 0.1 3.3 
(2.9-3.9) 
64 
(56-73) 
DEM 6.9 
(5.8-8.3) 
4.0 ± 0.2 0.7 
(0.7-0.8) 
1306 
(1119-1549) 
1.3 ± 0.1 1.0 
(0.9-1.2) 
189 
(162-221) 
 a SR =  LC50 of spirodiclofen alone / LC50 of spirodiclofen + synergist 
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Figure 4.3 Inhibition of reproductivity of LS-VL (a) and SR-VP (b) females 
after 24 h of spirodiclofen pre-treatment without (●) or with prior application of 
synergists PBO (○), DEF (▼) or DEM (∇) 
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3.3 Detoxification enzymes 
A significant difference in mono-oxygenase-mediated 7-EFC deethylation activity was found 
between adult females of LS-VL and SR-VP. After 5 months of selection with spirodiclofen, 
the activity was increased 11-fold in the resistant strain (Table 4.4). The mono-oxygenase 
activity in larvae of the susceptible strain did not differ from the activity in female adults. 
Activity in larvae collected from the SR-VP strain was enhanced 6-fold compared to the LS-
VL larvae (Table 4.4). Finally, the mono-oxygenase activities in the females from the 
reciprocal crosses were determined (Table 4.4). The activities of both reciprocal crosses were 
significantly different from their parental strains (t-test, P<0.05), but not significantly 
different from each other (t-test, P>0.05). A drop in activity by 2.9- and 4.0-fold compared to 
SR-VP was measured for LS-VL♀ × SR-VP♂ and SR-VP♀ × LS-VL♂ respectively.   
 
Table 4.4 Detoxifying enzyme activities in the LS-VL and SR-VP strain a 
 
 LS-VL SR-VP Ratio 
Mono-oxygenases    
   O-deethylation of 7-EFC b     
→ adult ♀    316 ± 26A 3437 ± 132B 11 
→ larvae    336 ± 92A 1962 ± 312B 5.8 
→ LS-VL♀ × SR-VP♂                       1250 ± 91   
→ SR-VP♀ × LS-VL♂                        903 ± 105  
Esterases     
   4-nitrophenyl acetatec    82.3 ± 1.8A  110.3 ± 2.6B 1.3 
   4-nitrophenyl propionatec  201.3 ± 1.6A  275.7 ± 7.1B 1.4 
   4-nitrophenyl butyratec  195.2 ± 3.8A  271.9 ± 5.4B 1.4 
   1-naphthyl acetated  271.0 ± 5.1A  395.7 ± 8.5B 1.5 
   1-naphthyl 2,2-dimethyl butyrated    16.7 ± 0.9A   33.7 ± 1.2B 2.0 
Glutathione-S-transferases     
   CDNB conjugatione 762 ± 78A 1438 ± 72B 1.9 
   MCBf  955 ± 78A 2388 ± 57B 2.5 
a Means (±SEM) within a row followed by the same capital letter are not significantly 
different (t-test, P>0.05)  
b pmol 7-hydroxy-4-(trifluoromethyl)-coumarin (30 min)-1 mg-1 protein (±SEM, n=3) 
c nmol 4-nitrophenol min-1 mg-1 protein (±SEM, n=3) 
d nmol 1-naphthol min-1 mg-1 protein (±SEM, n=3) 
e nmol glutathione conjugated min-1 mg-1 protein (±SEM, n=3) 
f relative fluorescence units (RFU) µg-1 protein (±SEM, n=3) 
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The esterase activities determined with the common substrates 4-NPA, 4-NPP, 4-NPB and 1-
NA are shown in Table 4.4 and reveal a significant, but not very high, increase in SR-VP. 
Interestingly, the esterase activity measured with the new 1-naphthyl derivative, 1-naphthyl 
2,2 dimethylbutyrate, clearly showed a 2-fold increase in SR-VP compared to LS-VL, though 
the absolute values were much lower than those measured with 1-NA. 
The conjugation of glutathione with the artificial substrate CDNB was significantly higher in 
the selected resistant compared to the sensitive strain (Table 4.4). Additionally, the GST 
activity was measured in a fluorometric assay with MCB. Compared to strain LS-VL, SR-VP 
exhibited a 2.5-fold increase in GST activity.  
3.4 Esterase activity gel profiles 
The esterase isozymes of adults and nymphs of both susceptible (LS-VL and London) and 
resistant (SR-VP and SR-TK) strains of T. urticae after separation with pI 3–7 IEF gels, were 
visualised with 1-NA activity staining (Figure 4.4). The overall banding pattern was similar, 
however, adults and deutonymphs of the resistant strains showed a highly intensified band at 
an estimated pH of about 5.12. This band also seems to be present in the susceptible strains 
but with a much lower activity. These results suggest that one esterase is mainly responsible 
for the enhanced esterase activity in the resistant strains, and although the increase in esterase 
activity measured by artificial substrates in the resistant strains is not very high, it might 
possibly be associated with spirodiclofen resistance. 
 
 
 
 
Figure 4.4 Esterase isozymes of adults and nymphs of two spirodiclofen resistant (SR-
VP and SR-TK) and two susceptible (LS-VL and London) strains of T. urticae after 
separation with IEF pH 3–7, visualised with 1-NA activity-staining. The marker was 
stained using GelCode Blue Stain Reagent. Arrows indicate the intensified band in the 
resistant strains. 
             Nymphs       
 SUSCEPTIBLE   RESISTANT
LS-VL  London  SR-VP SR-TK
Adult females pI=6.9 
pI=5.3 
pI=5.2 
pI=4.5 
 SUSCEPTIBLE  RESISTANT 
LS-VL London  SR-VP SR-TK 
pI=6.0 
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3.5 Effects of spirodiclofen on lipid content 
Mites of the LS-VL or the SR-VP strain that were exposed to different concentrations of 
spirodiclofen did not show any significant difference in total lipid content compared with the 
controls (Table 4.5). Also, no significant differences could be observed between different 
measurements in time. Only the lipid content in SR-VP mites treated with 1000 mg L-1 
measured after 5 days was significantly different from the lipid content 2 hours after treatment 
(Table 4.5). When the lipid content of 100 mites (instead of 10) was measured, again no 
significant differences were found between treatments within each strain (results not shown). 
However, comparing both strains, the lipid content in SR-VP mites appeared to be 
significantly higher than that in LS-VL mites, as can also be observed in most measurements 
in Table 4.5.  
 
Table 4.5 Total lipid content in female adults of LS-VL and SR-VP strain (µg/10 
spider mites) after a 12 h pre-treatment with 200 and 1000 mg L-1 spirodiclofen. 
Means (±SEM, n=3) within a column or row (and same strain) followed by the 
same small letter or capital letter, respectively, are not significantly different 
(non-parametric test, Kruskal-Wallis, p > 0.05). 
 
strain conc  female adult age (days) 
 (mg L-1)  4  6  9 
        
LS-VL 0  21.7 ±  2.3 a A  21.2 ±  0.2 a A 25.1 ±  2.1 a A 
 200 21.4 ±  0.2 a A 23.5 ±  1.9 a A 24.5 ±  2.4 a A 
 1000 19.0 ±  0.9 a A 19.6 ±  0.5 a A 21.4 ±  0.8 a A 
        
        
SR-VP 0  25.9 ±  1.4 a A * 33.7 ±  4.6 a A 34.1 ±  5.2 a A * 
 200 34.7 ±  3.1 a A 35.9 ±  1.9 a A 36.1 ±  2.3 a A 
 1000 25.9 ±  0.7 a A 29.0 ±  1.6 a AB 32.0 ±  0.7 a B 
      
 
* not significantly different with LS-VL (Kruskal-Wallis, p > 0.05) 
 
3.6 Mode of inheritance of spirodiclofen resistance 
The concentration-mortality curves of the parental strains and actual data points of the 
reciprocal crosses are shown in Figure 4.5. The fitted curves of the corrected results for the 
haploid male offspring are shown in the same figure. Without this correction there would be 
an overestimation of mortality at the lower concentrations for LS-VL♀ × SR-VP♂ and an 
underestimation of mortality at the higher concentrations for the other reciprocal cross. At the 
moment of the crossing experiments, the LC50 of the resistant SR-VP mites was 675. The 
(corrected) LS-VL♀ × SR-VP♂ and SR-VP♀ × LS-VL♂ reciprocal crosses had an LC50 
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(95% CI) of 68 mg L-1 (63-74) and 85 mg L-1 (69-103), respectively. Since the concentration-
mortality curves for the reciprocal F1 crosses were nearly identical (the 95% confidence 
intervals at LC50 overlapped), there was no pronounced maternal effect involved in the 
inheritance of resistance. Only at higher concentrations, differences in mortality could be 
detected. The LC90 values of both crosses were significantly different to each other (150 mg 
L-1 (136-170) for LS-VL♀ × SR-VP♂ and 236 mg L-1 (187-323) for SR-VP♀ × LS-VL♂) 
(results not shown). A visual examination of Figure 4.5 suggests spirodiclofen resistance is 
intermediate. This is confirmed by substituting the LC50 values of the LS-VL, SR-VP and 
reciprocal crosses into the formula of Stone (1968), resulting in degrees of dominance close to 
zero (Table 4.6). Figure 4.6 shows the observed concentration-mortality lines of spirodiclofen 
for the backcrosses, corrected for haploid male offspring. The dotted lines indicate the 
expected values for F2 females if spirodiclofen resistance was determined by a single major 
gene. Because 1) there is no plateau seen at the LC50 level for both crosses, and 2) the 
observed mortality for (LS-VL × SR-VP)♀ × LS-VL♂ and (SR-VP × LS-VL)♀× SR-VP♂ 
was significantly different (χ2=67.15, df=20 and  χ2=62.70, df=16, respectively, p<0.001) 
from that expected on the basis of monogenic inheritance, spirodiclofen resistance in SR-VP 
appears to be polygenic.  
The mortality curves of the haploid F1 progeny of strains LS-VL and SR-VP, and the haploid 
F2 progeny of the virgin F1 heterozygous females are represented in Figure 4.7. The dotted 
line indicates the expected mortality if a single gene conferred the spirodiclofen resistance. 
The intermediate and polygenic inheritance of resistance is also confirmed by the dominance 
factors calculated for the haploid F2 progeny (Table 4.6) and the absence of a plateau at 50% 
mortality for both crosses (Figure 4.7). A χ2 goodness-of-fit analysis of the observed mortality 
to the expected line indicated significant departure from the one major gene model 
(χ2=155.27, df=12 for LS-VL♀ × SR-VP♂, and χ2=133.14, df=13 for SR-VP♀ × LS-VL♂, 
p<<0.001). 
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Figure 4.5 Spirodiclofen concentration-mortality curves for LS-VL, SR-VP and 
reciprocal crosses. The triangles represent actual data points of the haploid and 
diploid progeny (▼ = LS-VL x SR-VP; ∇ =  SR-VP x LS-VL). The dashed lines 
represent the reciprocal crosses corrected for haploid males. 
 
 
Figure 4.6 Spirodiclofen concentration-mortality curves for the diploid progeny 
of the backcrosses (LS-VL × SR-VP)♀ × LS-VL♂ (●) and (SR-VP × LS-VL)♀× 
SR-VP♂(○). Circles are actual data points (corrected for haploid male progeny), 
the dashed lines are fitted curves. The dotted lines represent the response 
expected if spirodiclofen resistance were determined by a single major gene.  
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Figure 4.7 Spirodiclofen concentration-mortality curves for parental males 
and F2 males derived from virgin F1 females (▼ = LS-VL x SR-VP; ∇ =  SR-
VP x LS-VL). The dotted line represents the response expected if 
spirodiclofen resistance were determined by a single major gene. 
 
 
 
 
 
 
 
Table 4.6 Probit statistics for the reciprocal crosses tested against spirodiclofen (n = number of mites  
and D = degree of dominance) 
 
 Strain n Slope ± SE LC50 (95%CI)  (mg L-1) D 
diploid F1 progeny LS-VL♀ × SR-VP♂ 3843 3.7 ± 0.1 68 (63-74)  0.07 
 SR-VP♀ × LS-VL♂ 1812 2.9 ± 0.1   85 (69-103) 0.16 
      
haploid F2 progeny LS-VL♀ × SR-VP♂ 3887 2.5 ± 0.1 56 (50-62) 0.004 
 SR-VP♀ × LS-VL♂ 3737 2.0 ± 0.1 44 (40-49) -0.10 
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3.7 Sequence characterization of ACCase 
The cDNA sequence was 6957-bp long with an open reading frame and deduced amino acid 
sequence (AA) of  2318 amino acids (AA), giving an estimated  molecular weight of 261.8 
kDa. A BlastP search of the GenBank database revealed that the translated cDNA sequence 
displayed a moderate level of similarity with ACCase of Pediculus humanus corporis (60%), 
Acyrthosiphon pisum (60%) and Tribolium castaneum (59%). Analysis of the amino acid 
sequence with Scan Prosite (http://www.expasy.org/prosite) revealed the existence of several 
structural motifs typical of this enzyme (Appendix 5). These motifs include: 1) the BCC 
domain (residues 662-728), which contains a biotin group covalently linked to a conserved 
lysine (residue 696); 2) the BC domain (residues 31-528), that catalyzes the ATP-dependent 
carboxylation of this biotin group; and 3) the CT domain (residues 1639- 2143) that catalyzes 
the transfer of the carboxyl group from biotin to acetyl-CoA to produce malonyl-CoA. The 
amino acid sequence of binding sites for ATP (residues 220-235; Figure 4.8a), biotin 
(residues 689-701; biotin at 696; Figure 4.8b), carboxybiotin (residues 1615-1664; Figure 
4.8c), and acetyl-CoA (residues 1918-1929; Figure 4.8d) were highly conserved in animals 
and plants.  
To investigate whether spirodiclofen resistance could be mediated by target site insensitivity, 
full-length cDNA fragments of T. urticae ACCase gene were cloned from the spirodiclofen-
resistant (SR-VP and SR-TK) and susceptible strains (LS-VL and London). We compared 
their full length amino acid sequences and despite of several synonymous mutations, we could 
not detect any fixed non-synonymous mutations in the resistant strains. However, the 
electropherograms of the SR-VP strain showed the presence of two peaks at nucleotide 
position 3235, results in an alanine to threonine (A1079T) substitution.  
3.8 Association between ACCase expression and spirodiclofen resistance 
Real-time PCR was used to determine whether ACCase expression in the resistant strains is 
altered when compared to the susceptible strain. No change in expression levels was found in 
the spirodiclofen resistant strains.  
A Western blot assay of total protein extracts from spirodiclofen resistant and susceptible 
deutonymphs using streptavidin-HRP showed no difference in the biotin-binding protein 
pattern between strains, indicating that the resistance to spirodiclofen might not be due to an 
increase in the ACCase expression. 
 
  
 
 
 
Figure 4.8 Multiple sequence alignment of selected ACCase homologs from Tetranychus urticae (Tu), Pediculus humanus corporis (Phc, XP_002429216.1), 
Tribolium castaneum (Tc, XP_969851.2), Aedes aegypti (Aa, XP_001651879.1), Drosophila melanogaster ACCase isoform A (Dm, NP_610342.1), Homo 
sapiens ACCase1 (Hs, NP_942133.1), Gallus gallus (Gg, NP_990836.1), Triticum aestivum cytosolic ACCase (TaC, ACD46674), Triticum aestivum plastid 
ACCase (TaP, ACD46685), Zea mays (Zm, AAA80214), Oryza sativa (Os, AAM18728), Arabidopsis thaliana (At, AAC41645), Glycine max (Gm, 
AAA75528), Brassica napus (Bn, CAA54683). a ATP binding sites; b biotin binding sites; c acetyl-CoA binding sites; d carboxybiotin binding sites. Protein 
sequences were aligned using the CLUSTALW alignment algorithm. Sequences were shaded using the BoxShade program. Identical and conserved residues 
are shaded black and gray, respectively. 
Tu 
Phc 
Tc 
Aa 
Dm 
Hs 
Gg 
TaC 
TaP 
Zm 
Os 
At 
Gm 
Bn 
a       b      c                   d 
_____________________________________________Spirodiclofen resistance in T. urticae 
 103
3.9 ACCase functional expression 
3.9.1 Constructs 
Restriction analysis and sequencing of recombinant expression plasmid pMIB-ACC (after 
Klenow DNA polymerase treatment) revealed that the ACCase insert is in frame with the N-
terminal HBM secretion signal and His tag at the C-terminal.  
Also, sequencing of pEIA+ACC21 showed that the ACCase was correctly inserted and that a 
Kozak sequence and C-terminal polyhistidin tag for detection is present.  
The constructed pFast HTC12 and 17 were in frame with the N-Terminal 6×His tag and the 
stop codon was located in the vector polyadenylation signal. pFast HTC12 showed an N444D 
polymorphism that was possibly the result of a PCR error. 
Sequencing and double digestion using SalI/NotI showed that the pET-ACC construct, was in 
frame and correct. 
3.9.2 Expression using expression plasmids pMIB and pEIA+ in insect cells 
Transcription levels after transfection were analysed by RT-PCR using gene-specific primers. 
The gene was transcribed in both Sf9 and High Five cell lines, transfected with either one of 
the expression vectors. All RNA samples extracted from transfected cells were subjected to 
PCR without reverse transcription as control. The negative result indicated that RNA samples 
were free of genomic DNA contamination. Designed primers proved to be specific for T. 
urticae ACCase gene, since no amplification of the endogenous SF9 and High Five cell 
ACCase was detected in the non-transfected samples.  
Sf9 and High Five cells transfected with pMIB-ACC showed no ACCase expression after 
blotting with Anti-His or Anti-V5 antibodies. Contrary to Sf9-cells, High Five cells showed 
limited ACCase expression two days after transfection with pEIA+ACC21 (results not 
shown). However, the ACCase protein was mainly found in the insoluble fraction (cell-debris 
fraction), and these experiments need to be repeated. 
3.9.3 Baculovirus expression 
Transformation of recombinant pFast HTC12 and HTC17 into DH10Bac competent cells 
resulted in the construction of the recombinant bacmids and transfection of these bacmids 
generated recombinant viruses. RT-PCR confirmed transcription of the recombinant ACCase 
after infection of Sf9 cells by the baculoviruses. Western blots revealed detectable protein 2 
and 3 days after virus infection (Figure 4.9).  
Activity of the recombinant ACCase was analysed by monitoring the ACCase- and ATP-
dependent incorporation of radioactivity from acid labile H[14C]O3- into acetyl-CoA to form 
the acid-stable malonyl-CoA product. Comparison of test results in the presence and absence 
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of 10 µM spirotetramate-enol showed that more than 90% of the carbon dioxide incorporation 
into buffer-soluble, acid-resistant material can be readily inhibited. This means that the assay 
method specifically measured ACCase activity in the cell extracts. 24 h after infection there 
was no difference between the ACCase activities of infected (virus constructed using bacmid 
4) and mock-infected cells. The control activity can be attributed to the endogeneous ACCase 
activity of Sf9 cells. At 48 h after infection an increase in ACCase activity was observed in 
the infected cells (7.3 nmol min-1 mg-1) in comparison with the mock-infected cells. At 72 h 
after infection, almost no activity could be measured in the infected as well as in the mock-
infected cells, probably due to advanced cell damage (Figure 4.10). 
3.9.4 Expression in E. coli 
Promising results were also achieved by heat-shocking “Codon Rare” E. coli cells transfected 
with the pET-ACC vector. A Western blot probed with streptavidin-HRP (Figure 4.11) 
showed there was an approximately equal amount of protein of each treatment (1, 2 and 3 
hours after induction with IPTG and without IPTG induction) loaded on the Bis-Tris gel, 
while the same blot probed with anti-His antibody revealed there was ACCase expression 2 
and 3 hours after induction with IPTG (small band at 260 kDa). However, besides the 
ACCase protein band several other smaller protein bands were detected, indicating that the 
expressed ACCase protein had been degraded by proteases after expression. 
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Figure 4.9 Western blot analysis of the supernatant cell extracts of baculovirus infected Sf9 cells 1 
(lane 2), 2 (lane 4) and 3 (lane 6) days after infection and cell extracts from mock-infected Sf9 cells 
l (lane 3), 2 (lane 5) and 3 (lane 7) days after infection. The blots were probed with Streptavidin-
HRP antibody. Biotinylated molecular weight markers (lane 1) was used to control the 
electrophoresis and the electrotransfer of proteins. The arrows indicate the expressed recombinant 
ACCase. 
 
 
 
Figure 4.10 ACCase activity in the cell extracts. 24, 48 and 72 h after  
infection vs. control (mock-infected cells). 
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Figure 4.11 Western blot of supernatant cell extract of pET-ACC heat-shocked “Codon Rare” and 
BL21 DE3 E. coli cells 1, 2 and 3 hours after induction with IPTG. The blots were probed with 
Streptavidin-HRP- (right panel) or with anti-His (B) antibodies (left panel). The arrows indicate the 
expressed recombinant ACCase. 
 
4 DISCUSSION 
The main objective of this study was to make a biochemical, genetic and molecular analysis 
of a laboratory selected spirodiclofen resistant strain (SR-VP) of T. urticae. Selecting an 
acaricide-susceptible field strain of T. urticae (LS-VL) with increasing concentrations of 
spirodiclofen resulted in a gradual increase of the resistance ratio. The slow increase of 
resistance may be partly due to the low initial frequency of resistance alleles in the parental 
homogeneous LS-VL strain. It is possible that during selection an accumulation of resistance 
genes with minor effects occurred, creating a more heterogeneous population, of which the 
decreasing slopes of the concentration-mortality lines could be an indication (Robertson et al. 
2007). After 17 months of selection, the strain (SR-VP) reached a stable and high resistance 
ratio of 274. This is considerably higher than the previously reported resistance ratio (13 fold) 
after selecting an Italian field collected strain for 21 months (Rauch and Nauen 2002). 
Cross-resistance experiments revealed that the resistant SR-VP strain showed considerable 
cross resistance towards spiromesifen, another acaricide within the same chemical class of 
tetronic acid derivatives. The existence of cross-resistance among tetronic acid derivative 
acaricides has also been documented in the citrus red mite, Panonychus citri: a spirodiclofen 
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resistant population collected from Chinese citrus orchards, which had no previous history of 
spirotetramat application, proved to be resistant to spirotetramat (Hu et al. 2010). 
Our study could indicate that spirodiclofen and spiromesifen share a common detoxification 
route, but with a higher specificity towards spirodiclofen. Alternatively, it could also mean 
that SR-VP has an altered target site affecting binding of both compounds possibly in 
combination with a specific spirodiclofen detoxification mechanism. 
However, amino acid sequence alignment of ACCase revealed no consistent amino acid 
polymorphisms between the spirodiclofen resistant (SR-VP) and susceptible strain of T. 
urticae. The documented A1079T polymorphism was not fixed in this strain, and possibly not 
associated with spirodiclofen resistance. Another spirodiclofen resistant strain SR-TK 
(RR=90), obtained from Bayer CropScience, with a similar esterase isozyme profile and 
ACCase expression level, did not exhibit this mutation. Also, this residue is not located within 
any of the conserved functional domains. Previous findings in weeds revealed that variable 
mutations in the CT domain of homomeric plastidic ACCase within grass species were 
associated with resistance to ACCase-inhibiting herbicides. Also it has been found that a 
mutation in the BC domain of yeast ACCase can render the enzyme resistant to soraphen A, a 
potent inhibitor of eukaryotic ACCase (Shen et al. 2004). Next to sequence polymorphisms, 
we also analysed expression levels with RT-PCR, and no up- or down regulation in the 
resistant strains were detected. The experiment needs to be repeated since at least two 
reference genes are recommended. Using only one reference gene can result in errors. These 
results were confirmed on the protein level, since Western blots using streptavidin-HRP also 
showed no difference in the biotin-binding proteins in T. urticae deutonymphs of resistance 
and susceptible strains. Although not detected here, altered expression levels of ACCase have 
been linked with resistant in plants.  A johnsongrass, Sorghum halepense, biotype resistant to 
ACCase inhibiting-herbicides showed an ACCase that was still sensitive to the herbicides, but 
the specific activity of ACCase in the resistant biotype was two to three times higher than that 
of the susceptible biotype. It was suggested that resistance is conferred by an overproduction 
of ACCase in the resistant johnsongrass biotype (Bradley et al. 2001). 
Since target-site resistance is probably not involved, we conducted synergism studies and 
biochemical assays with model substrates to identify metabolic resistance mechanisms. Pre-
treating SR-VP larvae with PBO prior to spirodiclofen application resulted in a clear decrease 
of resistance (synergism ratio = 3.5), while the susceptibility of the LS-VL strain was hardly 
affected. This indicated that P450 mono-oxygenases might play an important role in 
spirodiclofen detoxification. Determination of detoxifying enzyme activities in vitro 
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confirmed this hypothesis, since the mono-oxygenase activity, measured by O-deethylation of 
7-EFC in adults and larvae of the resistant strain was increased 11 and 6-fold, respectively. In 
addition, pre-treatment with PBO increased the inhibitory effect of spirodiclofen on 
reproduction: pre-treatment of resistant females could partially restore the inhibition of the 
reproductive capacity caused by spirodiclofen. Rauch and Nauen (2002) also found P450 
mono-oxygenases to be important in spirodiclofen resistance in this species.  
Next, in vivo synergism assays revealed that the esterase inhibitor DEF, despite the low 
concentration (10 mg L-1), synergized spirodiclofen in the SR-VP strain to the same extent as 
PBO (3.3-fold), indicating the importance of esterases in the detoxification of spirodiclofen. 
DEF also synergized the effect of spirodiclofen on reproduction in females of the resistant 
strain. Further evidence was provided by the increase in mean esterase activity towards 
different substrates in the SR-VP strain. The increase was most prominent when measured 
with the purpose-designed substrate 1-naphthyl 2,2-dimethylbutyrate. The metabolism of this 
substrate, which mimics the acyl-ester side chain of spirodiclofen, might be a good 
representative for imitating the hydrolytic degradation of spirodiclofen (Rauch and Nauen 
2002). Probably, among the esterases of T. urticae only one is more expressed in 
spirodiclofen resistant strains, and this one apparently prefers 1-naphthyl 2,2-
dimethylbutyrate. This was confirmed when esterase isozymes were separated by native 
isoelectric focusing. A clearly enhanced esterase near pH 5 in the resistant strains was 
responsible for the higher esterase activity associated with spirodiclofen resistance. Using 
radiolabelled [14C]spirodiclofen Rauch and Nauen (2002) revealed that hydrolytic and 
oxidative degradation of spirodiclofen occurred more rapidly in the resistant strain.  
Although enzymatic assays with CDNB and MCB indicated that the resistant strain had a 
higher GST activity, in vivo synergism assays revealed that DEM did not synergize the 
spirodiclofen efficacy in the resistant strain. GST activity was also determined  to be 
significantly higher by Rauch and Nauen (2002) in the resistant compared to the parental 
strain. These results make the roles of GSTs in spirodiclofen resistance in T. urticae unclear, 
but there is no reason to exclude their roles completely. 
There are also some reports that PBO is able to inhibit some esterases as well (Young et al. 
2005). In theory, a synergistic effect of PBO can hence also be attributed to the inhibition of 
certain esterases. However, considering the highly increased P450 MO activity, this is most 
likely not the case.  Similarly, the esterase inhibitor DEF is also able to inhibit GSTs. So, 
caution must be taken when interpreting the results from tests with synergistic. 
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In conclusion, in contrast to our attempts to reveal an altered target-site, we found several 
indications that enhanced detoxification might be the major cause of resistance. 
We were not able to find a link between spirodiclofen treatment and lipid biosynthesis. 
However, the increase in lipid content over time, although not statistically significant, was 
more pronounced in resistant mites. Based on this experiment, it was not really possible to 
make conclusive remarks about the impact of spirodiclofen on the de novo lipid biosynthesis.  
However, total lipid content in the SR-VP strain was higher compared to the LS-VL strain, 
which could be an essential condition for spirodiclofen resistance. Higher lipid contents have 
been found in the resistant strains of M. domestica (Patil and Guthrie 1979) and in the cuticles 
of resistant tobacco budworm larvae (Vinson and Law 1971). A more detailed study of the 
different lipids may generate more relevant information to elucidate the spirodiclofen mode of 
action and the role of specific lipids in this process.  
An important observation from a resistance management perspective was the very low 
resistance in SR-VP eggs. Life stage variations in insecticidal susceptibility are not unusual 
and were previously reported (Brattsten 1988, Gunning et al. 1992, Sato et al. 2006, Nauen et 
al. 2008). This lack of relationship between ovicidal and larvicidal resistance may be related 
to a differential expression of the detoxifying enzymes causing variations in metabolic 
detoxification capacity between eggs and larvae. This is also consistent with the lack of an 
altered target-site, that would probably also protect eggs at least partially from spirodiclofen 
intoxication. Considering this developmental stage-dependent response to spirodiclofen in T. 
urticae, treatment of plants infested with resistant mites with the recommended field dose of 
spirodiclofen, will only kill eggs that come in direct contact with the acaricide, while others, 
e.g. eggs deposited on young, newly grown leaves or in the webbing after spraying, will hatch 
and larvae will still develop. To guarantee sustainable control of spider mite populations, it is 
important to spray at early infestation, at the very beginning of the population build up. 
Spirodiclofen might be used best as an ovicide, mixed with or in close succession with 
another acaricide with a different mode of action active against motile stages, in order to 
prevent migration of the adults and the outbreak of a new infestation. 
Our results regarding the resistance profile in female progeny of reciprocal crosses, both by 
visual examination of concentration-mortality curves and by calculating degrees of 
dominance suggest that spirodiclofen resistance in SR-VP strain has no substantial 
dominance. Similarity in dose-response curves for these reciprocal crosses, indicating that no 
apparent extranuclear inheritance was involved. The measurement of 7-EFC O-deethylation 
activity of these reciprocal crosses supports the role of metabolic detoxification via 
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cytochrome P450 mono-oxygenase activity. Although resistance was much lower when 
resistant and susceptible individuals mate, i.e. in heterozygous progeny, compared to the 
resistant strain, it would be expected that typical field rates of spirodiclofen (200 mg L-1) 
allow some heterogeneous individuals to survive. Models predict that resistance will be 
delayed substantially if the field doses of insecticide kill heterozygotes (Roush and McKenzie 
1987).  In spirodiclofen resistance, the resistance genes cannot be effectively swamped out by 
susceptible immigrants, as would be the case with a recessive inheritance mode (Yamamoto et 
al. 1995). Data for the backcrossing of F1 progeny to parental strains (F2 female progenies) fit 
a polygenic model, in which multiple loci contribute equally and additively to the resistance. 
To complement and support analyses of the responses of F1 female progeny, haploid 
reciprocal crosses were established. Due to arrhenotoky, haploid F2 males produced by virgin 
heterozygous F1 females would respond in a 1:1 ratio of phenotypes if resistance was 
conferred by a single major gene and they inherited resistance genes from their mothers 
(Robertson et al. 2007). However, the response of such F2 males to spirodiclofen showed no 
1:1 segregation of susceptible and resistant haplotypes, and confirmed that resistance was 
under control of more than one gene. This result, polygenic inheritance, is also consistent with 
in vitro and in vivo enzyme activity bioassays which showed that both an increased P450 
mono-oxygenase and specific esterase activity are associated with the resistance trait. Most 
laboratory selection programs may accumulate many altered genes, each having a small 
effect, resulting in polygenic resistance. In contrast, field treatments are thought to usually 
select a single, major resistance gene that can confer large increases in resistance 
immediately. Therefore, laboratory selection may not represent the real situation (Roush and 
McKenzie 1987, Cluck et al. 1990). However, in the case of spider mites, it has often been 
illustrated that both field collected and laboratory strains can acquire resistance by the 
combination of more than one factor, often the joint effect of different groups of detoxifying 
enzymes (Stumpf and Nauen 2002, Van Leeuwen et al. 2005, 2006b, Van Pottelberge et al. 
2009a), or by the same target site (Van Leeuwen et al. 2008). Moreover, laboratory selection 
is often the only practical means to develop resistant strains before widespread use of 
pesticide in the field. 
We assembled a full-length cDNA clone encoding the T. urticae ACCase inside four vectors, 
pMIB/V5-His B and pEIA+ for direct plasmid expression in insect cells, pETduet for E. coli 
expression and pFastBac shuttle vector for expression by baculovirus in insect cells. 
Sequencing results showed that all constructs were correct. Successful transfection and 
mRNA ACCase expression with insect cell systems was confirmed by RT-PCR. 
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Transfection of pMIB-ACC into Sf9 or High Five cells did not change growth of the 
transformed cells. Blasticidin treatment caused non-transfected cells to enlarge and detach 
from the plate while pMIB-ACC transfected cells continued to grow normally. Although we 
detected expression, we could not reproducibly detect ACCase protein with the tested 
expression plasmids (pMIB-ACC and pEIA+ACC21) in different insect cell lines. 
Transformed insect cells and transient expression by pMIB/V5-His (Gouveia et al. 2007) and 
pEIA vectors (Douris et al. 2006) have been used for the production of recombinant proteins 
but not for proteins with high molecular weight, like the eukaryotic ACCase.  
A Western blot probed with anti-His antibody on heat-shocking “Codon Rare” E. coli cells 
transfected with the pETduet-ACC vector revealed ACCase expression 2 and 3 hours after 
induction with IPTG. However, the expressed ACCase protein had been partly degraded by 
proteases after expression. Using lower temperatures during growing of transformed E. coli 
colonies and using other modified E. coli strains could maybe improve recovery of complete 
non degraded protein. Unexpectedly, the bacterial expression looked very promising after a 
first attempt, since a limited culture could produce detectable levels of full length protein. 
More exciting, we were able to detect expression in SF9 cells by Western blots with the 
baculovirus system. Moreover, enzyme activity assays revealed that the recombinant protein 
is active, and this activity can be fully inhibited by spirotetramate-enol. Using this 
baculovirus-insect cell system it will be possible to investigate whether mutations associated 
with resistance to ACCase-inhibiting herbicides in various weed species can also change 
biochemical properties of T. urticae ACCase and confer resistance to ACCase inhibiting 
insecticides. 
Looking back, the negative results of pMIB-ACC transfected cells could be related to the 
Western blot analysis sensitivity that possibly was not enough to detect small amounts of 
produced recombinant ACCase or to the fact that the ACCase was completely proteolysed. 
Since the mRNA production (transcription) was confirmed by RT-PCR, it is also possible that 
protein translation or post-translational modification failed. For the production of recombinant 
ACCase proteins, the baculovirus expression vector system and Escherichia coli expression 
have been previously used successfully (Weatherly et al. 2004, Cheng et al. 2007, Kim et al. 
2007). However, the big size and structural complexity of ACCase make its expression 
difficult and also, the high protease susceptibility of recombinant ACCase has been reported 
as well (Weatherly et al. 2004).  
In conclusion, selecting for spirodiclofen resistance yielded a strain with a very high 
resistance in larvae, which proved to be controlled by more than one gene, as was indicated 
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by the crossing experiments. However, spirodiclofen was still toxic to eggs of the resistant 
strain. The spirodiclofen resistant strain did not show any cross-resistance against other 
frequently used acaricides, except against spiromesifen. Synergism studies and biochemical 
assays suggested the involvement of the three detoxification enzyme systems in the metabolic 
detoxification of spirodiclofen, of which the P450 mono-oxygenases and esterases play 
significant roles. When esterase isozymes were separated by isoelectric focusing, only one 
esterase located near pH 5 was clearly enhanced in resistant strains. No evidence was found to 
support the existence of other resistance mechanisms, like mutations in the target site 
(ACCase) or overproduction of the target enzyme. In order to facilitate designing new 
ACCase inhibitor insecticides and understanding the mechanism of resistance to currently 
used ACCase inhibitors, we tried to clone and express T. urticae ACCase using different 
expression systems for further site-specific mutagenesis combined with functional 
characterization. The most promising results were achieved by a baculovirus expression 
system and also by heat-shocking Codon Rare E. coli cells with the pET-ACC vector. More 
efforts should be done to overcome several problems in expressing this enzyme to optimize 
conditions for higher levels of expression, protein solubility, activity and stability.
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1 INTRODUCTION 
Control of the two-spotted spider mite, Tetranychus urticae Koch populations mostly relies 
on the use of acaricides. However, this species rapidly develops resistance to acaricides due to 
its high reproductive potential, extreme short lifecycle and arrhenotokous reproduction. 
Genetically fixed resistance mechanisms in spider mites are thought to be similar with those 
documented in insects and involve enhanced detoxification through the enzymatic activity of 
esterases, glutathione-S-transferases and P450 mono-oxygenases and/or modification of the 
acaricide target-site (reviewed in Van Leeuwen et al. 2010a). Especially in greenhouses, the 
risk of developing resistance is particularly high because of the relative isolation of mite 
populations, the extended growing season and the intensive use of pesticides (Cranham and 
Helle 1985). The most threatening situation probably occurs in ornamental horticultural crops 
like potted plants and cut flowers, where biological control is not well established due to a 
zero pest tolerance. 
Rose is the top cut flower species sold at the Dutch auctions, with more than 0.8 billion euro 
turnover in 2008 (http://www.flowercouncil.org). In worldwide retail cut flower sales are 
worth approximately 11 billion US dollar per year (Short and Roberts 1991). Next to the fact 
that cut flowers are supposed to be pest free, they are also not edible and thus excluded from 
regulations on pesticide residues, resulting in intensive pesticide use. In rose greenhouses, this 
pesticide use poses a threat to occupational safety, which is as important as the enhanced risk 
of resistance development (Tenenbaum 2002). T. urticae is one of the economically most 
important pests on rose. Its quick resistance build up to acaricides is threatening proper rose 
production in greenhouses. 
In the present study the efficacy of 10 commercially important acaricides, applied at different 
rates to 15 T. urticae strains collected at different locations in the Dutch rose cultivation areas 
was investigated. The selected acaricides included some older compounds with a long history 
of widespread use (such as pyrethroids and organophosphates), some currently registered and 
frequently used compounds, and a potential candidate for European registration 
(cyflumetofen). Many studies in the past have linked an increase in detoxifying enzyme 
activities to a certain resistant phenotype. In this study we determined the activity of esterases, 
glutathione-S-transferases (GST) and cytochrome P450 mono-oxygenases (MFO) in 10 
selected strains to determine whether or not a correlation exists between the general 
detoxifying activity and the observed resistance status. 
Although the molecular elucidation of target-site resistance in mites has not keep pace with 
that in insects, recently a number of studies have documented resistance mutations in genes of 
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major acaricide targets such as acetylcholine esterease (Khajehali et al. 2010, Kwon et al. 
2010a), the para sodium channel (Tsagkarakou et al. 2009b, Kwon et al. 2010b), glutamate-
gated chloride channel (Kwon et al. 2010c) and cytochrome b (Van Leeuwen et al. 2008, Van 
Nieuwenhuyse et al. 2009, Van Leeuwen et al. 2010b). These genes and their proteins are the 
target sites of organophosphates, pyrethroids, avermectins and mitochondrial complex III Qo 
inhibitors, respectively (reviewed in Van Leeuwen et al. 2010a).  To estimate the importance 
of these previously reported mutations, we also amplified and sequenced the relevant gene 
regions of 10 selected Dutch field strains. 
 
2 MATERIAL AND METHODS 
2.1 Strains 
The susceptible SAMB strain was initially collected on Sambucus nigra (L.) in the 
Netherlands and obtained from the Centre de Biologie et de Gestion des Populations, 
Montpellier, France. The German susceptible strain GSS was obtained from Bayer 
CropScience and originates from Schering AG (Berlin, Germany). It was originally collected 
from an unknown host in Germany. 
Fifteen field strains were collected from rose greenhouses in the Dutch provinces of North 
Holland, South Holland and Limburg from September 2008 till July 2009 (Figure 5.1). In 
every location, samples were taken throughout the greenhouse in hot-spots of mite infestation 
and put together. In order to have sufficient mites to conduct bioassays, the collected mites 
were manually transferred from the sampled leaves to non-treated potted kidney bean 
(Phaseolus vulgaris L. cv. Prelude) plants and reared for 2-4 weeks in a climatically 
controlled room at 26±0.5 °C, 60% RH and 16/8 h (L/D) photoperiod. Each strain was tested 
within 2-4 months after arrival at the laboratory. To test the stability of resistance, four strains 
were re-examined approximately one year after their arrival in the laboratory. 
Species identification and genetic variability between strains was analysed using a large 
partial sequence of mitochondrial cytochrome oxidase subunit I gene (COI), based on the 
complete genome sequence (Van Leeuwen et al. 2008). A 1257-bp COI fragment was 
amplified by PCR using the primers TuCOIF1 and TuCOIR1 (Table 5.1) and sequenced 
directly with the original PCR primers on both strands at Agowa Sequencing Service (Berlin, 
Germany).
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Figure 5.1 Map of collection sites of T. urticae strains from rose greenhouses in the Netherlands 
 
 
2.2 Chemicals 
All tested acaricides were commercial formulations that were kindly provided by Dennis 
Eekhof (Certis Europe, The Netherlands) and Wim Petersen (Bayer Cropscience, The 
Netherlands) (Table 5.2). Bifenazate, acequinocyl, tebufenpyrad, milbemectin, abamectin, 
cyflumetofen, bifenthrin and chlorpyrifos were tested on adult female mites, whereas 
spiromesifen, hexythiazox and etoxazole were tested on larvae (Table 5.2). 
2.3 Bioassays 
Toxicity bioassays on adult female mites or newly hatched larvae were performed as 
previously described (Van Leeuwen et al. 2004) with some modifications.  Briefly, 30-40 
young adult female mites were introduced to the upper side of 9 cm2 square cut kidney bean 
leaf discs placed on wet cotton, after which the disc with mites was sprayed in a Cornelis 
spray-tower (1.5 ± 0.05 mg aqueous acaricide deposit cm-2).  For larval bioassays, 20-30 adult 
female mites were allowed to lay eggs for 24 hours on the leaf discs, which were sprayed 
directly after the hatching of the larvae.  The treated discs were subsequently transferred to a 
climatically controlled room and kept at 26±0.5 °C; 60% RH; 16/8 (L/D) photoperiod. 
Mortality was assessed after 4 days. 
Chapter V___________________________________________________________________ 
 
 118
For all tested acaricides the field dose (FD), one fifth of field dose (FD/5) and five times of 
field dose (5FD) were used to discriminate between susceptible and resistant mites (Table 
5.2). Three replicates were used per concentration. Concentrations were prepared in de-
ionized water. Blank controls were sprayed with de-ionized water only. The mortality data 
were corrected using Abbott's formula (Abbott 1925). Resistance levels were classified based 
on the percent mortality (M) as follows: susceptible (M > 90% in FD), intermediate (90% in 
FD > M >90% in 5FD) and resistant (M < 90% in 5FD). Cross-resistance amongst acaricides 
was analysed by calculating the correlation coefficient between percentage mortality at the 
FD. The correlation coefficient was calculated using PROC CORR (SAS Institute 1996). 
 
Table 5.1 Primers and amplified PCR products used for the analysis of the genetic variability and the 
detection of resistance associated mutations in T. urticae strains. 
 
Gene Fragment size Mutation Primers Sequence (5’ – 3’) 
 TuCOIF1 TCAACAAATCATAAAAATATTGGAAC COI  
 
1306 
  TuCOIR1 AAAAATCAGAATATCGTCGAGGT 
AchEdiaF2 TACCTGCCTCTGAATTGGTTGC 
AChE 
 
579 
 
F or Y331W A 
 
AchEdiaR2 GAACTTCTGCAGGCGTATAACC 
KdrF4 CAACATTCAAAGGTTGGACAAT 
226 F1538I B KdrR1 TCTTCCGTCATCAACATCTCC 
KdrF2 TGCATCTCAATTGTCCAAGG 
255 A1215D B KdrR2 GTTTCTTCCAGG CAACATGG 
KdrF5 TGATTGTTTTCCGTGTCCTG 
Para SC 
292 
 
L1025V B 
 KdrR5 CTGCGAAGCTGCTTAAGTCC 
TuGluF1 TGTGCCCTGTTGTATGTTGG 
Glutamate 
channel 
522 
 
G323D C 
 TuGluR1 AAAATGGCGAAAAGGAAAGG 
Cytbdia2F TTAAGAACTCCTAAAACTTTTCGTTC 
Cytb 
 
1577 
 
all mutations 
in Qo site 
 
Cytbdia2R GAAACAAAAATTATTATTCCCCCAAC 
cytbWTF CGGAATAATTTTACAAATAACTCATGC 
cytbWTR TGGTACAGATCGTAGAATTGCG 
PEWYF1 AAAGGCTCATCTAACCAAATAGG Cytb Sequencing primers 
PEWYR2 AATGAAATTTCTGTAAAAGGGTATTC 
A,B,C Torpedo numbering, Musca domestica numbering and T. urticae numbering, respectively.  
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Table 5.2 List of tested acaricides tested with their trade names, active ingredient, IRAC1 
classification, tested mite stages, recommended field rates and registration date of the compound. 
 
Product Active Ingredient 
IRAC 
MOA2 
Tested 
Mite  
Stage 
Formulated 
Field Rate 
L-1 
a.i.  
Field Rate 
(ppm) 
Registration 
date 
Masai 25%WG Tebufenpyrad group 21A Adults 0.125 g 31.25 January, 1997  
Milbeknock 1%EC Milbemectin group 6 Adults 0.5 ml 5 September, 2002 
Vertimec 1.8%EC Abamectin group 6 Adults 0.25 ml 4.5 April, 1988 
Danisaraba 20%SC Cyflumetofen  unknown Adults  1 ml  200 not registered 
 Talstar 8%SC Bifenthrin group 3A Adults  0.5 ml 40 August, 1999 
Oberon 24%SC Spiromesifen group 23 Larvae 0.5 ml 120 October, 2004  
Nissorun 25%SC Hexythiazox group 10A Larvae 0.2 ml 50 September, 1987 
Borneo 11%SC Etoxazole group 10B Larvae  1 ml 110 September, 2009 
Floramite 24%SC Bifenazate unknown Adults 0.4 ml 96 April, 2003 
Cantack 16.4%SC Acequinocyl group 20B Adults 1 ml 164 June, 2007  
Dursban 48%EC Chlorpyrifos group 1B Adults 1 ml 480 - 
1 Insecticide Resistance Action Committee (www.irac-online.org ) 
2 IRAC mode of action classification 
 
2.4 Enzyme assays 
The in vitro activity of cytochrome P450 mono-oxygenases was quantified by measuring the 
O-deethylation of 7-ethoxy-4-trifluoromethylcoumarin (7-EFC) while esterase activity was 
measured with the substrate 4-nitrophenylacetate (4-NPA), as outlined by Van Leeuwen et al. 
(2005). Glutathione-S-tranferase (GST) activity was measured with 1-chloro-2,4-
dinitrobenzene (CDNB) as described by Van Pottelberge et al.(2009b). Enzyme activities 
were compared by analysis of variance (ANOVA). Significant differences were assessed 
using Tukey’s method and SAS 6.12 (SAS Institute 1996). 
2.5 Detection of resistance associated mutations 
Genomic DNA was extracted from approximately 400 female mites per strain as described by 
Van Leeuwen et al. (2008). Briefly, adult mites were homogenised in a 2 ml Eppendorf tube 
containing 800 µl SDS buffer (2% SDS, 200 mM Tris-HCl, 400 mM NaCl, 10 mM EDTA, 
pH = 8.33) followed by DNA extraction using the phenol-chloroform extraction method 
(Sambrook and Russell 2001). The resulting DNA solution was used as template for PCR 
carried out in a Biometra TProfessional Thermocycler (Biometra, Germany). Primers for PCR 
amplification of regions with reported mutation in several target-sites are listed in Table 5.1. 
PCR reactions were performed in 50 µl containing 2 mM MgCl2, 0.2 µM of each primer, 0.2 
mM dNTP mix (Invitrogen, USA), 5 µl 10× PCR-buffer (Invitrogen, USA), 1 µl template 
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(between 100 and 200 ng/µl) and 1 U Taq DNA polymerase (Invitrogen, USA). PCR was 
performed under the following conditions for all primer pairs: 2 min at 94 °C, 35 cycles of 20 
s at 94 °C, 30 s at 54 °C, 60 s at 72 °C and a final extension of 3 min at 72 °C. Cytb sequences 
of the strains were obtained as described by Van Leeuwen et al. (2008) performing long-PCR 
(Expand Long Range PCR kit, Roche, Belgium). All PCR products were purified using the 
EZNA Cycle-Pure Kit (Omega Biotek, USA) according to the manufacturer's instructions and 
sequenced directly on PCR product with the original PCR primers at Agowa Sequencing 
Service (Berlin, Germany). For complete cytb sequencing four additional internal primers 
were used: cytbWTF, cytbWTR, PEWYF1, PEWYR2 (Table 5.1). The obtained sequence 
data were analyzed with BioEdit 7.0.1 software (Hall 1999) and mutation frequency was 
estimated with proportional sequencing (Van Leeuwen et al. 2008). The occurrence of 
mutations was categorised based on a visual inspection of sequencing chromatographs as: not 
detected, present and fixed (when no background was detected at the investigated position). 
 
3 RESULTS 
3.1 COI amplification, sequencing and analysis  
A partial COI sequence of 1257 nucleotides was amplified, sequenced and analysed in 10 of 
the collected T. urticae strains. Comparison with available COI sequences in public databases 
(NCBI) identified all strains as T. urticae. A total of 6 haplotypes was detected.  No insertion 
or deletions were found in the sequenced region. The number of nucleotide substitutions and 
nucleotide divergence percentage are presented in Table 5.3. Strain 003 differed from all other 
strains by 9-12 substitutions (0.72-0.95% divergence), while the sequences of the other strains 
displayed only zero to four substitutions. 
 
Table 5.3 Number of nucleotide substitutions (below the diagonal) and nucleotide divergence 
percentage (above the diagonal) calculated from the COI sequences of T. urticae strains 
 
  GSS 001 003 005 006 007 008 011 013 020 
GSS  0,32 0,80 0,32 0,24 0,24 0,16 0,16 0,24 0,16 
001 4,00  0,95 0,00 0,08 0,08 0,16 0,16 0,08 0,16 
003 10,00 12,00  0,95 0,88 0,88 0,80 0,72 0,88 0,72 
005 4,00 0,00 12,00  0,08 0,08 0,16 0,16 0,08 0,16 
006 3,00 1,00 11,00 1,00  0,16 0,08 0,08 0,16 0,08 
007 3,00 1,00 11,00 1,00 2,00  0,08 0,24 0,00 0,24 
008 2,00 2,00 10,00 2,00 1,00 1,00  0,16 0,08 0,16 
011 2,00 2,00 9,00 2,00 1,00 3,00 2,00  0,24 0,00 
013 3,00 1,00 11,00 1,00 2,00 0,00 1,00 3,00  0,24 
020 2,00 2,00 9,00 2,00 1,00 3,00 2,00 0,00 3,00   
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3.2 Resistance levels 
The mortality percentages at FD/5, FD and 5FD of 15 strains from rose and two susceptible 
laboratory strains of T. urticae are presented in Table 5.4. The strains originating from 
different rose greenhouses exhibited various levels of susceptibility to each acaricide. Most 
strains showed moderate to high levels of resistance to several acaricides. Strains 007, 008 
and 032 were highly resistant to at least six acaricides. Hexythiazox resistance was the most 
widespread since 12 out of 15 strains were highly resistant, followed by tebufenpyrad 
resistance and bifenthrin resistance (9 out of 15 strains).  Only nine strains were treated with 
chlorpyrifos. They all showed a moderate level of resistance. Strains 003, 007, 008, 013, 028 
and 032 appeared to be resistant to the recently introduced acaricide bifenazate while strains 
028 and 029 were resistant to acequinocyl. 
3.3 Stability of resistance 
Table 5.5 displays the susceptibility of strains 007, 008, 022 and 028 to the tested acaricides 
after one year of laboratory rearing without acaricide exposure. The resistance level was 
stable for tebufenpyrad and bifenthrin in these four strains, but dropped for most other tested 
acaricides. In strain 008, resistance levels to all compounds seemed to be stable after one year.  
3.4 Resistance correlation  
Correlation coefficients between percentage corrected mortality at the FD amongst the tested 
acaricides are presented in Table 5.6. Except for acequinocyl and chlorpyrifos, there was a 
significant correlation amongst the tested acaricides. The highest correlation was found 
between abamectin and milbemectin. Next, mortality percentages at FD between 
tebufenpyrad, abamectin, milbemectin, bifenthrin and hexythiazox were highly correlated. 
3.5 Detoxifying enzyme activities 
Detoxifying enzyme activities of 9 field strains and a laboratory susceptible strain are 
presented in Table 5.7. A significant difference was observed in P450 O-deethylation activity 
measured by 7- EFC between susceptible and resistant strains. P 450 mono-oxygenase 
activity in the field strains increased 1.33 (strain 006) to 7.29 (strain 003) times compared to 
the susceptible GSS. In addition, significant differences in esterase activity were detected in 5 
out of 9 strains, while in GST activity was found in 6 out of 9 strains (Table 5.7). Mean 
general esterase activity peaked in strain 007. GST activity was highest in strain 008. 
  
Table 5.4 Percent corrected mortality (mean + SEM) at FD/5, FD and 5FD of different acaricides for strains of T. urticae. Mortality assessed 2-4 months after 
populations arrived, White, light grey and dark grey boxes indicate susceptible, intermediate and resistant population(s) to the tested acaricide, respectively. 
  strains of T. urticae  
Acaricides GSS SAMB 001 003 005 006 007 008 011 013 020 022 025 028 029 032 033 
43±5.2 82±1.6 37±3.1 10±3.1 6±0.7 10±2.7 5±1.4 9±1.5 16±3.3 1±1.2 74±10.3 26±3.5 17±3.9 5±3.4 2±4.9 27±2.3 10±2.3 
100 89±0.9 97±3.5 44±2.2 5±1.5 18±6.7 8±2.8 18±5.2 80±2.7 20±1.9 98±1.3 45±4.6 54±3.7 57±6.1 5±2.6 35±8 29±5.4 Tebufenpyrad  
100 100 100 93±1.6 8±2 63±4.7 86±7.1 23±2.9 97±1.4 84±2.5 100 92±6.6 74±0.4 96±1.8 18±9.8 64±3.1 77±7.7 
24±1.4 51±3.8 31±0.6 13±4.8 3±2.4 18±2.3 3±2.3 15±5.4 41±4.6 16±1.6 93±2.1 0 61±3.9 9±0.8 19±1.4 0.1±1.7 60±3.6 
88±0.2 98±1.8 93±1.1 64±1.2 26±4.9 74±4.1 21±3.7 17±1.8 84±1.1 32±3.7 100 74±2.6 92±0.7 60±1.1 76±5.7 73±2.7 95±1.4 Milbemectin 
100 100 100 98±1.1 96±2.3 91±3.3 95±0.3 98±1.6 100 94±1.7 100 100± 100 100 100 86±1.2 100 
100 100 98±1.6 43±3.0 4±2.3 46±1.8 5±1.6 14±3 88±1.2 6±0.9 100 35±3.3 81±2.2 19±4.9 2±2.0 42±2.4 64±3.1 
100 100 100 57±11.1 4±2 72±5.6 8±1.8 24±4.0 96±0.7 45±2.5 100 80±3.0 95±1.2 100 29±3.9 69±1.2 97±1.9 Abamectin 
100 100 100 91±2.5 34±6.4 95±0.9 60±7.6 61±1.6 100 81±3.7 100 99±1.4 100 100 95±2.9 91±1.1 100 
100 100 100 69±1.4 72±5.3 72±4.0 4±1.8 19±4.9 92±1.5 94±1.3 82±7.4 26±4.7 95±2.9 19±3.1 87±4.6 80±6.7 97±1.3 
100 100 100 92±3.9 92±1.3 91±1.3 57±3.4 35±1.1 100 100 98±2.4 56±6.9 98±2.3 47±5.1 97±1.5 95±0.8 98±2.3 Cyflumetofen 
100 100 100 99±1.2 100 98±1.0 89±4.4 84±2.3 100 100 100 96±2.5 100 100 100 97±3.1 100 
28±3.9 93±1.4 23±2.5 14±1.1 4±2.2 8±1.2 12±4.8 13±0.8 48±2.0 6±1.7 84±4.7 16±3.2 10±2.5 51±9.1 27±3.2 0 7±2.5 
84±3.3 100 72±2.9 26±2.6 7±1.3 11±1.5 26±7.2 16±3.0 87±4.7 27±2.4 97±3.3 41±7.2 52±4.4 94±1.0 39±2.3 12±3.0 44±5.0 Bifenthrin 
100 100 85±5.7 56±3.6 23±2.3 22±3.1 46±3.1 23±2.2 92±2.4 47±2.6 100 91±2.4 94±1.7 99±1.2 62±3.7 26±4.8 83±2.1 
100 100 100 71±8.8 100 88±2.9 14±3.8 46±5.3 100 71±3.5 100 75±3.9 100 95±1.2 100 97±1.4 84±1.5 
100 100 100 97±0.5 100 97±0.6 31±3.2 61±7.1 100 88±4.5 100 97±0.9 100 100 100 99±0.9 97±1.7 Spiromesifen 
100 100 100 99±0.5 100 99±0.7 58±11.8 74±11.6 100 98±2.2 100 99±0.6 100 97±1.9 100 98±2.5 99±1 
100 100 98±1.0 25±4.6 00 13±3.0 00 17±2.5 40±5.3 24±5.3 100 26±6.2 82±2.9 4±1.8 32±1.4 27±3.7 68±1.6 
100 100 99±1.2 46±5.1 11±3.2 18±5.1 00 26±1.9 70±0.7 29±5.0 100 52±8.6 90±2.3 4±2.2 41±6.5 60±2.3 73±0.5 Hexythiazox 
100 100 100 64±6.4 11±5.3 13±4.3 7±4.1 24±4.3 64±3.9 28±11.1 100 66±2.7 92±0.8 15±2.6 47±6.0 66±3.3 81±2.0 
100 100 100 96±0.4 89±0.7 93±0.8 96±0.9 4±8.1 95±0.6 99±1.1 100 99±0.8 100 100 100 74±2.1 100 
100 100 100 94±1.0 97±0.9 94±1.1 97±0.6 2±3.5 95±1.4 99±1.3 100 99±0.4 100 100 100 79±3.8 100 Etoxazole 
100 100 100 97±2.0 99±0.6 98±1.8 98±0.8 31±11.4 98±1.1 100 100 100 100 100 100 83±2.2 100 
100 100 100 75±7.9 20±1.6 75±9.5 6±0.2 3±3.0 96±1.9 8±6.3.0 99±0.8 40±13.5 100 7±2.1 4±1.8 49±17.2 93±3.8 
100 100 100 90±5.3 99±1.3 97±2.6 50±25.2 10±1.1 100 26±2.0 99±0.7 97±1.8 100 57±8.9 42±15.6 90±2.9 99±0.9 Bifenazate 
100 100 100 89±5.7 100 100 18±5.3 7±1.4 100 76±5.2 97±0.7 100 100 74±12.6 92±0.7 87±4.4 99±1 
100 100 100 61±6 30±2.2 27±2.7 3±0.4 28±5.0 100 38±3.5 100 57±12.7 100 1±1.2 11±1.7 69±7.7 85±5.6 
100 100 100 96±2.1 97±1.3 83±3.1 66±6.9 90±1.6 100 97±1.7 100 73±2.3 100 5±1.1 26±6.9 91±4.8 89±2.8 Acequinocyl 
100 100 100 100 100 100 99±0.9 100 100 100 100 94±1.6 100 6±1.0 50±4.2 98±1.8 100 
100 83±1.6 45±5.2 19±2.6 53±8.1 25±2.4 15±3.5 50±3.5 25±6.8 8±1.5 0       
100 100 85±1.3 29±7.7 83±6.0 49±3.0 35±3.2 63±4.8 38±7.3 24±0.8 1±0.5       Chlorpyrifos 
100 100 100 100 100 99±1.2 96±2.3 100 100 100 100       
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Table 5.5 Percent corrected mortality (mean + SEM) at FD/5, FD and 5FD of different acaricides for 
strains of T. urticae. Mortality assessed approximately one year after populations arrived, White, light 
grey and dark grey boxes indicate susceptible, intermediate and resistant population(s) to the tested 
acaricide, respectively. 
 
 strains of T. urticae 
Acaricides 007 008 022 028 
8±4.0 2±2.2 24±2.8 59±3.7 
21±8.9 20±1.6 59±4.0 58±1.62 Tebufenpyrad  
62±3.3 57±1.9 71±7.6 92±3.1 
86±4.0 85±1.5 37±4.7 57±3.9 
100 99±1.4 97±2.9 100 Milbemectin 
100 100 100 100 
100 100 100 100 
100 100 100 100 Abamectin 
100 100 100 100 
100 100 100 100 
100 100 100 100 Cyflumetofen 
100 100 100 100 
12±1.8 6±1.6 58±4.9 13±2.5 
86±3.6 39±4.1 92±1.6 89±3.9 Bifenthrin 
96±2.1 61±2.2 100 100 
93±6.8 97±2.1 85±4.2 89±6.3 
99±0.7 97±1.5 91±7.2 85±1.7 Spiromesifen 
100 100 96±1.8 94±3.5 
87±1.3 29±1.4 95±1.3 99±0.6 
99±0.3 61±2.3 96±0.4 100 Hexythiazox 
100 68±2.1 100 100 
100 89±0.9 100 100 
100 89±0.7 100 100 Etoxazole 
100 94±1.1 100 100 
100 10±1.8 100 100 
100 49±9.0 100 100 Bifenazate 
100 27±10.9 100 100 
100 38±7.1 100 100 
100 99±0.9 100 100 Acequinocyl 
100 100 100 100 
 
Table 5.6 Correlation coefficient (r) between percentages of the field dose corrected mortality (field 
strains) of tested acaricides 
 
Tebufenpyrad 
M
ilbem
ectin 
A
bam
ectine 
C
yflum
etofen 
B
ifenthrin 
Spirom
esifen 
H
exythiazox 
Etoxazole 
B
ifenazate 
A
cequinocyl 
C
hlorpyrifos 
Tebufenpyrad 1.00                     
Milbemectin 0.67* 1.00          
Abamectine 0.80* 0.84* 1.00         
Cyflumetofen 0.23 0.55* 0.26 1.00        
Bifenthrin 0.83* 0.57* 0.71* 0.07 1.00       
Spiromesifen 0.41 0.68* 0.59* 0.58* 0.32 1.00      
Hexythiazox 0.75* 0.82* 0.68* 0.56* 0.50 0.48 1.00     
Etoxazole 0.22 0.46 0.33 0.56* 0.33 0.41 0.17 1.00    
Bifenazate 0.50 0.69* 0.56* 0.52* 0.24 0.57* 0.55* 0.55* 1.00   
Acequinocyl 0.25 0.10 0.07 0.46 -0.20 0.05 0.49 -0.12 0.39 1.00  
Chlorpyrifos -0.19 -0.23 -0.26 -0.15 -0.36 0.06 -0.16 -0.24 0.08 0.06 1.00 
* Values are significantly different from zero (p<0.05)
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Table 5.7 Detoxification enzyme activities in different strains (mean + SEM) 
Strain P450 mono-oxygenases  Esterases Glutathione-S-transferases 
 
O-de-ethylation of 
EFCA 
Ratio 
to GSS 
 4-NPA activityB 
Ratio 
to GSS 
CDNB conjugationC 
Ratio 
to GSS 
GSS 134.66 (± 15.01)c -  79.23 (± 0.51)d - 444.12 (± 49.31)e - 
001 314.91 (± 10.57)bc 2.34  79.62 (± 10.23)d 1.00 572.87 (± 16.34)cde 1.29 
003 982.22 (± 187.28)a 7.29  116.29 (± 3.22)ab 1.47 532.75 (± 19.62)de 1.20 
005 325.20 (± 25.56)bc 2.41  83.11 (± 4.72)cd 1.05 719.03 (± 21.74)ab 1.62 
006 179.74 (± 11.70)c 1.33  110.43 (± 1.95)ab 1.39 705.00 (± 17.24)abc 1.59 
007 451.72 (± 4.15)bc 3.35  120.61 (± 4.38)a 1.52 783.74 (± 34.61)a 1.76 
008 359.65 (± 52.46)bc 2.67  86.60 (± 2.98)cd 1.09 794.47 (± 18.05)a 1.79 
011 257.66 (± 34.99)bc 1.91  95.28 (± 3.15)bcd 1.20 636.06 (± 23.09)bcd 1.43 
013 571.01 (± 90.42)b 4.24  103.20 (± 3.07)abc 1.30 758.83 (± 25.70)ab 1.71 
020 585.76 (± 75.71)b 4.35  115.20 (± 3.70)ab 1.45 514.43 (± 20,77)de 1.16 
Means (± SEM) within the same column followed by the same letter are not significantly different (Tukey 
method, α = 0.05). 
A pmol 7-hydroxy-4-trifluoromethylcoumarin (30min)-1 mg-1 protein (± SEM) 
B nmol 4-nitrophenol min-1 mg-1 protein (± SEM) 
C nmol glutathione conjugated min-1 mg-1 protein (± SEM)  
 
3.6  AChE, para SC, Glutamate-gated chloride channel and cytb genotypes  
An overview of the detected genotypes is presented in Table 5.8. 
The organophosphate resistance allele F/Y331W was detected in all tested field strains. In the 
para sodium channel of T. urticae, the F1538I substitution, known to confer strong resistance 
to pyrethroids, was only detected in stains 005 and 008. Another reported substitution in para 
SC with an unknown function (A1215D) was present in 6 out of 9 tested field strains, and 
already fixed in 4 strains (003, 005, 007 and 013). None of the tested strains harboured 
L1025V (according to Musca domestica numbering) mutation reported by Kwon et al (2010b).  
The putative abamectin resistance mutation, G323D, in the T. urticae glutamate-gated 
chloride channel was not detected in any strain.  
Several point mutations at conserved regions in the mitochondrial cytb previously linked with 
bifenazate and acequinocyl resistance were detected (Van Nieuwenhuyse et al. 2009). Strains 
001, 003, 005, 007, 008 and 013 harboured the G126S mutation and this mutation was fixed 
in the strains 007, 008 and 013. In strain 008 mutation G126S was combined with mutation 
I136T. This combination, which was fixed, is known to confer high resistance to bifenazate. 
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A P262T mutation was found in strain 003, but was not fixed. No amino acid substitutions in 
the cytb at positions 141 and 161 were detected in any strain. 
 
Table 5.8 Amino acid substitutions in different strains of T. urticae 
Strain  
Acetylcholine
esterase 
GenotypeA 
 
para sodium 
channel 
GenotypeB 
Glutamate- 
gated 
chloride 
channelC 
cytochrome b residues at 
different positionsC 
  331  1538 1215 1025 323  126 136 141 161 262 
GSS  F(Y)  F A L G  G I S D P 
001  F(Y)/W  F A L G  G/S I S D P 
003  F(Y)/W  F D L G  G/S I S D P/T 
005  W  F/I D L G  G/S I S D P 
006  F/W  F A L G  G I S D P 
007  F/W  F D L G  S I S D P 
008  F/W  F/I A/D L G  S T S D P 
011  F(Y)/W  F A/D L G  G I S D P 
013  F/W  F D L G  S I S D P 
020  F/W  F A L G  G I S D P 
 
A,B,C Torpedo numbering, Musca domestica numbering and T. urticae numbering, respectively. 
 
4 DISCUSSION 
4.1 Resistance status  
Since about 5 years, many Dutch rose growers have reported to be unsatisfied with the 
decreased efficacy of the acaricides they use for spider mite control in their greenhouses. 
Since problems in the chemical control of  mites can be caused by many reasons which are 
not related to resistance, including operational factors such as an incorrect spray technique, 
the use of tank mixes and a wrong application time, the main aim of this study was to separate 
facts from fiction regarding spider mite resistance in Dutch rose culture. Unfortunately, the 
results revealed high levels of resistance to some acaricides in almost all tested strains 
collected on cut roses from different locations in the Netherlands (Table 5.4). Although 
monitoring of resistance is usually based on calculating resistance ratios or by comparing 
LD50’s or LD90’s, mainly due to the heavy workload, we surveyed the resistance status in the 
Dutch rose greenhouse strains of T. urticae using three discriminating doses. This type of 
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diagnostic test can be more efficient than dose-response curves, especially for detecting an 
initial resistance outbreak (Roush and Miller 1986), since the presence of resistant individuals 
at low frequency will not greatly influence calculated LC50 values, but can be detected easily 
when testing a discriminating dose such as FD or 5FD. 
The most striking and prominent result is the presence of resistance to hexythiazox (12 out of 
15 strains), bifenthrin (9 out of 15 strains) and tebufenpyrad (9 out of 15 strains), which is 
now confirmed in the laboratory. These acaricides have been used since long (at least 10 
years) in Dutch horticulture (Table 5.2), and it is clear that at the time of collection for this 
study, their efficacy has become very low. The observed intermediate and (mainly) high 
resistance to these compounds probably reflects prolonged selection on isolated greenhouse 
populations. Also, the activity of abamectin and milbemectin seemed to have decreased in 
many strains and might become problematic in the near future. Abamectin has also been 
registered for more than 20 years, and many strains that developed resistance to abamectine 
might show cross resistance to the more recently introduced milbemectin.  Bifenazate is 
probably one of the most popular acaricides amongst rose growers at this time, due to its 
compatibility with natural enemies of spider mites and the complete lack of phytotoxicity. 
Hence, the occurrence of resistance in Dutch horticulture has been previously documented 
(Van Leeuwen et al. 2008, Van Nieuwenhuyse et al. 2009). In the present survey, 6 out of 15 
strains proved to be resistant to bifenazate, while most other strains remained fully 
susceptible. The quite recently introduced compounds spiromesifen, etoxazole and 
acequinocyl showed the best activity in our study, although resistance was also already 
detected in some strains. Next to the differences in resistance amongst acaricides, we could 
also observe significant differences between strains were in place. Two strains (007 and 008) 
were resistant to almost all tested acaricides, including cyflumetofen, a new acaricide with 
new mode of action that has never been used in Europe. Similarly, these two strains were also 
resistant to spiromesifen, a recently registered molecule in Dutch rose culture, and possibly a 
common mechanism is responsible for such a broad cross-resistance in these two strains. 
Finally, also strain 032 was found to be resistant to 6 out of 15 compounds, including both 
older (tebufenpyrad, bifenthrin and hexythiazox) and more recent (etoxazole, bifenazate) 
compounds. 
4.2 Resistance mechanisms  
In previous studies, the occurrence of resistance in T. urticae has been linked with various 
resistance mechanisms, for the bigger part with an increased detoxification by metabolising 
enzymes such as P450 mono-oxygenases, esterases and glutathione-S-transferases and, more 
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recently, with point mutations in acaricide target proteins (reviewed in Van Leeuwen et al. 
2010a). The elucidation of resistance mechanisms might also help in explaining cross-
resistance or the observed correlation between acaricide resistance patterns. In this study, we 
first quantified the activity of detoxifying enzymes in a selection of 10 strains, in an attempt 
to establish a link between the activity of these enzymes and the observed resistance status of 
a certain strain. The results in Table 5.7 indeed reveal that all field strains have an increased 
metabolic activity when compared to the susceptible strain. However, there was no clear 
correlation between overall activity and resistance status. Of all tested strains, strain 020 was 
the most susceptible, but it shows one of the most prominent increased P450 mono-oxygenase 
and esterase activities, comparable to or higher than the activities measured in the multi-
resistant strains 007 and 008. The lack of clear correlation between detoxifying enzyme 
activity and resistance levels yet again clearly stresses the need for synergism tests. Only 
controlled experiments assessing the effects of synergists on metabolic enzymes carried out 
on both susceptible and resistant strains, can correlate a certain resistant phenotype to the 
involvement of one or several of these enzyme systems. Our results reveal that the 
determination of detoxifying enzyme activities without synergism tests has probably limited 
predictive value for resistance development and monitoring in spider mites.  
The molecular mechanisms of organophosphate target-site resistance are well understood in 
insects and several point mutations resulting in an insensitive AChE have been documented 
(reviewed in Oakeshott et al. 2005a).  In the spider mite T. urticae, the F331W substitution of 
AChE1 has been detected in strains from Japan and Europe. Although other mutations might 
play a role in resistance, such as G119S, A201S, A280T and G328A (Khajehali et al. 2010, 
Kwon et al. 2010d), the F331W mutation has been functionally characterized  in insects and 
was shown to drastically reduce the sensitivity of OP compounds to AChE1 (Oh et al. 2006).  
We screened 10 strains for the presence of this substitution on genomic DNA and found that 
all field strains harboured this mutation, while it was not present in the susceptible GSS 
(Table 5.8). The presence of this mutation probably attributes to the general low activity of 
the OP compound chlorpyrifos in all strains. However, the situation might be more complex, 
since extensive gene duplication, with each copy carrying a different mutation, has also been 
reported (Kwon et al. 2010a). OPs are currently not registered anymore for spider mite 
control, but until recently, they played an important role in insect control, so mites can still 
get into contact with the compounds. An insensitive AChE might also have more indirect 
consequences in current mite control. It was shown that the use of OPs can antagonize 
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bifenazate efficacy in laboratory conditions, and that this risk increases when an insensitive 
AChE is present (Van Leeuwen et al. 2007, Khajehali et al. 2009). 
Recently, a F1538I mutation in domain III segment 6 of the para sodium channel was found 
to be associated with high bifenthrin resistance levels in T. urticae (Tsagkarakou et al. 
2009b). The same mutation was previously identified in the sodium channel of pyrethroid 
resistant Boophilus microplus (He et al. 1999) and has been functionally characterized and 
expressed in Xenopus laevis oocytes. It is considered as one of the most effective resistance 
loci for synthetic pyrethroids up to date (Tan et al. 2005). Another point mutation, L1025V, 
was reported to elicit high resistance to fenpropathrin in a South-Korean strain of T. urticae 
(Kwon et al. 2010b). Remarkably, both reported mutations were accompanied by an A1215D 
substitution located in the intracellular linker between domains I and II, but its role is still 
unknown. We amplified and sequenced the corresponding regions for these mutations in 9 
Dutch field strains resistant to bifenthrin. Only two strains harboured the F1538I resistance 
mutation, but it was not fixed, while the L1025V mutation was not detected in any strain. 
These two strains (005 and 008) showed, together with strain 006, the highest levels of 
resistance to bifenthrin. Selection with bifenthrin under field conditions could increase the 
frequency of this mutation and lead to a more pronounced resistance phenotype.  
Interestingly, the A1215D mutation was detected in 4 out of 10 strains, fixed in 2 strains and 
it occurred in combination with the F1538I substitution. Although this might be a 
coincidence, the involvement of this substitution should be better studied. However, since we 
were not able to detect any of the reported para sodium channel mutations in the majority of 
the strains, it seems unlikely that an altered target-site is the main cause of bifenthrin 
resistance in Dutch field strains. High bifenthrin resistance was previously linked to an 
increased esterase hydrolysis mechanism in a Belgian field collected strain (Van Leeuwen et 
al. 2005, Van Leeuwen and Tirry 2007), and this could well be the most common mechanism 
of bifenthrin resistance. 
The molecular mechanisms of abamectin resistance were recently investigated by Kwon et al. 
(2010c). It was shown using isogenic lines that a G323D mutation in one of the 
transmembrane regions of the glutamate gated chloride channel was tightly linked to 
resistance. Although most strains under investigation in this study displayed a decreased 
abamectin and milbemectin susceptibility, and 4 strains were found to be highly resistant, the 
reported G323D mutation was not detected in these strains. This indicates that alternative 
mechanisms are in place, possibly including increased metabolism as was previously reported 
(Stumpf and Nauen 2002).  
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Bifenazate resistance has been linked to mutations in the mitochondrial cytochrome b gene in 
a number of studies (Van Leeuwen et al. 2008, Van Nieuwenhuyse et al. 2009, Van Leeuwen 
et al. 2010b), which led to the hypothesis that bifenazate acts as a Qo inhibitor of complex III 
(Van Leeuwen et al. 2008). We amplified and sequenced the complete cytochrome b of 10 
strains, of which 4 displayed resistance to bifenazate. These four strains (003, 007, 008 and 
013) all contained point mutations at the suspected positions: G126S + P262T (non fixed), 
G126S (fixed), G126S + I136T (fixed) and G126S (fixed), respectively. All other strains were 
found to be susceptible to bifenazate and showed the wild-type cytb genotype. Strain 008 was 
clearly the most resistant (Table 5.4) and the only strain where the combination of G126S + 
I136T was fixed, as no background in sequencing chromatographs was detected. It was 
previously reported that a combination of at least two mutations in the cd1-helix is necessary 
for a potent resistant phenotype (Van Leeuwen et al. 2008) and this seems to be reconfirmed 
in this study. Although it is clear that there is a correlation between mutations in the cytb and 
bifenazate resistance, our dataset also supports the presence of additional mechanisms 
responsible for decreased bifenazate efficacy. Bifenazate toxicity at 5FD in strain 007 is very 
low, while this strain harbours a single G126S (without S141F) mutation that confers only 
limited resistance to bifenazate, as was previously shown (Van Leeuwen et al. 2008).    
4.3 Resistance correlation, cross-resistance and stability of resistance  
For an effective resistance management strategy, insights into cross-resistance amongst 
compounds are essential. Several reports document potential cross-resistance amongst 
acaricides in T. urticae (reviewed in Van Leeuwen et al. 2009). Cross-resistance can have 
different underlying mechanisms. Most common is a shared target-site, or cross reactivity of 
an increased detoxifying enzyme. A possible approach to detect cross-resistance patterns is to 
study the correlation between acaricide resistance patterns. It is then assumed that the 
possibility of cross-resistance is higher when the correlation coefficient between acaricides is 
higher, as stated by Koh et al. (2009). High correlation coefficients were found between 
tebufenpyrad and abamectin (0.80), bifenthrin (0.83), and hexythiazox (0.75). Although cross-
resistance between some of these compounds has been previously reported, such as cross-
resistance between METI acaricides and pyrethroids (Devine et al. 2001, Koh et al. 2009), the 
underlying mechanism has not been found. A partial explanation of the high correlation 
coefficients may be that all these compounds have been in use for 10-15 years in rose 
greenhouses. The observed correlation might reflect the long period for resistance selection of 
each chemical separately. Hexythiazox is an ovo-larvicide and growers have mixed it 
frequently with other acaricides for more than 10 years, which has apparently led to the 
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complete loss of efficacy. More puzzling is the pronounced resistance to tebufenpyrad in most 
strains, since this acaricide has never been popular amongst rose growers. However, several 
other studies have documented that a limited use of tebufenpyrad can lead very quickly to 
resistance, e.g. in apple orchards in Australia (Herron and Rophail 1998) and hops in England 
(Devine et al. 2001). This resistance is usually based on metabolic detoxification and linked to 
an increased P450 activity (Van Pottelberge et al. 2009a). It gives broad cross-resistance to 
other METIs such as pyridaben, fenpyroximate and fenazaquin. Remarkably, we found that 
after laboratory cultivation for approximately one year without selection pressure, 
tebufenpyrad resistance seemed to be stable in all strains, in contrast to hexythiazox, 
abamectin and bifenthrin resistance. Tested rose strains of T. urticae showed the highest and 
lowest resistance to hexythiazox and the recently registered etoxazole respectively. Despite a 
nearly similar mode of action, cross-resistance between hexythiazox and etoxazole has not 
been reported, except for one Japanese population (Asahara et al. 2008). In this study FD 
corrected mortality of hexythiazox showed the highest correlation coefficient with 
milbemectin and tebufenpyrad and the lowest with chlorpyrifos and etoxazole. Hexythiazox 
resistance was reported to be stable by Herron et al. (1993), however, in this study, it 
appeared to be stable in only one of four tested strains in the absence of selection pressure. 
The highest correlation amongst acaricides was found between abamectin and milbemectin. 
Abamectin was first registered in 1988 and is one of the oldest compounds used in Dutch 
horticulture. It has remarkably retained some of its efficacy on several strains, although 4 
strains proved to be resistant. Milbemectin, a chemically similar molecule belonging to the 
same mode of action (group 6, IRAC classification) was more recently registered in 2002. 
The high correlation found between these compounds can be due to similar resistance 
mechanisms. We did not find evidence that the previously documented resistance mutation 
G323D in the glutamate gated sodium channel is present in Dutch strains, and it is also 
currently unknown whether this mutation provides cross-resistance to milbemectin. However, 
cross-resistance between abamectin and milbemectin has been previously reported (Nicastro 
et al. 2010) and might be linked to a joint detoxification mechanism, explaining the high 
correlation between both compounds that were registered with a 15 years interval. In our 
study, strains resistant to abamectin showed significantly higher GST activities. Also, 
metabolic resistance has already been documented for abamectin (Stumpf and Nauen 2002). 
Another interesting point is the lack of correlation between bifenazate and acequinocyl, both 
compounds that are thought to act as Qo inhibitors. This study showed that the previously 
reported resistance mutations do occur in Dutch field strains resistant to bifenazate. However, 
____________________Acaricide resistance in T. urticae populations from rose greenhouses 
 131
the exact combination of two cd-1 helix mutations is important, since it determines the 
potential cross-resistance risk with acequinocyl. The combination of mutations G126S and 
S141F that was reported in a laboratory selected resistant strain (Van Leeuwen et al. 2008) 
leads to a 100-fold cross resistance to acequinocyl (Van Nieuwenhuyse et al. 2009), but this 
combination was not found in the field yet. In contrast, the combination G126S and I136T 
previously found in Dutch field strains has no effect on acequinocyl toxicity. This observation 
is confirmed in this study, since strain 008 is fully susceptible to acequinocyl. The same study 
revealed that a single P262T substitution in the ef-helix region of the cytb can lead to a 
limited (50-fold) cross resistance to acequinocyl, on condition that this mutation is fixed in 
the population. Although this mutation was detected in one strain with decreased bifenazate 
activity, it was not fixed and it had no effect on the field performance of acequinocyl. Given 
the low cross-resistance ratios between bifenazate and acequinocyl that were reported for this 
mutation (Van Nieuwenhuyse et al. 2009), it is doubtful that it could lead to acequinocyl 
resistance under field conditions. Bifenazate resistance seemed to be unstable in 2 out of 3 
resistant strains. Only strain 008 retained bifenazate resistance (Table 5.5) and in this strain 
the combination of two bifenazate resistance mutations in the cd1 helix were fixed at the time 
of analysis (Table 5.8). From a resistance management point of view, this might be an 
important observation, since resistance mutations seem to dilute quickly in an unselected 
population, possibly due to a fitness cost. Hence, one or two applications of bifenazate in the 
field per season could probably safeguard the efficacy of bifenazate for a longer period. Given 
the potential cross-resistance risk with acequinocyl, a combined anti-resistance strategy 
should be put forward. However, as stated previously, bifenazate is very popular amongst 
growers that sometimes apply bifenazate more than 10 times in one growing season. The 
resistance seemed to be generally stable in strain 008, which can be characterized as 
problematic. It is not clear which mechanism gives such broad cross-resistance, even to 
chemically not related and not registered acaricides with a new mode of action such as 
cyflumetofen (Sasama et al. 2007).  When looking at the genetic distance between strains 
expressed as nucleotide divergence of COI sequence, there is no correlation between COI 
polymorphism, geographical location of sampling and resistance status.  The COI gene was 
shown to be well suited for intraspecific analysis in spider mites because of its high 
polymorphism within the species in several studies (Navajas et al. 1998, Xie et al. 2006). In 
comparison to results obtained from a study on the genetic structure of  T. urticae in China, 
rather low percentage of divergence was found (< 0.3), except for strain 003 (between 0.72-
0.95) which might be recently introduced in the region, possibly by imported plant material. 
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One could expect that bifenazate resistance could fix a single mitochondrial haplotype 
resulting in a selective sweep, and that should be detectable in the population and studied by 
examining the COI polymorphism variation in single mites form different locations.  
4.4 Conclusions 
Our study revealed that mite populations present in the Dutch rose cultivation area have 
acquired resistance to many of the acaricides that were used for control of T. urticae. 
Traditional acaricides such as tebufenpyrad, bifenthrin, hexythiazox and abamectin have been 
in use for a long time, resulting in the presence of high levels or resistance in many strains. 
Tebufenpyrad resistance was stable up to 1 year after collection from the field (in the absence 
of selection pressure). Based on these results, it could be advised not to use this compound 
anymore in the field. Resistance to hexythiazox, abamectin and bifenthrin proved to be 
generally unstable. These compounds might still remain useful for mite control when 
integrated in a proper resistance management strategy. The efficacy of the recently introduced 
acaricides spiromesifen and etoxazole was good, except for a few strains that seemed to be 
multi-resistant to almost all tested molecules, including cyflumetofen, an acaricide with new 
mode of action that was never used in Europe. The mechanisms behind such a broad 
resistance are currently unclear. Bifenazate resistance was reported in some strains and 
correlated with point mutations in the mitochondrial cytb, but stability tests revealed that 
reversion to susceptibility is possible when resistance mutations are not fixed in the 
population, leaving a great opportunity for a well thought-out resistance management 
program.  Although some strains were resistant to the recently introduced active ingredient 
acequinocyl, which has a similar mode of action as bifenazate, no evidence was found for 
cross-resistance between these compounds under field conditions.  Resistance to abamectin 
was detected in several populations, and was linked to a decreased activity of milbemectin, a 
compound with a similar mode of action. Care should be taken when including both 
compounds in control programs. The activity of detoxifying enzymes was increased in all 
strains, but our results indicate they are not necessarily predictive for the resistance status of a 
certain strain.  
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Acaricide resistance  
The evolution of pesticide resistance in insects and mites has become a major problem 
worldwide, since it has a major impact on crop yield. Unravelling the resistance mechanisms 
both at the biochemical and molecular level is useful and necessary to provide essential 
information for the development of insecticide resistance management (IRM) strategies. 
Identification of the resistance mechanism may also facilitate the development of alternative 
chemistry which can lead to insecticides which are not affected by a given resistance 
mechanism. The main objective of this study was the characterization of mechanisms of 
acaricide resistance in T. urticae. While the original idea was to focus on the most common 
mechanisms of target site resistance, with time it grew towards a more in-depth approach, 
including, amongst others,  the in vitro expression of a target site protein.  
 
Pyrethroids and point mutations in the para sodium channel 
The widespread development of resistance to pyrethroids (Chapters II and V) in the two-
spotted spider mite is rendering some of the important and widely used acaricides, such as 
bifenthrin, ineffective. Pyrethroid resistance mechanisms were investigated in two strains of T. 
urticae from Greece. Both strains were highly resistant to bifenthrin and showed a high 
degree of cross-resistance to another pyrethroid, fluvalinate. Synergism studies in which 
bifenthrin and inhibitors of detoxifying enzymes were applied in susceptible and resistant 
strains suggested that the resistance might be due to a mutation within the target site of 
pyrethroids rather than to enhanced metabolic detoxification. 
In many arthropod pests, pyrethroid resistance due to reduced sensitivity of the neurons is 
linked to point mutations in the sodium channel genes (Chapter I). Since the T. urticae para 
sodium channel sequence was not available at the time this work was initiated, a number of 
degenerate primers was chosen based on conserved regions of Acari sodium channel genes. A 
large cDNA fragment encoding for an 1108 amino acid sequence of the T. urticae para 
sodium channel gene (domains II-IV) was amplified for the first time using a long PCR 
strategy. The overall similarity of the deduced amino acid sequence from this cDNA fragment 
to insect species was lower than 50%. This might be a partial explanation for the fact that 
insects and mites have different sensitivities to pyrethroids (Khambay and Jewess 2005, Dong 
2007).  
The amino acid sequence comparison between susceptible and resistant strains revealed two 
amino acid substitutions, F1538I in domain IIIS6 and A1215D within the II/III intracellular 
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linker region. The F1538I substitution was proposed to play a major role in bifenthrin 
resistance because this mutation has previously been associated with pyrethroid resistance in 
the southern cattle tick, B. microplus (He et al. 1999) and it has been shown to confer strong 
insensitivity to a range of pyrethroids when functionally expressed in an in vitro assay system 
(Tan et al. 2005). In addition, F1538I is one of several aromatic residues in the IIIS6 helix that 
form part of a putative hydrophobic binding site for pyrethroids in a computer-generated 3D 
model of the housefly sodium channel (O'Reilly et al. 2006, Davies et al. 2008). 
The second substitution (A1215D) lies within the domain II-III intracellular linker which is 
one of the most variable regions of the protein amongst species. There has been no report on 
any mutation in this intracellular loop that is associated with pyrethroid resistance. Although 
Kwon et al. (2010b) also found this substitution in a fenpropathrin resistant strain of T. 
urticae, they concluded that it may not be directly involved in resistance. Also, when testing a 
range of T. urticae strains collected from cut roses, this mutation was present in some 
bifenthrin resistant strains. It is possible that it is a simple polymorphism that is fixed in the 
resistance allele. Nevertheless, the possibility that this mutation also contributes to the 
resistance, comparable to the mutations in the I/II linker region in the cockroach sodium 
channel (Tan et al. 2002a), can not be excluded completely. Also, there is the possibility of 
the occurrence of additional mutation(s) outside the IIS4-IVS6 gene region which we have 
analysed in this study, associated with or contributing to the resistance phenotype. Kwon et al. 
(2010b) reported an L1025V mutation could be linked to pyethroid resistance. However, this 
mutation was not found in the bifenthrin resistant strains from Greece, nor in the bifenthrin 
resistant strains collected from cut roses (Chapter V). 
The mode of inheritance of bifenthrin resistance was determined to be incompletely recessive, 
which is in agreement with studies of sodium channel insensitivity in other species (Halliday 
and Georghiou 1985, Sayyed et al. 2005). The recessive mode of inheritance means that the 
trait will be mainly expressed in homozygous individuals. Our results on the mechanism and 
inheritance of the pyrethroid resistance in the two-spotted spider mite allow the early detection 
of heterozygotes, using the F15381I substitution as a prime target for developing a DNA-
based screening method for pyrethroid resistance in field populations of T. urticae. This could 
of course be important in pyrethroid resistance management. 
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Resistance to organophosphates and carbamates 
In 2007, Van Leeuwen et al. reported on the antagonism between OP and bifenazate in 
laboratory experiments. These findings encouraged us to evaluate this antagonism in a more 
realistic field situation. We found that mixtures of the OP chlorpyrifos with bifenazate, when 
applied on OP resistant strains (which can tolerate higher doses of OP and CARB 
insecticides), were a major risk for bifenazate control failure, due to antagonism. However, all 
other tested OP and CARB insecticides did not cause any antagonism when mixed with 
bifenazate. It could be concluded that mixing OP and CARB insecticides with bifenazate can 
result in an antagonistic effect, depending on the OP and CARB type, as well as the mite 
strain. OP resistant mites seem to be a greater risk for antagonism-based control failure, since 
they survive OP treatments targeting other pests, while the OP insecticides in the meanwhile 
compromise bifenazate activation.  
In order to elucidate the molecular basis of OP resistance, the characteristics of resistance 
were studied in three OP resistant strains of T. urticae. Biochemical experiments confirmed 
that the AChE insensitivity is probably the major resistance mechanism, since detoxification 
metabolism mediated resistance only plays a minor role in OP resistance. The 
acetylcholinesterase gene AChE1 from both organophosphate-resistant and susceptible strains 
has been fully cloned and sequenced. Comparison of the deduced amino acid sequences 
revealed four amino acid substitutions in the mature AChE1 that are present in one or more 
resistant strains and absent in the susceptible ones. The F331W substitution occurred 
consistently in all resistant strains. Since the 331 position in AChE1 has been associated with 
OP-resistance in many species and since the functional expression has clearly illustrated the 
effect of the substitutions on AChE sensitivity (Oh et al. 2006), it seems plausible that the 
F331W substitution reduces the enzyme sensitivity and results in OP resistance. This was 
further supported by the presence of this mutation in all strains collected from roses (Chapter 
V) that showed a moderate resistance level to chlorpyrifos. Two other substitutions, A201S 
and G328A, may have been selected by the application of other unknown OPs in the history 
of the tested populations. It is possible that different mutations are selected and maintained in 
populations of T. urticae, each one conferring an advantage against one or more OP or CARB 
insecticides. One hypothesis can be that these mutations might reduce the fitness cost 
associated with the F331W substitution, thereby allowing its persistence even in the absence 
of OP pressure. However, the situation might be more complex, since extensive gene 
duplication, with each copy carrying a different mutation, has also been reported in T. urticae 
AChE (Kwon et al. 2010a). Since the early detection of insecticide resistance is a prerequisite 
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for resistance management strategies, and since this mutation was consistently present in all 
resistant spider mite strains from different geographical regions, including the strains 
collected from rose greenhouses, we set up a simple and rapid molecular diagnostic method 
for the detection of the F331W mutation.  This tool can support us in the quick and early 
detection of OP resistance in T. urticae in the field 
 
Resistance to spirodiclofen and ACCase expression 
In order to investigate the inheritance, biochemical and molecular mechanisms of resistance to 
the recently introduced compound spirodiclofen in T. urticae, a laboratory selection was set 
up, resulting in the SR-VP strain, which showed a resistance ratio of 274 (Chapter IV). 
Although it has been hypothesized that selection for resistance in the laboratory and in the 
field would result in different forms of pesticide resistance, in reality there are several cases 
where similar resistance mechanisms occurred in laboratory- and field-selected strains (Pedra 
et al. 2004, Van Leeuwen et al. 2008, Van Leeuwen et al. 2010a).  
Biochemical analysis using synergist experiments and in vitro enzyme assays showed that the 
elevated levels of P450s, esterases and glutathione S-transferases in the resistant strain could 
be involved in the metabolic detoxification of spirodiclofen. The higher level of esterases in 
the resistant strain, when measured with the purpose-designed substrate 1-naphthyl 2,2-
dimethylbutyrate, indicated that possibly only a few esterases of T. urticae are more expressed 
in spirodiclofen resistant strains. This finding was further supported when esterase isozymes 
were separated by native isoelectric focusing. Since in the resistant strains only the mobile 
stages were resistant, while the eggs remained more susceptible, expression of the detoxifying 
genes should be different in eggs, compared to other stages. In order to find candidate genes 
whose expression is different between these stages, the next goal is to construct a microarray 
containing fragments from several hundreds of genes which are putatively involved in 
insecticide metabolism.  
The results of the crossing experiments suggested that resistance to spirodiclofen in this T. 
urticae strain is controlled by polygenic and intermediate inherited factors. Further research 
on the genetics of spirodiclofen resistance in field strains and its possible fitness costs is 
essential to achieve a better understanding of this phenomenon and its implications in spider 
mite control. 
Next to the metabolic detoxification, the existence of an altered target site (acetyl-CoA 
carboxylase, ACCase) was also investigated. We therefore used a resistant field strain as well 
as the laboratory selected strain. Sequence analysis of ACCase showed no amino acid 
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substitution between the spirodiclofen resistant and susceptible strains of T. urticae. 
Moreover, RT-PCR analysis of expression of this gene revealed no up-regulation in the 
resistant strains. Western blot analysis also showed no difference in the biotin-binding 
proteins in T. urticae deutonymphs of resistance and susceptible strains. It can be concluded 
that the resistance in the tested strains was not due to an overexpression or structural change 
in T. urticae ACCase, the suggested target site for spirodiclofen. 
Since the ACCase is a new and interesting target, a complete understanding of the structure 
and function of this enzyme in T. urticae is necessary to screen effective and specific 
acaricides and to prevent or manage resistance to currently used ACCase inhibiting acaricides. 
Obtaining sufficient quantities of purified T. urticae ACCase from living mites for enzymatic 
studies proved to be very difficult, so there was a need to produce recombinant enzymes. To 
develop an optimal protocol to express T. urticae recombinant ACCase, we assembled a full-
length cDNA inside three vectors, pMIB/V5-His B, pEIA and pET and also into pFastBac 
shuttle vector for expression in baculovirus. The most promising results were achieved using 
a baculovirus expression system and also the heat-shocking Codon Rare E. coli cells with the 
pET vector. Preliminary enzyme assays confirmed that the ACCase expressed in Sf9 cells 
infected with recombinant baculovirus proved to be active. More efforts are needed for high-
level recombinant expression of active full-length T. urticae ACCase. When the enzyme is 
available in higher quantities, it will be possible to characterize it in terms of its kinetic 
properties and its inhibition by spirodiclofen. Also by using these expression systems it will 
be possible to investigate whether mutations associated with resistance to ACCase-inhibiting 
herbicides in various weed species can also change biochemical properties of T. urticae 
ACCase and confer resistance to ACCase-inhibiting insecticides/acaricides. 
 
Acaricide resistance in rose greenhouses 
The effectiveness of 11 acaricides was tested on 15 Dutch rose greenhouse strains of the two-
spotted spider mite. Instead of dose-response bioassays, we used three doses:  FD/5, FD and 
5FD. This approach can be more efficient than dose-response curves for detecting an initial 
resistance outbreak (Roush and Miller 1986). The selected doses were useful to create a 
general overview of the resistance status since they provided more than 99% mortality in the 
susceptible strains.  
Toxicity tests revealed that most strains have different levels of resistance to tested chemicals. 
The quantification of detoxifying enzyme activities in a selection of 10 strains showed that all 
field strains have an increased metabolic activity compared to the susceptible strains. 
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However, when using only enzyme activities, no clear correlations were found between 
overall activity and the resistance status of the strains (Chapter V). This fact clearly points 
out the need that synergism experiments are needed to be able to draw sound conclusions.  
Two strains showed high levels of resistance to most tested acaricides, even against 
cyflumetofen, a novel selective acaricide which has not been registered in Europe. The 
majority of the tested strains showed resistance to acaricides which have been in use for more 
than a decade, including hexythiazox (12 out of 15 strains), bifenthrin (9 out of 15 strains) and 
tebufenpyrad (9 out of 15 strains). In order to check for target site resistance, we looked for 
amino acid substitutions known to be involved in resistance to different groups, in different 
strains. The corresponding regions for three mutations in the T. urticae para sodium channel, 
the target site of pyrethroids, were amplified and sequenced in nine Dutch field strains. Only 
two bifenthrin resistant strains harboured the F1538I resistance mutation (Chapter II), but it 
was not fixed yet. The L1025V mutation reported by Kwon et al. (2010b) was not detected in 
any strain. Although the role of A1215D mutation in the resistance to pyrethroids has not 
been confirmed (Tsagkarakou et al. 2009b, Kwon et al. 2010b), it was detected in 4 out of 10 
Dutch field strains and showing that the involvement of this substitution in resistance should 
be better studied. 
All tested strains exhibited reduced susceptibility to chlorpyrifos. This could easily be linked 
to the presence of F331W mutation in all these strains. Although other mutations might play a 
role in resistance (i.e. G119S, A201S, A280T and G328A), the F331W mutation (Chapter 
III)has been functionally characterized in insects and was shown to drastically reduce the 
sensitivity of AChE to OP compounds (Oh et al. 2006).  As was already mentioned, the use of 
OP compounds can antagonize bifenazate efficacy in laboratory conditions, and this risk 
increases when an insensitive AChE is present (Chapter III). 
Abamectin and milbemectin exhibited reduced activity in many strains and it can lead to 
future problems. Abamectin resistance has been reported to be linked to a G323D mutation in 
the glutamate gated chloride channel but this mutation was not detected in the abamectin 
resistant strains. 
Six out of 15 strains were resistant to bifenazate, while nine strains remained fully 
susceptible. All tested bifenazate resistant strains contained point mutations in the 
mitochondrial cytochrome b gene, while bifenazate susceptible strains showed the wild-type 
cytb genotype. This data again show the correlation between mutations in the cytb and 
bifenazate resistance, as described earlier (Van Leeuwen et al. 2008, Van Nieuwenhuyse et al. 
2009). It also supports the presence of additional mechanisms responsible for decreased 
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bifenazate efficacy. Although some strains were resistant to the recently introduced 
acequinocyl, a compound which has a similar mode of action as bifenazate, there was no 
evidence for cross-resistance between these compounds under field conditions.  
The efficacy of the recently introduced acaricides spiromesifen and etoxazole was still good, 
with the exception of a few strains that seemed to be multi-resistant to almost all tested 
molecules including cyflumetofen. The mechanisms behind such a broad resistance are 
currently unclear. 
Widespread occurrence of acaricide resistance and also cross/multiple resistance in T. urticae 
strains collected from rose greenhouses in the Netherlands, demands for accurate resistance 
monitoring and thoughtful and systematic resistance management programs to prevent the 
loss of effective acaricides that can contribute to controlling spider mites. 
 
Perspectives for future research 
To elucidate mechanism of resistance to pyrethroids, organophosphate and carbamate 
acaricides, sequence characteristics of the target genes of susceptible and resistant strains 
were compared and several amino acid substitutions were identified. Some substitutions have 
previously been proved to confer resistance, but the role of other mutations in the resistance 
trait is not clear and needs to be clarified.  Functional expression of these substitutions in an in 
vitro assay system can demonstrate their possible role in the para sodium channel insensivity 
or AChE insensivity. Determination of the number of origins of the resistance-associated 
mutations will be useful in modeling their spread and in designing resistance managing 
programs. Sequence phylogeny from an exon (which contains the resistance associated 
mutation) and part of a flanking intron of a wide range of globally collected resistant and 
susceptible strains can be explored in finding the number of origins. 
Spirodiclofen resistance in T. urticae was documented to be mediated primarily by increased 
detoxifying enzyme activities. Since the T. urticae genome data now are available, the 
specific detoxifying genes can be identified and their expression followed with microarray 
analysis. A pharmacokinetic approach can also be explored to clarify exclusively the 
spirodiclofen metabolism in susceptible and resistant strains. Further investigation into field 
resistant strains, with possible target site mutation(s), will be helpful in the clarification of 
spirodiclofen resistance. The baculovirus expression system for T. urticae ACCase developed 
in this study needs to be optimized (time after infection, cell density at infection, MOI, 
extraction protocol) but can possibly in the future be used to check the effect of field reported 
mutations on inhibitor binding.  
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In conclusion … 
The results obtained in this research raise some more tips of the veil and may collectively lead 
to better understanding of acaricide resistance mechanisms in T. urticae, leading to more 
efficient resistance management programs. 
Future investigations should focus on the biochemical and molecular mechanisms of multiple 
resistance commonly observed in T. urticae field strains coming from glasshouse growing 
areas. Utilizing high-throughput genomic strategies, further dissecting the whole genome 
sequence and proteomic data of susceptible and resistant T. urticae strains will further 
elucidate mechanisms of resistance to acaricides in the two-spotted spider mite that hopefully 
will result in a long-lasting resistance management strategy for the established and new 
acaricides. 
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The two-spotted spider mite Tetranychus urticae is an economically important pest in many 
agricultural crops worldwide. Its high reproductive potential and extremely short life cycle, 
combined with the frequent acaricide applications usually required to maintain the population 
below economic threshold, facilitates rapid resistance build-up. This has led to the 
development of resistance against almost all commercially used compounds. In this study we 
tried to unravel the mechanisms behind the resistance against a number of acaricides with 
different mode of action at the toxicological, biochemical, genetic and molecular level.  
In a first series of experiments, we investigated pyrethroid resistance in Greek T. urticae 
strains. Combined data from toxicological bioassays and biochemical and synergistic studies 
indicated that although enhanced P450 mono-oxygenase activities were associated with 
resistance, target site insensitivity proved to be the major resistance component. In order to 
get a better insight in the latter, a 3.3 kb cDNA fragment of the T. urticae para sodium 
channel gene encompassing segment 4 of domain II to segment 6 of domain IV was obtained 
by a degenerate PCR strategy. The T. urticae sequence showed highest identity (56%) to the 
scabies mite, Sarcoptes scabiei, and was phylogenetically classified within the divergent 
group of Arachnida. Comparison of resistant and susceptible strains identified the point 
mutation F1538I in segment 6 of domain III, which is known to confer strong resistance to 
pyrethroids, along with a second mutation (A1215D) in the intracellular linker connecting 
domains II and III, which still has an unknown role. Also, three alternative splicing variants 
were identified, of which two correspond to the mutually exclusive k/l exon pair already 
identified in insects. The mode of inheritance of resistance was confirmed to be almost 
completely recessive, which is consistent with studies on the target site mechanism for 
pyrethroids in other organisms. 
In T. urticae, organophosphate and carbamate resistance is often caused by 
acetylcholinesterase insensitivity. By combining toxicological, biochemical and molecular 
data from three reference laboratory and three organophosphate resistant (OP) strains, the 
AChE1 mutations associated with resistance in T. urticae were characterised. The resistance 
ratios of the OP strains varied from 9 to 43 for pirimiphos-methyl, from 78 to 586 for 
chlorpyrifos, from 8 to 333 for methomyl and from 137 to 4164 for dimethoate. Compared to 
the reference strains, the insecticide concentration needed to inhibit 50% of the AChE1 
activity in the OP strains was at least 2.7, 55, 58 and 31 times higher for the OP pirimiphos-
methyl, chlorpyrifos oxon, paraoxon and omethoate respectively, and 87 times higher for the 
carbamate carbaryl. By comparing the AChE1 sequence between laboratory and OP strains, 
four amino acid substitutions were detected: (1) F331W which was present in all three OP 
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strains; (2) T280A found in the three OP strains but not in all clones; (3) G328A, found in two 
OP strains; (4) A201S found in only one OP strain. F331W, G328A and A201S are possibly 
involved in resistance to organophosphate and carbamate insecticides. These findings were 
also confirmed by means of a structural model. F331W is probably the most important and the 
most common in T. urticae. It can be easily detected by a diagnostic PCR-RFLP assay 
developed in this study. 
We also evaluated the possible antagonism of organophosphate and carbamate insecticides on 
the toxicity of bifenazate in T. urticae when applied in mixtures. Bifenazate, a new and 
frequently used carbazate, is a pro-acaricide which needs to be activated by carboxylesterases. 
Two OP strains were used and several organophosphate (chlorpyrifos, azinphos methyl and 
phosmet) and carbamate (carbaryl and methomyl) insecticides were evaluated. Mixing 
chlorpyrifos with bifenazate strongly decreased bifenazate toxicity in both tested strains. 
However, in the strain with a higher esterase activity, antagonism decreased after 2 days. Of 
all other tested chemicals, only methomyl displayed an antagonistic effect 1 day after 
treatment. These findings indicate that mixing organophosphate and carbamate insecticides 
with bifenazate may inhibit bifenazate efficacy under field conditions, especially when 
resistant strains are present. 
Spirodiclofen, a recently developed and commercialized acaricide, is a selective, non-
systemic tetronic acid derivative. In order to develop strategies to minimise resistance in the 
field to spirodiclofen, we selected a T. urticae population for spirodiclofen resistance in the 
laboratory. This selection yielded a strain with a resistance ratio of 274, determined on the 
larval stage. This strain was used to determine genetic, toxicological, biochemical and cross-
resistance data. The egg stage of the resistant strain remained far more susceptible than the 
mobile stages. No cross-resistance was found against other acaricides, except for 
spiromesifen, another tetronic acid derivative. Based on synergist experiments and enzyme 
assays, it appeared that especially P450 mono-oxygenases, but also esterases and glutathione-
S-transferases, could be involved in the metabolic detoxification of spirodiclofen. Pre-
treatment of the resistant females with the synergists PBO or DEF could increase the 
inhibitory effect of spirodiclofen on reproduction, again demonstrating the possible 
involvement of mono-oxygenases and esterases. Among the esterases of T. urticae, probably 
only a few are more expressed in spirodiclofen resistant strains, and these apparently prefer 
the purpose-designed substrate 1-naphthyl 2,2-dimethylbutyrate. This was also confirmed by 
separating esterase isozymes by native isoelectric focusing. Because spirodiclofen interferes 
with lipid biosynthesis, total lipid content was measured in female adults. No significant 
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differences between treated and non-treated female adults were found, both in the susceptible 
and resistant strain. However, the total lipid content in the resistant females was significantly 
higher than in susceptible females. The genetic analysis using crossing experiments showed 
that the resistance is inherited as an intermediate trait under control of more than one gene. 
Resistance to spirodiclofen in the laboratory selected strain exceeded by far the recommended 
field rate, showing the capacity for quick resistance development in the field. A good 
acaricide resistance management programme is necessary to prevent fast resistance build-up 
in the field. However, without selection pressure, resistance tends to be unstable and can 
decrease in the presence of susceptible individuals owing to the intermediate, polygenic 
inheritance mode.  
No evidence was found to support the existence of other resistance mechanisms, like 
mutations in the target site (ACCase) or overproduction of the target enzyme. In order to 
facilitate designing new ACCase inhibitor insecticides and understanding mechanism of 
resistance to currently used ACCase inhibitors, we tried to clone and express T. urticae 
ACCase using different expression systems. The most promising results were achieved by a 
baculovirus expression system and also by heat-shocking Codon Rare E. coli cells with the 
pET-ACC vector. More efforts should be done to overcome several problems in expressing 
this enzyme e.g. by optimizing conditions to get higher levels of expression, protein 
solubility, activity and stability. 
We also performed a practical screening in Dutch cut rose glasshouses due the fact that 
growers complained on failing spider mite control. In order to check whether control failure 
was caused by resistance, the susceptibility of 15 strains, sampled from infested roses, was 
tested to 11 acaricides: tebufenpyrad, milbemectin, abamectin, cyflumetofen, bifenthrin, 
spiromesifen, hexythiazox, etoxazole, bifenazate, acequinocyl and chlorpyrifos. Three doses 
were used to discern between resistance and susceptibility: the recommended field dose (FD), 
FD/5 and FD x 5. Ten of these strains were screened for known resistance mechanism such as 
elevated detoxifying enzyme activities and previously reported resistance mutations using 
biochemical and molecular diagnostics. Potential cross-resistance between acaricides was 
estimated by correlation analysis. The strains showed different levels of resistance to tested 
acaricides.  Twelve out of 15 strains showed resistance against hexythiazox, and 9 out of 15 
against bifenthrin and tebufenpyrad. Two strains were found which showed high levels of 
resistance to most tested insecticides, even against one which has not been registered in 
Europe. A high correlation was found between some acaricides, e.g. between abamectin and 
milbemectin. Without selection pressure, resistance seemed to be unstable in most cases, after 
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one year. All field strains had an increased metabolic activity, compared to the susceptible 
strains. A number of amino acid substitutions known to be involved in resistance to different 
groups were present in different strains. The best example was the presence of the F331W 
substitution in the acetylcholine esterase, which was present in all field strains tested. 
 
The results obtained in this research may all together lead to a better understanding of 
acaricide resistance in T. urticae, which, in turn, may lead to more efficient resistance 
management programs. 
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De bonenspintmijt Tetranychus urticae veroorzaakt wereldwijd economisch belangrijke 
schade in een groot aantal land- en tuinbouwgewassen. De combinatie van een groot 
vermenigvuldigingsvermogen, een zeer korte levenscyclus en frequente acariciden-
toepassingen, die noodzakelijk zijn om de populatie onder de economische schadedrempel te 
houden, werkt een snelle resistentie-opbouw in de hand. Dit heeft geleid tot de ontwikkeling 
van resistentie tegen bijna alle gewasbeschermingsmiddelen die tegen deze mijten worden 
gebruikt. In deze studie hebben we geprobeerd om de mechanismen te ontrafelen die leiden 
tot resistentie tegen een aantal acariciden met verschillende werkingswijze, en dit op 
biochemisch, genetisch en moleculair niveau. 
In een eerste reeks experimenten werd de pyrethroïdenresistentie in Griekse stammen van  T. 
urticae onderzocht. De combinatie van toxiciteitsdata, biochemische en synergistische testen 
toonden aan dat, ondanks het feit dat er een verhoogde P450 mono-oxygenase-activiteit werd 
gedetecteerd, de belangrijkste oorzaak van de resistentie toch de ongevoeligheid van de 
inwerkingsplaats was. Om hierin een beter inzicht te krijgen werd met behulp van een 
gedegenereerde PCR methode uiteindelijk de sequentie van  een cDNA fragment van 3.3 kb 
van het para-natriumkanaal bepaald. Deze sequentie omvat een gebied lopende van segment 4 
van domein II tot segment 6 van domein IV. Het partieel geamplificeerde para-natriumkanaal 
van T. urticae vertoonde de hoogste gelijkenis (56%) met de schurftmijt Sarcoptes scabiei, en 
werd fylogenetisch ingedeeld binnen de divergente groep van Arachnida. Door vergelijking 
van resistente en gevoelige stammen werd de puntmutatie F1538I in segment 6 van domein 
III geïdentificeerd. Van deze mutatie is bekend dat ze een hoge resistentie tegen pyrethroïden 
veroorzaakt. De functie van een tweede mutatie (A1215D) in de intracellulaire 
verbindingsdomeinen II en III is tot op heden onbekend. Ook werden alternatieve transcripten 
geïdentificeerd, waarvan er twee overeen komen met het “mutually exclusive” k/l exonpaar, 
dat reeds in insecten werd vastgesteld. De wijze van overerving van de resistentie bleek bijna 
volledig recessief, wat overeenkomt met onderzoeken omtrent de dominantie van 
natriumkanaal in andere organismen. 
Resistentie tegen organofosfaten en carbamaten wordt in T. urticae dikwijls veroorzaakt door 
ongevoeligheid van acetylcholinesterase. Door het combineren van toxicologische, 
biochemische en moleculaire gegevens van 3 referentielaboratoriumstammen en 3 
organofosfaatresistente (OPR) stammen werden de mutaties in het AChE1 gen, die 
geassocieerd zijn met resistentie bij T. urticae, gekarakteriseerd. De resistentieratio’s van de 
OPR stammen varieerden van 9 tot 43 voor pirimifos-methyl, van 78 tot 586 voor 
chloorpyrifos, van 8 tot 333 voor methomyl en van 137 tot 4164 voor dimethoaat. Vergeleken 
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met de referentiestammen was de insecticideconcentratie nodig om 50 % van de AchE1 
activiteit te onderdrukken in de OPR stammen minstens 2.7, 55, 58 en 31 keer hoger voor 
respectievelijk pirimifos-methyl, chloorpyrifos-oxon, paraoxon en omethoaat, en 87 keer 
hoger voor carbamaat-carbaryl. Bij het vergelijken van de AChE1 sequentie van 
laboratoriumstammen met OP stammen kwamen 4 aminozuursubstituties aan het licht: (1) 
F331W, aanwezig in alle 3 de OP stammen; (2) T280A, gevonden in 3 OP stammen, maar 
niet in alle klonen; (3) G328A, gevonden in 2 OP stammen; (4) A201S, gevonden in slechts 1 
OP stam. F331W, G328A en A201S zijn mogelijk betrokken bij resistentie tegen 
organofosfaat- en carbamaatinsecticiden. Deze bevindingen werden ook bevestigd met behulp 
van een structureel model. De F331W substitutie is waarschijnlijk de belangrijkste en meest 
voorkomende in T. urticae. Ze kan eenvoudig opgespoord worden met een diagnostische 
PCR-RFLP test, ontwikkeld in deze studie.  
We onderzochten ook het mogelijk antagonistisch effect van organofosfaat- en 
carbamaatinsecticiden op de toxiciteit van bifenazaat in T. urticae bij toepassing in mengsels. 
Bifenazaat, een nieuw en veelvuldig gebruikt carbazaat, is een pro-acaricide dat geactiveerd 
moet worden door carboxylesterasen. Twee OPR stammen werden gebruikt om het effect van 
verschillende organofosfaat- (chloorpyrifos, azinfos-methyl en fosmet) en carbamaat-
insecticiden (carbaryl en methomyl) te evalueren. Menging van chloorpyrifos met bifenazaat 
leidde tot een sterke daling van de bifenazaattoxiciteit in beide onderzochte stammen. Bij de 
stam met een hogere esterase-activiteit verminderde het antagonisme echter al na 2 dagen. 
Van alle geteste producten vertoonde enkel methomyl een antagonistisch effect 1 dag na 
behandeling. Deze bevindingen tonen aan dat menging van organofosfaat- en 
carbamaatinsecticiden met bifenazaat de werkzaamheid van deze laatste onder 
veldomstandigheden kunnen inhiberen, vooral wanneer resistente stammen aanwezig zijn.  
Spirodiclofen, een recent ontwikkeld en gecommercialiseerd acaricide, is een selectieve, niet-
systemische verbinding, afgeleid van tetronzuur, die de werking van ACC-ase inhibeert. We 
selecteerden een spiridiclofen-resistente T. urticae stam in het laboratorium, met de bedoeling 
om informatie te verzamelen die nuttig kon zijn om resistentie-ontwikkeling in het veld te 
vermijden. De resistentieratio van deze stam, bepaald op het larvaal stadium, was  274. Deze 
stam werd gebruikt om genetische, toxicologische, biochemische en kruisresistentie-gegevens 
te bepalen. De eitjes van de resistente stam bleken veel gevoeliger dan de mobiele stadia. Er 
werd geen kruisresistentie tegen andere acariciden gevonden, behalve tegen spiromesifen, een 
andere afgeleide van tetronzuur. Op basis van synergist- en enzymtesten bleek dat vooral  
P450 mono-oxygenasen, maar ook esterasen and glutathione-S-transferasen, betrokken waren 
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bij de metabolische detoxificatie van spirodiclofen. Voorbehandeling van resistente wijfjes 
met de synergisten PBO of DEF konden het inhibitie-effect van spirodiclofen op reproductie 
verhogen, wat opnieuw een aanwijzing was voor een mogelijke betrokkenheid van mono-
oxygenasen en esterasen. Binnen de groep van de esterasen van T. urticae zijn er 
waarschijnlijk maar enkele die meer tot expressie gebracht worden in spirodiclofenresistente 
stammen. Precies deze esterasen hebben een sterke voorkeur voor het voor dit doel ontworpen 
substraat 1-naftyl-2,2-dimethylbutyraat. Dit werd ook bevestigd door scheiding van de 
esterase-isozymen met behulp van natieve IEF. Aangezien spirodiclofen interfereert met de 
lipidensynthese, werd de totale hoeveelheid lipiden van volwassen wijfjes gemeten. Zowel in 
de gevoelige als de resistente stam werden geen significante verschillen tussen behandelde en 
niet-behandelde volwassen wijfjes gevonden. De totale hoeveelheid lipiden in de resistente 
wijfjes was echter beduidend hoger dan deze in de gevoelige wijfjes. De genetische analyse 
via kruisingsexperimenten toonde aan dat resistentie overerft als een intermediair kenmerk dat 
gestuurd wordt door meer dan één gen. De laboratoriumgeselecteerde stam was totaal 
ongevoelig voor een behandeling met de aanbevolen velddosis van spirodiclofen, waardoor 
men er mag van uitgaan dat ook in het veld het risico voor een snelle resistentie-ontwikkeling 
groot is. Een goede strategie voor het beheer van de acaricideresistentier is noodzakelijk om 
snelle resistentie-opbouw in het veld te voorkomen. Zonder selectiedruk blijkt de resistentie 
niet stabiel te zijn. Ze kan snel verminderen in aanwezigheid van gevoelige individuen,  door 
de intermediaire, polygene overerving.  
Er werd geen bewijs gevonden dat er buiten de metabolische detoxificatie andere 
resistentiemechanismen, zoals mutaties in de inwerkingsplaats (ACCase) of de overproductie 
van het doelenzym, aanwezig waren. Om het ontwerp van nieuwe ACCase-inhiberende 
insecticiden te vereenvoudigen en om het resistentiemechanisme van de op dit moment  
gebruikte ACCase inhibitoren beter te begrijpen, probeerden we T. urticae ACCase te 
kloneren en tot expressie te brengen met verschillende expressiemethoden De beste resultaten 
tot nu toe werden bereikt met een baculovirus expressiesysteem en expressie in E. Coli  
Codon Rare cellen via de vector pETDuet-1. Deze methode kan echter nog verbeterd worden, 
bv. door het optimaliseren van omstandigheden om hogere expressieniveaus en een betere 
eiwitoplosbaarheid, activiteit en stabiliteit te verkrijgen.  
In een laatste deel was het de bedoeling om de verworven kennis te toetsen aan de praktijk. 
We contacteerde daarvoor een aantal Nederlandse snijrozenkwekers die geconfronteerd 
werden met een falende spintmijtbestrijding. Om na te gaan of dit falen veroorzaakt werd 
door resistentie, werden 15 stammen, verzameld op snijrozen in serres, getest met 11 
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acariciden: tebufenpyrad, milbemectine, abamectine, cyflumetofen, bifenthrin, spiromesifen, 
hexythiazox, etoxazole, bifenazaat, acequinocyl and chloorpyrifos. Om duidelijk resistentie 
van gevoeligheid te onderscheiden werden drie dosissen gebruikt: de aanbevolen velddosis 
(FD), FD/5 en FD x 5. Met het gebruik van biochemische en moleculaire technieken werden 
tien stammen onderzocht op een gekend resistentiemechanisme, zoals verhoogde detoxificatie 
of mutaties die leidden tot resistentie. Mogelijke kruisresistentie tussen acariciden werd 
ingeschat door middel van een correlatie-analyse. De stammen vertoonden verschillende 
niveaus van resistentie tegen de geteste acariciden.  Twaalf van de 15 stammen waren 
resistent tegen hexythiazox en 9 van de 15 tegen bifenthrin en tebufenpyrad. Er werden twee 
stammen gevonden die een hoge resistentie vertoonden tegen de meeste geteste insecticiden, 
zelfs tegen een product dat nog niet in Europa geregistreerd werd. Tussen sommige acariciden 
werd een hoge kruisresistentie gevonden, bv. tussen abamectine and milbemectine. Zonder 
selectiedruk bleek de resistentie in de meeste gevallen onstabiel na één jaar. Alle 
veldstammen vertoonden een verhoogde metabolische activiteit in vergelijking met de 
gevoelige stammen. Een aantal aminozuursubstituties, waarvan bekend is dat ze betrokken 
zijn bij resistentie tegen producten met verschillende werkingswijzen, werden teruggevonden. 
Het duidelijkste voorbeeld was de F331W substitutie in acetylcholine-esterase, dat in alle 
veldstammen werd teruggevonden.  
 
De resultaten van dit onderzoek dragen bij tot een beter begrip van acaricideresistentie bij T. 
urticae, en bij uitbreiding tot efficiëntere strategieën voor resistentiebeheer. 
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Appendix 1 The map and features of the pMIB/V5-His A, B, and C vectors, contains OpIE2 
promoter, OpIE2 Forward priming site, Honeybee melittin secretion site, Multiple cloning site, V5 
epitope, Polyhistidine (6xHis) region, OpIE2 Reverse priming site, OpIE2 polyadenylation sequence, 
pUC origin, OpIE1 promoter, EM7 promoter, Blasticidin resistance gene (bsd), Ampicillin resistance 
gene (bla). 
 
Appendix 2 The map and features of the pEIA contains actin promoter (B. mori A3 cytoplasmic actin 
promoter), baculoviral (BmNPV) homologous region 3 enhancer  (hr3), baculoviral (BmNPV) DNA 
fragment containing the IE1 transactivator gene under the control of its native viral promoter (IE1), 
The black box downstream of the promoter indicates the position of the cloning sites 
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Appendix 3 The map and features of the pFastBac HT A contains f1 origin, Ampicillin resistance 
gene, pUC origin, Tn7R, Gentamicin resistance gene, Polyhedrin promoter (PPH), Initiation ATG, 
6xHis tag, TEV recognition site, Multiple cloning site,  SV40 polyadenylation signal, Tn7L 
 
 
 
Appendix 4 The map and features of the pETDuet-1 vector contains the pBR322-derived ColE1 
replicon, lacI gene and ampicillin resistance gene, two multiple cloning sites (MCS), each of which is 
preceded by a T7 promoter/lac operator and a ribosome binding site (rbs) 
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Appendix 5 Sequence alignment of selected ACCase homologs  Tu     1 ------------------------------------------------------------ Ph     1 ------------------------------------------------------------ Tc     1 ------------------------------------------------------------ Aa     1 MITLVLTGVVLFVYIFLQKWWSSTTSDDLASQISAVSKASKDKRKHPPDGDSAAESCDTE Dm     1 MLITILGTLAAFLAFLLTLIFGRGQKRSKPVQSSAATSATTATTGDSDNGNTNHNSSVIA Hs     1 ------------------------------------------------------------ Gg     1 ------------------------------------------------------------ TaC    1 ------------------------------------------------------------ TaP    1 ------------------------------------------------------------ Zm     1 ------------------------------------------------------------ Os     1 ------------------------------------------------------------ At     1 ------------------------------------------------------------ Gm     1 ------------------------------------------------------------ Bn     1 ------------------------------------------------------------   Tu     1 ------------------------------------------------------------ Ph     1 ------------------------------------------------------------ Tc     1 ------------------------------------------------------------ Aa    61 PPVIKKSSQHIHTNGNVEPEIAIDAVAQQIKRVSFSNANHIYEDQESSSEKLNNHCASNH Dm    61 ATATATTTSSKPPIAPAAPPSAVKASDKRFPKACIKKVQFSSESLRSDVDELCDQLKDSA Hs     1 ------------------------------------------------------------ Gg     1 ------------------------------------------------------------ TaC    1 ------------------------------------------------------------ TaP    1 ------------------------------------------------------------ Zm     1 ------------------------------------------------------------ Os     1 ------------------------------------------------------------ At     1 ------------------------------------------------------------ Gm     1 ------------------------------------------------------------ Bn     1 ------------------------------------------------------------   Tu     1 ------------------------------------------------------------ Ph     1 ------------------------------------------------------------ Tc     1 --------------------------------------MTETDKTIENGVQWTLGDESRE Aa   121 TSSSSLDSVNENVAGNG----------------------------MDSNSGDGGGGDRPN Dm   121 LSNLSNDNIRIACHQNNNNSSINKNQNNNSIDISISISKMSETNESNDTAAQSAEGERPS Hs     1 ----------------------MDEPSPLAQPLELNQHSRFIIGSVSEDNSEDEISNLVK Gg     1 ----------------------MEESSQPAKPLEMNPHSRFIIGSVSEDNSEDETSSLVK TaC    1 ------------------------------------------------------------ TaP    1 -----MGSTHLPIVGLNASTTPSLSTIRPVNSAGAAFQPSAPSRTSKKKSRRVQSLRDGG Zm     1 --------MSQLGLAAAASKALPLLPNRQRSSAGTTFSSSSLSRPLNRRKSHTRSLRDGG Os     1 ------------------------------------------------------------ At     1 ------------------------------------------------------------ Gm     1 ------------------------------------------------------------ Bn     1 ----MEMRALVSCSAAGNGASDRFRLSNVSPWITSARGASGSDSPATVKLGSSSMIRAFK   Tu     1 ------------------------------------------------MSGPNLSSQDQD Ph     1 -----------------------------------------------MSQ.MINNRSLEK Tc    23 QEDIFPQNGDSFDNLPPAARSDGQGGLTPQEQKALIEKRKRLKPSMSQGTVMLQNRLQEK Aa   153 FIVGEDGLEENEAKDEFPQNTQNGMQSHAAYEVNLNEKRRRLRPSMSHGT.LG.ERGHER Dm   181 FLVGDEIDERAAEAGEACDEFPLKMQNDVRQNGDISERRKRLRPSMSRGT.LGQDRHQDR Hs    39 LDLLEEKEGSLSPASVGSDTLSDLGISSLQDGLALHIRSSMSGLHLVKQGRDRKKIDS.R Gg    39 LDLLEEKERSLSPVSVCSDSLSDLGLPSAQDGLANHMRPSMSGLHLVKQGRDRKKVDV.R TaC    1 --------------------------------------------------MVESDQINGT TaP   56 DGGVSDPNQSIRQGLAGIIDLPKEGTSAPEVDISHGSEEPRG---SYQ.N.ILNEAHNGR Zm    53 DGVSDAKKHSQSVRQGLAGIIDLPSEAPSEVDISHGSEDPRGPTDSYQ.N.IINETHNGR Os     1 -----------------------------------------MEGSYQMNGIL.GM.NSRH At     1 -------------------------------------------MAGSVNGNHSAVGPGIN Gm     1 -----------------------------------------MADIGRRNGYS.SVLPNRP Bn    57 GVSIYKNKTRRNVLSQRNKQFRPMAYLGRKDLSSPDPTSFCDNDISEPQGTGSINGN.HS   Tu    13 AAIISTPEEFVRRFDGRKVIKTVLIANNGIAAVKCMRSIRRWAYEIFRNERAIRFVVMVT Ph    14 DFTVAS.....K..K.TR..NK....................S..M.KF..S........ Tc    83 DFTVA......K..N.T...NK................V...S..M.K....V....... Aa   213 DFVL..T....KK.N.TRA.NK.......................M.K....V....... Dm   241 DFH.A.T....K..G.TR..NK.......................M.K............ Hs    99 DFTVAS.A...T..G.N...EK....................S..M.............. Gg    99 DFTVAS.A...T..G.NR..EK....................S..M.............. TaC   11 PNRM.SVD..CKALG.DSP.HS..V....M....F.....T..L.T.G..K..LL.A.A. TaP  113 H.SL.KVV..CMALG.KTP.HS..V....M..A.F...V.T..N.T.GS.K..QLIA.A. Zm   113 H.SV.KVV..CAALG.KTP.HSI.V....M..A.F...V.T..NDT.GS.K..QLIA.A. Os    20 PSSP.EVD..CKALG.DSP.HS..V....M....F.....T..L.T.GT.K..LL.A.A. At    18 YETV.QVD..CKALR.KRP.HSI......M....FI..V.T....T.GT.K..LL.G.A. Gm    20 P.A..EVD..CNALG.NRP.HSI......M....FI..V.S....T.GS.K..LL.A.A. Bn   117 .VRV.QVD..CKAHG.KRP.HRI.V.T..M....FI..V.A.S.QT.GS.KS.SL.A.A. 
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 Tu    73 PEDLKANAEYIKMADHYVPVPGGPNNNNYANVDLIVDIAIRMKAQGVWAGWGHASEYPRL Ph    74 .......................A........E..L...L.CQV.A..........N.K. Tc   143 .......................T........E......T.LQV.A..........N.K. Aa   273 .......................S........E......L.TQV.A..........N.K. Dm   301 .......................S........E......L.TQV.A..........N.K. Hs   159 ................................E..L...K.IPV.A..........N.K. Gg   159 ................................E..L...K.IPV.A..........N.K. TaC   71 ....RI...H.RI..QFLE....T........Q...E..E.TRVSA..P.......N.E. TaP  173 ...MRI...H.RI..QF.E....T........Q...E..V.TGVSA..P.......N.E. Zm   173 ...MRI...H.RI..QF.E....T........Q...GM.QKLGVSA..P.......N.E. Os    80 .....I...H.RI..QF.E....T........Q...E..E.THVSA..P.......N.E. At    78 ...MRI...H.RI..QF.E....T........Q...EM.EVTRVDA..P.......N.E. Gm    80 ...MRI...H.RI..QF.E....T........Q..LEM.EITHVDA..P.......N.E. Bn   177 ...MRI...H.RI..QFMQ....T........H...EM.EATGVDA..P.......N.E.   Tu   133 PELLNKAGIAFMGPPHHAMWALGDKIASSIVAQTARVPTLSWSGSGLVDSNYVE---GKP Ph   134 ....H.NN.V.I...EK...T..............EI...P......IATFSER---N.R Tc   203 ....H.N....I...DK..................DI...P....D.KAQYTG-----.K Aa   333 ....H.K.LV.L...ER........V.........EI...P....E.KAQYSG-----.K Dm   361 ....H.E.LV.L...ER........V.........EI...P....D.KAQYSG-----.K Hs   219 ....L.N........SQ..................GI...P......RVDWQENDFSKRI Gg   219 ....H.N........SQ..................GI...P.N....RVDWQENDLQKRI TaC  131 .DA.MEK..I.L...SA..G......G..LI..A.G....P....HVKVPQET------C TaP  233 .DA..AN..V.L...SSS.N.....VG.ALI..A.G....P....QVEIPLE.C-----L Zm   233 .DA.TAK..V.L...ASS.N.....VG.ALI..A.G....A....HVEVPLECC-----L Os   140 .DA.KEK..I.L...SA..A......G..LI..A.G....P....HVKIPPES------C At   138 .DA.DAK..I.L...ASS.A......G..LI..A.D....P....HVKIPPNSN-----L Gm   140 .DA.KAK..V.L...AIS.A......G..LI..A.E....P....HVKIPPESS-----L Bn   237 .DA.KAK.VI.L..TAAS.L......G..LI..A.D....P....HVKIPPGSS-----L   Tu   190 IKISADLYRKGCVSDEVEGLEASYKIGFPVMIKASEGGGGKGIRKCESADEFSIKFRQVQ Ph   191 ....SE..KE...QTVED..A.AQ.....................V..GE..PNQ..... Tc   258 ....S..FAR...QTAEQ..A.AQ.....................V.N..D.PAA..... Aa   388 ....S..FAR...TTSEQ..I.AG....................RVDH....PAL..... Dm   416 ....SE.FAR...TNVEQ..A.VN....................RVDTTE..PGL..... Hs   279 LNVPQE..E..Y.K.VDD..Q.AEEV.Y.................VNN..D.PNL..... Gg   279 LNVPQE..E..Y.K.ADD..R.AEEV.Y.................VNN..D.PNL..... TaC  185 HS.PEEI.KNA...TTD.AVASCQVV.Y.A.....W.........VHND..VRAL.K... TaP  288 DS.P.EM...A...TTE.A.ASCQM..Y.A.....W.........VNND.DVRAL.K... Zm   288 DA.PEEM...A..TTTE.AVASCQVV.Y.A.....W.........VHND..VRAL.K... Os   194 NS.PEEM..SA...TTE.AVASCQVV.Y.A.....W.........VHND..VRAL.K... At   193 VT.PEEI..QA..YTTE.AIASCQVV.Y.A.....W.........VHND..VRAL.K... Gm   195 .T.PDEI..EA..YTTE.AVASCQVV.Y.A.....W.........VHND..VRAL.K... Bn   292 VT.PEEM..QA..YTTE.AVASCQVV.Y.A.....W.........VHDD..VRAL.K...   Tu   250 NEVPGSPIFIMKLATCARHLEVQLLADQYGNAISLFGRDCSIQRRHQKIIEEAPCVIANE Ph   251 A.............R.......................................AI..KL Tc   318 T.I......V....K.......................................A...AS Aa   448 A........V....RG......................................AI..EP Dm   476 A........V....RG......................................AIV.QP Hs   339 A........V.R..KQS......I.................V............AT..TP Gg   339 A........V.R..KQS......I.................V............AS..TS TaC  245 G...........V.SQS........C.KH..VAA.HS....V..........G.ITV.PP TaP  348 G..........R..SQS........C.....VAA.HS....V..........G.VTV.PR Zm   348 G........V.R..SQS........C.....VAA.HS....V..........G.VTV.PR Os   254 G...........V.SQS........C.KH..VAA.HS....V..........G.ITV.PS At   253 G...........V.SQS........C.KH..VSA.HS....V..........G.ITV.PP Gm   255 G...........V.SQS........C.....VAA.HS....V..........G.ITV.TI Bn   352 G...........V.SQS........C.....VSA.HS....V..........G.ITV.PR   Tu   310 EAFAEMEEAAVRLAKMVGYESTGTVEYLYDPAENKFYFLELNPRLQVEHPCSEMVSDVNL Ph   311 .V.ED..R...........V.A........-TNGNY...............T........ Tc   378 DV.ED..K...........V.A........-TSGHY...............T........ Aa   508 .V.ED..K...........V.A........-..GRYF..............T...AE... Dm   536 .V.ED..K...........V.A........-P.GRYF..............T...A.... Hs   399 AV.EH..QC..K.......V.A.......S-QDGS................T...A.... Gg   399 VV.EH..QC..K.......V.A.......S-QDGS................T...A.... TaC  305 .TIK.L.Q..R....C.Q.QGAA......SMETGEY..............VT.WIAEI.. TaP  408 .TVK.L.Q..R....A...VGAA......SMETGEY..............VT.WIAE... Zm   408 .TVKAL.Q..R....A...VGAA......SMETGDY..............VT.WIAE... Os   314 .TVK.L.Q..R....C.H.VGAA......SMETGEY..............VT.WIAEI.. At   313 .TVKKL.Q..R....S.N.VGAA.I....SMDTGEY..............VT.WIAEI.. Gm   315 .TVKKL.Q..R...IS.N.VGAA......SMETGEY..............VT.WIAEI.. Bn   412 DTVKKL.Q..R....S.N.VGAA...F..SMDTGDYF.............VT.RIA.I.. 
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 Tu   370 PACQLQIAMGLPLYRIKDIRLLYGEPPLNDNPID----------FKLG--RAQPWGHVIA Ph   370 ..A...V.......K..........S.WG..E..----------.DQPRHKP........ Tc   437 ..A..........HY..........S.WGNSE..----------.DQPRHKP........ Aa   567 .......G..I..............N.WGSTV..----------.DVPTTKPR.R..... Dm   595 ..A....G..I....L.........S.WGSSV..----------.ENPPNKPR.S..... Hs   458 ..A.......I.........MM..VS.WG.S...----------.EDSAHVPC.R..... Gg   458 ..A.......I..H......VM..VS.WG.GS..----------.ENSAHVPC.R..... TaC  365 ..S.VVVG..I...N.PE..RF..IEHGGGYHAWKEISAVATKFDLDKAQSVK.K..CV. TaP  468 ..A.VAVG..I..WQVPE..RF..MDNGGGYD.WRKTAALATPFNFDEVDSQW.K..CV. Zm   468 ..A.VAVG..I..WQ.PE..RF..MDYGGGYD.WRKTAALATPFNFDEVDSQW.K..CV. Os   374 ..A.VVVG..V...N.PE..RF..MEHGGGYDAWRKISAVATKFDLDNAQSVK.K..CV. At   373 ..A.VAVG..I..WQ.PE..RF..IEHGGGYDSWRKTSVVAFPFDFDKAQSIR.K..CV. Gm   375 ..A.VA.G..V..WQ.PE..RF..VEHGGGYDAWRKTSVLATPFDFDKAQSTR.K..CV. Bn   472 ..A.VAVG..I..WQ.PE..RF..IEQ---YDSWRTTSLLASPFNFDKAESVR.K..CV.   Tu   418 ARITSENPDEGFKPSSGTVQELNFRSNKNVWGYFSVGASGGLHEFADSQFGHCFSWGEDR Ph   420 ..........................S.........A.....................T. Tc   487 ..........................S.........A.....................N. Aa   617 ..........................SQ........A.....................N. Dm   645 ..........................S.........A.....................N. Hs   508 ....................................A.A...................N. Gg   508 ....................................A.A...................N. TaC  425 V.V...D..D....T..R.E....K.KP...A....KSG.AI...S......V.AF..S. TaP  528 V.....D..D....TG.K.K.IS.K.KP...A....KSG..I..........V.AY.VS. Zm   528 V.....D..D....TG.K.K.IS.K.KP...A....KSG..I..........A.AY.LS. Os   434 V.V...D..D....T..R.E....K.KP...A....KSG.AI...S......V.AF..S. At   433 V.V...D..D....T..R....S.K.KP...A....KSG..I...S......V.AF..S. Gm   435 V.V...D..D....T..K......K.KP...A....KSG..I...S......V.AF..S. Bn   529 V.V...D..D....T..Q....S.K..P........KSG..I...S......V.AF..S.   Tu   478 EQARENLVIALKELSIRGDFRTTVEYLITLLETEAFQKNEIDTGWLDKLISERVQSDKPK Ph   480 .................................KS..E.S...A...I..A..M.AE..N Tc   547 .................................KS..E.T...A...I....K.E.E..N Aa   677 Q................................NS.LE.T...A...A..A...KA...D Dm   705 Q................................NR.LD.S...A...A..A.....E..D Hs   568 .E.IS.M.V...................K.....S..M.R.......R..A.K..AER.D Gg   568 .E.IS.M.V...................K.....S..Q.R.......R..A.K..AER.D TaC  485 SL.IA.M.LG...IQ...EI..N.D.TVD..NAAEYRE.K.H.....SR.AM..RAER.P TaP  588 AA.IT.MSL....IQ...EIHSN.D.TVD..NASD.KE.R.H.....NR.AM...AER.P Zm   588 PA.IT.MSL....IQ...EIHSN.D.TVD..NASD.RE.K.H.....TR.AM...AER.P Os   494 SL.IA.M.LG...IQ...EI..N.D.TVD..NAAEYRE.K.H.....SR.AM..RAER.P At   493 AL.IA.M.LG...IQ...EI..N.D.T.D..HASDYRD.K.H.....SR.AM..RAER.P Gm   495 AL.IA.M.LG...IQ...EI..N.DNT.D..NASDYRE.K.H.....SR.AM..RAER.A Bn   589 AM.IA.M.L....IQ...EV..N.D.T.D..HAFDYRE.K.H.....SR.AM..RAER.P   Tu   538 TSLALICGSIHVADAQFSGNWQNFESSLQKGQIPHATTLTNSVNVELIYENVKYLFNVAK Ph   540 VLVGV.S.AL....RAITN.F.S.QQA.ER...QGSN.IDHT.S....N.GL..KVQ.T. Tc   607 VM.GV....L.I..KTI.TAF.E.QN..ER...QGSN....V.D....HGGN..KVQAT. Aa   737 II.GV...AL.I..RKITEAFTS.KT.ME....QA.N....V.D....S.GIR.KVQP.. Dm   765 IL.GVM...L.I..R.ITESFSS.QT..E....QA.N....V.D....NDGIR.KVQA.. Hs   628 .M.GVV..AL....VSLRNSVS..LH..ER..VLP.H..L.T.D......G...VLK.TR Gg   628 .M.GVV..AL....VS.RNSVS..LH..ER..VLP.H..L.T.D......GR..VLK.TR TaC  545 WY.SVVG.ALYE.SSRS.SVVTDYVGY.S.....PKHISLVNLT.T.NIDGS..TIETVR TaP  648 WYISVVG.ALYKTITSNTDTVSEYV.Y.V.....PKHISLVHST.S.NI.ES..TIETIR Zm   648 WYISVVG.ALYKTVTTNAATVSEYV.Y.T..H..PKHISLVNST.N.NI.GS..TIETVR Os   554 WY.SVVG.ALYE.SSRS.SVVTDYVGY.S.....PKHISLVNLT.T.NI.GS..TIETVR At   553 WY.SVVG.ALYK.S.TSAAVVSDYVGY.E.....PKHISLVHSQ.S.NI.GS..TID.VR Gm   555 WY.SVVG.ALYK.SDSSAALVTDYVGY.E.....PKHISLVHSQ.S.NI.GS..TIDMIR Bn   649 WY.SVVS.ALYK.S.TGAAVVSDYIAY.D.....PKHISLVHSQ.S.NI.GS..TID.VR   Tu   598 SGPNSYFVVLNDSYKEVEVHQMSDSGLLLSVDGSSIVTYMKEEIDQYRVIVANQTCVFSK Ph   600 ...T...L.M.GHF..I...RL..G........A.CI......V.R..IVIG......E. Tc   667 ....T..LMM.GTF..I...RLT.G.I........FT......V.R..IVIG...V..E. Aa   797 T..ST..L.M.G.F......RL..G.M.I.L....YT......V.R..IVIG......D. Dm   825 ..A....LLM.S.F..I...RL..G...I.LE.A.YT......V.R..IVIG......E. Hs   688 QS....V.IM.G.CV..D..RL..G.....Y....YT......V.R..ITIG.K....E. Gg   688 QS....V.IM.S.CV..D..RL..G.....Y....YT......V.R..ITIG.K....E. TaC  605 G..R..KLRI.E.EV.A.I.SLR.G...MQL..N.H.I.AET.AAGT.LLINGR..LLQ. TaP  708 ..QG..RLRM.G.VI.AN.QTLC.G...MQL..N.H.I.AE..AGGT.LLIDGK..LLQN Zm   708 T.HG..RLRM...TV.AN.QSLC.G...MQL..N.H.I.AE..AGGT.LQIDGK..LLQN Os   614 R..R..TLRM.G.EI.A.I.SLR.G...MQL..N.H.I.AET.AAGT.LLINGR..LLQ. At   613 G.SGT.RLRM.K.EVVA.I.TLR.G...MQL..K.H.I.AE..AAGT.LLIDGR..LLQN Gm   615 G.SG..RLRM.Q.EI.A.I.TLR.G...MQL..N.H.I.AEG.AAGT.LLIDGR..LLQN Bn   709 ..SG..KLRM.N.EVAA.I.TLR.G...MQL..K.H.I.AQ..TSGT.LLIDGK..LLQN 
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 Tu   658 ENDPTILRSPSPGKLQQFLVEDGSHVSAGQPYAEIEVMKMIMTLTTSESGIIRHAKRFGS Ph   660 ....SL.....A...LN..ID..G.LE...A.........V...SAT.T.TLVYV..P.A Tc   727 ...........A...IS..ID..G..DK..A.........V....S....T.FYV..P.A Aa   857 ....SL.....A...INL.I...A..VK............V....AG.T.TVSFVR.P.A Dm   885 ....SL.....A...INMI....A...K..A.........V....SQ.A.TVTFVR.P.A Hs   748 ....SVM....A...I.YI....G..F...C.........V....AV...C.HYV..P.A Gg   748 ....S......A...I.YV....G..F...CF........V....AG...C.HYV..P.A TaC  665 .H..SR.LADT.C..LR...A.....V.DT....V.....C.P.LLPA..V.HFVMPE.Q TaP  768 DH..SR.LAET.C..LR...A..A..E.DV....V.....C.P.LSPAA.V.NVLLSE.Q Zm   768 DH..SK.LAET.C..LR...A..A..D.DV....V.....C.P.LSPA..V.HCMMSE.Q Os   674 .H..SK.LADT.C..LR...A.....D.DT....V.....C.P.LLPA..V.HFVMPE.Q At   673 DH..SK.MAET.C..MRY.IS.N.NID.DT....V.....C.P.LSPA..V.HFKMSE.Q Gm   675 DH..SK.VAET.C..LRY..A.D...D.DT....V.....C.P.LSPA....HFTMSE.Q Bn   769 .H..SK.MAET.C..LRY..S.D.SID.DT....V.....C.P.LSPA..V.HFKMCE.Q   Tu   718 VLEAGCILARLDLDDPTKVRRAELYSEGWQELMARDIVGKNPSETDSAHPQKLNVTFSSV Ph   720 ..D..SLI.H.E...ASLITK.LD.KG.FPDADVSAPIVG----------E...QLHN.Y Tc   787 .....STI.S.E....SL.TK.M..KGPFP..DVSQPIVS----------E...HIHN.Y Aa   917 ..D..SL.GH.E....SL.TK.QP.KNP.PLTGDSVQ.P-----------E...RVH..Y Dm   945 ..D..SL.GH.E....SL.TK.QPFKGQFLQP-ENAP.P-----------E...RVHNTY Hs   808 A.DP..V..KMQ..N.S..QQ...HTGSLPRIQSTALR.-----------E..HRV.HY. Gg   808 ..DP..VI.K.Q....SR.QQ...HTGTLPQIQSTALR.-----------E..HRI.HY. TaC  725 AMQ.SDLI........SS.....PFHGTFPK.GPPTAISG-----------------KVH TaP  828 PMQ..DLI........SA.K...PFNGSFP.MSLPIAASG-----------------QVH Zm   828 A.Q..DLI........SA.K...PFDGIFPQMELPVA.SS-----------------QVH Os   734 AMQ.ADLI........SS.....PFHGTFPK.GPPTA.SG-----------------KVH At   733 AMQ..ELI.N......SA..K..PFHGSFPR.GLPTAISG-----------------RVH Gm   735 AMQ..ELI........SA..K..PFTGSFPV.GPPTAISV-----------------KVH Bn   829 .MLP.ELI.N...A..ST..K..PFHG.FPR.GLPTEISA-----------------KVH   Tu   778 KSHLENFLAGYVLPEPFYTTKMQENVTLFMRCLKDPQLPLLELQDIISSQSGRIPPSVES Ph   770 RCM.D.I....C..D.YHEPRVR.VIEK..TS.R..S...M...EV...I.....I...K Tc   837 .AV...T....C..D.YNAPRLR.VIEK..SS.R..S.......QVMA.I......A..K Aa   966 .TI...T....C..D.YNAPRLR.IIEK..QS.R..S.......EV.A.I.....L...K Dm   993 ..I...T....C.....NAQRLRDIIEK..QS.R..S.......EV.A.I.....I...K Hs   857 LDN.V.VMN..C..D..FSS.VKDW.ERL.KT.R..S.........MT.V......N..K Gg   857 LDN.V.VMN..C....YFSS.VKGW.ERL.KT.R..S.........MT.V......N..K TaC  768 QKFAASVNSAHMILAGYEHNINHVVQD.LN-..DS.E..F.QW.ELM.VLAT.L.KDLRN TaP  871 .RCATSLN.ARMVLAGYDHPINKVVQD.VS-..DA.E..F.QWEELM.VLAT.L.RLLK. Zm   871 .RYAASLN.ARMVLAGYEHNINEVVQD.VC-..DN.E..F.QWDELM.VLAT.L.RNLK. Os   777 QKFAASVNSAHMILAGYEHNINEVVQD.LN-..DS.E..F.QW.ELM.VLAT.L.KDLRN At   776 QRCAATLN.ARMILAGYEHKVDEVVQD.LN-..DS.E..F.QW.ECFAVLAT.L.KNLRN Gm   778 QKCAASLN.ARMILSGYEHNIDEVV.QSLLN..DS.E..F.QW.ECLAVLAT.L.KELKN Bn   872 QRCAATLD.ARMILAGYEHQVDEVVQDFVS-..DS.E..F.QW.ECFAVLAT.L.KDLRI   Tu   838 SIKKLMQKYAKNITAVLQIFPSQEIASVIDSYAATLEKRSDRDVFFLNTQGIVQLVQRYR Ph   830 K.R...SL.ER...S..AQ....Q............Q..T.......T............ Tc   897 K.RR..SL.ER...S..AQ....Q.......H..SMQ..AE..G...A.ES......... Aa  1026 K.R....L.ER...S..AQ....Q......MH....Q..T.......T............ Dm  1053 K.R...TL.ER...S..AQ....Q.......H....Q..A.......T..S......... Hs   917 ....E.AQ..S...S..CQ....Q..NIL..H....NRK.E.E...M...S......... Gg   917 ....E.AQ..S...S..CQ....Q..NIL..H....NRK.E.E...M...S......... TaC  827 ELDAKYKE.EL.ADFRKSKDFPAKLLRGVIEANLAYCSEK..VTSERLVEPLMS..KS.E TaP  930 ELEGKYSE.KL.VGHGKSKDFPSKMLRE.IEENLAHGSEKEIATNERLVEPLMS.LKS.E Zm   930 ELEDKYKE.KL.FYHGKNEDFPSKLLRD.IEENLSYGSEKEKATNERLVEPLMN.LKS.E Os   836 ELDGKYKE.EL.SDFRKNKDFPAKLLRG.IEANLAYCSEK..VTNERLVEPLMS..KS.E At   835 MLESKYREFESISRNS.TTDFPAKLLKG.LEAHLSSCDEKE.GALERLIEPLMS.AKS.E Gm   838 ELESKY.EFEGIS-SSQIVDFPAKLLKG.IEAHLSSCPDKEKGAQERLVEPLLS..KS.E Bn   931 MLESKYME.ECISRNS.TADFPAKLLKG.LEAHVASCDETE.GALARLIEPLMS.AKC.E   Tu   898 NGIRGRLRSCVQDLLKNYIDVEQHFQAGDYDKCVSALTEKYKDEGMSKAVANIFSHLNVA Ph   890 ......MK.V.HE...Q.YA..SQ..L.H.......IR..H..D-.AAVTSL....GQ.S Tc   957 ......MKVA..E..RQ.Y...SQ..Q.S.....AL.R..H..D-.QSVSNT....SQ.. Aa  1086 ......MKAA.HE..RQ.YA..SQ..H.H.....A.IR..H..N-.DVV.GT....SQ.. Dm  1113 ......MKAA.HE..RQ.Y...SQ..Y.H.....GLVR.HN..D-.QTV.NT....SQ.. Hs   977 S....HMKAV.M...RQ.LR..TQ..N.H.....F..R.EN.SD-.NTVLNY....AQ.T Gg   977 S....HMKAV.M...RQ.LK..TQ..H.H.....F..R.EN.SD-.NAVLNY....AQ.T TaC  887 G.RESHA.AV.KS.FEE.LS..EL.SDDIQSDVIER.RLQHAKD-LE.V.YIV...QG.K TaP  990 G.RESHAHFI.KS.FED.LS..EL.SD.IQSDVIER.RQQHSKD-LQ.V.DIVL..QG.R Zm   990 G.RESHAHFV.KS.FEE.LT..EL.SD.IQSDVIET.RHQHSKD-LQ.V.DIVL..QG.R Os   896 G.RESHA.VV.KS.FEE.LS..EL.SDNIQSDVIER.RLQHAKD-LE.V.YIV...QG.R At   895 G.RESHA.VI.HS.FEE.LS..EL.NDNMLADVIERMRQL..KD-LL.I.DIVL..QGIK Gm   897 G.RESHAHII..S.FDE.LS..EL.SDNIQADVIER.RLQ..KD-LL.I.DIVL..QGIK Bn   991 G.RESHACVI.RS.FEE.LS..EL.NNNMLADVIERMRHE..KD-R..I.DIVL..QGLK 
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 Tu   958 KKNQLIIKLIDHLAGQEPGLTEELSNILNALTALNRSENVKVALRARQVLISAHQPPYAL Ph   949 ...F.VT.....IWDN.....D..AS...E..S...Q.HSR..........A....A.E. Tc  1016 ...L.VTM.....WSN.....D..APA.TE..S.....HSR..........A....A.E. Aa  1145 ...L.VTL.V...WAN.....D..AAT.SE..S...A.HSR..........A....A.E. Dm  1172 ...L.VTL.....WAN.....D..A.T.SE..S...A.HSR....S.....A....A.E. Hs  1036 ...L.VTM...Q.C.RD.T..D..L...TE..Q.SKTT.A...........AS.L.S.E. Gg  1036 ...L.VTM...Q.C.RD.T..D..I...TE..Q.SKTT.A...........AS.L.S.E. TaC  946 S..K..LR.MEA.VYPN.---SAYRDQ.IRFS...HTAYSGL..K.S.L.EHTKLSELRT TaP 1049 N.TK..LT.MEK.VYPN.---AAYKDQ.TRFSS..HKRYY.L..K.SEL.EQTKLSELRT Zm  1049 N.AK.VTA.MEK.VYPN.---GGYRDL.VRFSS..HKRYY.L..K.SEL.EQTKLSELRA Os   955 T..K..LR.MEA.VYPN.---SAYRDQ.IRFSG..NTVYSEL..K.S.L.EHTKLSELRT At   954 N..K.VLR.MEQ.VYPN.---AAYRDK.IRFST..HTNYSEL..K.S.L.EQTKLSELRS Gm   956 S..K..LQ.M.K.VYPN.---VAYRDQ.IRFSL.HHTNYSEL..K.S.L.EQTKLSELRS Bn  1050 S..K.VLG.ME.FVNAN.---AMYRDK.IRFLK..HTNYSE.V.K.S.L.KQRKLSELRS   Tu  1018 RFSQMEAMFLSVIDMYS-------HEFDANNMNKLIISETSIFDVLHQFFYHSNIVVRKA Ph  1009 .HN...SI...AV...G-------...HPE.IQ...Q.......I..D......KA.CN. Tc  1076 .HN...SI...AV...G-------...HPE.LQ...V.......I..D....A.RA.CN. Aa  1205 .HN...SI...AV...G-------.D.HPE.LQR..L.......I..D......RA.CN. Dm  1232 .HN...SI...AV...G-------.D.HPE.LQR..L.......I..D......RA.CN. Hs  1096 .HN.V.SI...A....G-------.Q.CIE.LQ...L.........PN......Q...M. Gg  1096 .HN.V.SI...A....G-------.Q.CIE.LQ...L.........PN......Q...M. TaC 1003 SIARSLSELEMFTEEGERISTPRRKMAINER.ED.VCAPVAVE.A.VAL.D..DPTLQRR TaP 1106 SIARSLSELEMFTE---------ERTAISEI.GD.VTAPLPVE.A.VSL.DC.DQTLQQR Zm  1106 SVARSLSDLGMHKG---------EMS-IKD..ED.VSAPLPVE.A.ISL.DY.DRT.QQK Os  1012 SIARSLSELEMFTEEGERVSTPRRKMAINER.ED.VGAPLAVE.A.VAL.D..DPTLQRR At  1011 NIARSLSELEMFTEDGENMDTPKRKSAINERIED.VSASLAVE.A.VGL.D..DHTLQRR Gm  1013 NIARSLSELEMFTEDGENIDTPKRKSAINDR.ED.VSAPFAVE.A.VGL.D..DHTLQRR Bn  1107 SILSELE..AEDGEN-------MDTPKRKCA.ED.VSAPLAVE.A.VGL.D..DRTLQRL   Tu  1071 SLEVYVRRAYICYEMVALQHLFIRNSPNDSGSIELSNSYAEQNDSVIPTAVFHFILPSSH Ph  1062 A.......T..S.DLTC....ELSG--------------------EVSLVH.Q.L..... Tc  1129 A.........TS.DITC....ELSG--------------------EV.VVH.Q.L..PT. Aa  1258 A.........TS..LTC....ELSG--------------------EV.LVH.Q.L..TA. Dm  1285 A.........TS..LTC....ELSG--------------------GL.LVH.Q.L..TA. Hs  1149 A..........A..LNSV..RQLKD--------------------NTCVVE.Q.M..T.. Gg  1149 A..........A..LNSV..RQLKD--------------------NTCVVE.Q.M..T.. TaC 1063 VV.T.I..L.QH.LVRGSVRMQWHR--------------------SGLI.LWE.SEEHIE TaP 1157 VI.T.IS.L.QPHLVKDSIQ.KYQE--------------------SGVI.LWE.AEAH.E Zm  1156 VI.T.IS.L.QPHLVKDSIQMKFKE--------------------SGAITFWE.YEGHVD Os  1072 VV.T.I..L.QP.LVKGSVRMQWHR--------------------SGLI.LWE.SEEHIK At  1071 VV.T.I..L.QP.VVKDSVRMQWHR--------------------SGLL.SWE.LEEHME Gm  1073 VV.S.I..L.QP.LVKGSARMQWHR--------------------SGLI.TWE.YDEYIE Bn  1160 VV.T.I..L.QP.VVKESVRMQWHQ--------------------YGFI.SWE.LDDHME   Tu  1131 PSIAS------------QPQSQNTEGLSNNFSGESSAHLHSNYRIGVIAAFKNLEHVEEH Ph  1102 .N---------------RIPINKLNHD..DLECSL.FSPQNWF.T..MT..QSF.QF.MY Tc  1169 .N---------------RLIKLDDFKD.EDGPK----VVDTFQ.T.CM...Q.FQEF.QY Aa  1298 .N---------------RYKLLPDG------TETDN-IFD.FM.T.CM...DSF..FTQY Dm  1325 .N---------------RLF.RMSSPDGLDQAAAE.-LGN.FV.T.A....DSF..F.MY Hs  1189 .NRGNIPTLNRMSFSSNLNHYGM.HVA.VSDVLLDNSFTPPCQ.M.GMVS.RTF.DFVRI Gg  1189 .N--------RMSFSSNLNHYGMVHVA.VSDVLLDNSFTPPCQ.M.GMVS.RTF.DFVRI TaC 1103 QRNG-----------------------QSASLLKPQVEDPIGR.W..MVVI.S.QLLSTA TaP 1197 KR------------------------------------------L.AMVIV.S..S.SAA Zm  1196 TRNG-------------------------------HGAIIGGK.W.AMVVL.S..SASTA Os  1112 QRNG-----------------------QDAM.LKQQVEDPEEK.W..MVVI.S.QYLSSA At  1111 RKNIG--------------------LDDPDT.EKGLVEKR.KRKW.AMVII.S.QFLPSI Gm  1113 RKNG----------------------VEDQSLSKTVEEK..EKKW..MVII.S.QFLPAI Bn  1200 RKNSEG-------------------SDDQET.EKVFVEKRRKKKK.FMVII.S..FLPNI   Tu  1179 FDSLLNALTDFDKDLAAEHFDAPESNHQSSSPSDKGSSD---MNGYNGPDTEESQNKESN Ph  1147 A.EI.DLVK.SLRNVNVSNKVLEAVENA.E.RNSGSN.----VSLNL.DAIRIEEQNQKS Tc  1210 A.EI.DLIE..ANPATISAK.LIAVESG.E.RNSTSIN----VSLSLEGQRGGEE-SCMH Aa  1336 S.EI.DL.E..ASPSFVNAKVLEAVEAGD.DRRMST.INVSISDPISR.AETDGIATHPA Dm  1369 S.EI.DL.E..VSPAMVNAKVLEAVEAAD.ISDSRH.TSINVSLSDPVTRANAAEEAK.T Hs  1249 ..EVMGCFS.SPPQSPTFPEAGHT.-------------------------LYDEDKVPRD Gg  1241 ..EVMSCFC.SPPQSPTFPEAGHA.-------------------------LYDEDKAARE TaC 1140 IEAA.KETSHYGAGVGSVSNGN.INLNG.NMLHIALVGI----.NQMSTLQDSGDEDQAQ TaP 1215 IGAA.KGTSRYA-------------SSEGNIMHIALLGA----DNQMHGTEDSGD.DQAQ Zm  1225 IVAA.KDSAQ.N-------------SSEGNMMHIALL.A----ENESNISGIS.D-DQAQ Os  1149 I.AA.KETSHYKAGAGNVSNGNSA.SSHGNMLHIALVGI----.NQMSTLQDSGDEDQAQ At  1151 ISAA.RETKHN--.YETAG-----APLSGNMMHIAIVGI----.NQMSLLQDSGDEDQAQ Gm  1151 ITAA.REA.NN--PHE.LTSGSV.PVNYGNMMHIGLVGI----.NQMSLLQDSGDEDQAQ Bn  1241 ITAAALTE.NHIDYGESAG-----.PLSGNIMHIAVLDS----ENE------------ED 
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 Tu  1236 EPIHIINIAIKPEG-ADDEILSKKCEAFCQSRSKLLIERGVRRVTFIVCNLY-------- Ph  1203 .....LS..V.DHNKS..ST...MFGD..RTNLEE.TD..I..I..L.L.K--------- Tc  1265 .....LHVG..DK.DT..SSM..IFGG..VRHKEE..S..I..I..AALKH--------- Aa  1396 .A...LS..VRDM.DM..LQMEHVFGS..AQHREE.LS.R...I..AALKK--------- Dm  1429 .....VSV.VRET.EL..LQMAQIFGNY..EHNEE.FQ.RI..I..AALKK--------- Hs  1284 .....L.V...TDCDIE.DR.AAMFRE.T.QNKAT.VDH.I..L..L.AQKDFRKQVNYE Gg  1276 .....L.V...TD.DV..DG.AAMFRE.T..KKSV...H.I..L..L.AQK--------- TaC 1196 .R.NKLSKIL.DNTITSHLNGAGVRVVS.IIQRDEGRSPMRHSFKWSSDK.--------- TaP 1258 VR.DKLSATLEQNTVTA.LRAAGVKVIS.IVQRDGALMPMRHTFLLSDEK.--------- Zm  1267 HKMEKLSKIL.DTSV.S.LQAAGLKVIS.IVQRDEARMPMRHTFLWLDDKS--------- Os  1205 .R.NK.SKIL.DSTVTSHLNGAGVRVVS.IIQRDEGRPPMRHSFQWS.DKI--------- At  1200 .RVNKLAKIL.E.EVSSSLCSAGVGVIS.IIQRDEGRTPMRHSFHWSLEKQ--------- Gm  1205 .R.NKLAKIL.EQEVGSTIRAAGVGVIS.IIQRDEGRAPMRHSFHWSEEK.--------- Bn  1280 QAQERVEKIL.E.EVSSSLCSAGVGVVS.IIERDEGRTPIRHSFHWSMEKQ---------   Tu  1287 -------CFPRYFTYRQRDGFTEDRIYRHLEPALAFQLEINRLRNYDLEAIPTANQRMHL Ph  1254 ------KQ...F.........Q..........GM.....L..M.T.....LA...RK.Y. Tc  1316 ------KQS.KF..F.S..D.K..K........C.....L..M...N...L..S..K... Aa  1447 ------RQ..KF....A..N.E...........C.....L..M.T.....L.....K... Dm  1480 ------RQ..KF..F.A..K.............S..H..L..MKT.....L.....K... Hs  1344 VDRRFHRE..KF..F.A..K.E.................L..M..F..T...C..HK... Gg  1327 ------RE..KF..F.A..K.E.................L..M..F..T...C..HK... TaC 1247 -------------------YYE..PML..V..P.STF..LDKVNLEGYNDAKYTPS.DRQ TaP 1309 -------------------CYE.EPVL..V..P.SAL..LGK.KVKGYNEVKYTPS.DRQ Zm  1318 -------------------CYE.EQ.L..V..P.STL..LDK.KVKGYNEMKYTPS.DRQ Os  1256 -------------------YYE..PML..V..P.STF..L.KVNLDGYNEVKYTPS.DRQ At  1251 -------------------YYV.EPLL.....P.SIY..LDK.KG.SN--.QYTPS.DRQ Gm  1256 -------------------YYA.EPLL.....P.SIY..LDK.KA.EN--.RYTPS.DRQ Bn  1331 -------------------YYA.EPML.....P.SIY..LDK..G.EN--.QYTPT.DRQ   Tu  1340 YLGKAKSTHTK--QLIDYRFFIRTIIRHS--------------DLITKEASYEFLQNEGE Ph  1308 ......VAKGQ--EVT.......S.....--------------........F.Y...... Tc  1370 ......GIGG.--EVT.......S.....--------------........F.Y...... Aa  1501 ...R..VPKGQ--EVT.F.....S.....--------------........F.Y...... Dm  1534 ......VSKGQ--EVT.......S.....--------------........F.Y...... Hs  1404 ...A..VEVGT--EVT.....V.A.....--------------..V.....F.Y...... Gg  1381 ...A..VEVGT--EVT.....V.A.....--------------..V.....F.Y...... TaC 1288 WHMYTLVKNK.DPRSN.Q.M.L...V.QPSVTNGFLFG-SIDNEV---Q..SS.TS.SIL TaP 1350 WNIYTLRNTEN--PKMLH.V.F..LV.QPGASNKFTSGNISDVEVGGA.E.LS.TSSSIL Zm  1359 WHIYTLRNTEN--PKMLH.V.F...V.QPNAGNKFRSAQISDAEVGCP.E.LS.TS.SIL Os  1297 WHIYTLIKNK.DQRSN.Q.L.L...V.QPGVTNGFLSG-NVDNEVGRAQ..SSYTSSSIL At  1290 WHLYTVTDK----PVPIK.M.L.SLV.QATMNDGFILQQGQDKQ.SQTLI.MA.TSKCVL Gm  1295 WHLYTVVD.K---PQPIQ.M.L..LV.QPTTNEGFSSYQRLDAETSRTQLAMS.TSRSIF Bn  1370 WHLYTVTDNKP---VPVR.M.L.SLV.QGQDNQ---------------------.SQTLV   Tu  1384 RFLLEALDELEVAFTHPAAKQTDCNHIFLNFVP--------------------KVTMDPL Ph  1352 .V....M.......S..HS.R............--------------------T.I...A Tc  1414 .V....M.......S..HSRR..........I.--------------------T.I...A Aa  1545 .V....M.......S..Q..R............--------------------T.I...A Dm  1578 .V....M.......S..H..R............--------------------T.I...A Hs  1448 .L....M.......NN-TNVR............--------------------T.I...S Gg  1425 .L....M.......NN-TNVR............--------------------T.I...S TaC 1344 .S.MA..E.I.LRAHSET-GMSGHS.MY.CIMREQRLFDLIPS-SRMTNEVGQDEKTACT TaP 1408 .S.MT.IE...LHAIRT-----GHS.M..CILKEQKLLDLVPVSGNKVVDIGQDEATAC. Zm  1417 .S.MT.IE...LHAIRT-----GHS.MY.CILKEQKLLDLIPFSGSTIVDVGQDEATACS Os  1356 .S.MA..E.I.LHAHNET-VRSSYS.MY.CILRVQQLFDLIPF-SRTIDNVGQDEATACT At  1346 .S.MD.ME...LNAHNA.-MKP.HA.M..CILRDEQIDDLVPFPRRVEVNAEDEE.TVEM Gm  1352 .S.MA.ME...LNAHNVN-IKSGHA.MY.YIIREQQIDDLVPYPKRINIEAGKEEITVEA Bn  1406 .S.MD.ME...LNAHKEDGAKP.HA.M..CLLREQHINDLVPYPRRVEVNAEVEE.GIEM   Tu  1424 RIAENVKNTVKNYASRLRKLRVLQAELRMRIRMTTNGKCTPFRLYVSYESGYSLAIHLYK Ph  1392 K.E.S.T.M.MR.GP..W.........K.T..T.P.S.TETI..CLAND...Y.D.CM.. Tc  1454 K.E.A.TSM.MR.GP..W.........K.I..LAP.APTQTI..CLAND...Y.D.NM.T Aa  1585 K.E.S.TKM.MR.GP..W.........K.V..Q..QSPT.SV..CIAND...F.D.AM.T Dm  1618 K.E.S.TKMIMR.GP..W.........K.V..QSPQSPTQAV..CIAND...F.D.SM.T Hs  1487 K.E.S.RSM.MR.G...W.........KIN..L.PT..AI.I..FLTN....Y.D.S... Gg  1464 K.E.S.RSM.MR.G...W.........KIN..L.PT..AI.I..FLTN....Y.D.S... TaC 1402 LLKHM.M.IYEHVGV.MHR.S.C.W.VKLWLDSDGQA-NGAW.VV.TSVT.HTCTVDI.R TaP 1463 LLK.MALQIHELVGA.MHH.S.C.W.VKLKLDSDGPA-SGTW.VVTTNVTSHTCTVDI.R Zm  1472 LLKSMALKIHELVGA.MHH.S.C.W.VKLKLDCDGPA-SGTW.VVTTNVT.HTCT.DI.R Os  1414 LLKNMAL.IYEHVGV.MHR.S.C.W.VKLWLDCDGQA-SGAW.VV.TNVT.HTCTVDI.R At  1405 ILE.AAREIHRSVGV.MHR.G.CEW.V.LWLVSSGLA-.GAW.VV.ANVT.RTCTV.I.R Gm  1411 VLE.LAREIHSSVGV.MHR.G.VVW.IKLWMAACGQA-NGAW.VI.NNVA.HTCTV...R Bn  1466 ILE.T.REIH.SAGV.MHR.G.CEW.V.L.LAS------GVW.AV.TNVT.RTCTV.I.R 
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 Tu  1484 ETRDPASGLTKFEAWGAPYYEPGPLNDQPISSPYRTKDYLQSKRFLAQSNGTTYIYDFPV Ph  1452 .IT..KT.TI....Y.S---KQ..MHGL..TV..V......Q...Q...T....V..I.D Tc  1514 .EV..DT.II..R.Y.K---KQ..MHGL...T..LA.....Q.......A....V..Y.D Aa  1645 .VT..ETHVI..Q.Y.N---RQ...HGL......M......Q...Q........V..I.D Dm  1678 .QTE.ET.II..K.Y.E---KQ.S.HGH...T..M...F..Q...Q........V..V.D Hs  1547 .VT.SRTAQIM.Q.Y.D---KQ...HGML.NT..V...L......Q...L.......I.E Gg  1524 .VT.SRT.QIM.Q.Y.D---KQ...HGML.NT..V...L......Q...L..S.V..I.E TaC 1461 .VE..NTHKLFYRSATP---TA...HGIALHE..KPL.AIDL..AA.RK.E...C....L TaP 1522 .VE.TE.QKLVYHSAPS---SS...HGVALNT..QPLSVIDL..CS.RN.R...C....L Zm  1531 .VEEIE.QKLVYHSASS---SA...HGVALNN..QPLSVIDL..CS.RN.R...C....L Os  1473 .VE.SNTHKLFYHSVTP---SL...HGIVLDE..KPL.AIDL..YS.RK.E...C....L At  1464 .VET.GRNSLIYHSITK---KG-..HET...DQ.KPLG..DRQ.LA.RRSN...C....L Gm  1470 .KE.TITHKVVYSSVSV---KG-..HGVAVNEN.QPLGVIDR..LS.RK.S...C....L Bn  1520 .VEATG.NSLIYQSITK---KG-..HGT..NDQ.KPLGH.VRQ.LA.RRSN...C....L   Tu  1544 MFQTALTQIWREYLKSKEDYELE--MPKTVLSYVELVVDFS-TGKMTEQNRQPGENECGM Ph  1509 ..RQMTDKL..D.MDENPQEDIS--I.SQLMN.....L.--DDN.LI.TK.L....DV.. Tc  1571 ..RQMVDLQ.KQ.MNQRISEHIQ--P.DKLMDF...IL.PETESRLI..K.V....NV.. Aa  1702 ..RQMTERL.K.FS.ARPTEDIR--I.EKI.LVCNEL.LK--GDTLE.IQ.L....NV.. Dm  1735 ..RQMTERH...FS.ARPTVDIR--T.DKI.IECKEL.LE--GDNLV.MQ.L....N... Hs  1604 ..RQS.IKL.ESMSTQAFLPSPP--L.SDM.T.T...L.D--Q.QLVHM..L..G..I.. Gg  1581 ..RQS.IKL.DSMNEHAFLPTPP--L.SDI.T.T...L.D--Q.QLVHM..L..G..I.. TaC 1518 A.E...KKS.ESGISHVAESNEHNQRYAE.TELIFADSTG.WGTPLVPVE.P..S.NF.V TaP 1579 A.E..VQKS.SNISSDTN------RCYVKATEL.FAHKNG.WGTPVIPME.PA.L.DI.. Zm  1588 A.E...QKS.QSNGSTVSEGNENSKSYVKATEL.FAEKHG.WGTPIIPME.PA.L.DI.. Os  1530 A.E...KRS.KST.SVVAEANEHNKSYAK.TELMFADSTG.WGTPLVPVE.S..I.DI.I At  1520 A.G...ELL.ASQHPGVKKPYKD--TLIN.KEL.FSKPEG.SGTSLDLVE.P..L.DF.. Gm  1526 A.E...E.S.AIQQPGFQRAKDK--NLLK.TELKFADKEG.WGTPLVPVENY..L.DV.. Bn  1576 A.E...EEL.ESQHPGVKKPFKN--TLTN.EEL.FSTPEG.----LIPVK.P..L.D...   Tu  1601 VAWHFTLFTPEYPEGRDIIVIGNDITHQLGIFGPREDIAFNLASVRARELGIPRIYISAN Ph  1565 ...KVS.N.....T..E....A..L.YLI.S......KV.C...EM..K.K.......V. Tc  1629 ...RL..Y.....D...V...A.....MI.S......KV.G...EI..CMK.....LA.. Aa  1758 ...RIV.A...F.D..E.V..A..L.YFI.S...Q..ML.CK..ELS.QRKC......V. Dm  1791 ...RIV.A.....N..E....A..L.YLI.S..IK..VL.AK..QL..Q.KV......V. Hs  1660 ...KM.FKS.................YRI.S...Q..LL.LR..EL..AE......V... Gg  1637 ...KM..K..................YRI.S...Q..VL.LR..EL..TH......VA.. TaC 1578 ...NMK.S...F.G..E...VA..V.FKA.S......AF.DAVTNL.C.RK..L..L..T TaP 1633 ...ILDMS.....N..Q.V..A....FRA.S......AF.ETVTNL.C.RKL.L..LA.. Zm  1648 ...IMEMS...F.N..Q...VA....FRA.S......AF.ETVTNL.C.RKL.L..LA.. Os  1590 ...IMK.S...F.S..E...VS..V.FKA.S......AF.DAVTNL.C.RKL.L..L..T At  1578 ...CLDMS...F.M..KLL..A..V.FKA.S......AF.LAVTEL.CAKKL.L..LA.. Gm  1584 ...FMEMC...F.S..T.L.VA..V.FKA.S......AF.RAVTDL.CTKKL.L..LA.. Bn  1630 ...TLEMS...F.K..K..IVA..V.FKA.S......AF.LAVTEL.CAEKL.L..LA..   Tu  1661 SGAKIGLAEEVKSIFEICWIDKNIPDKGFHYLYLSPENYKKIEKS--INAELIEDEGEQR Ph  1625 ...R......I.AL.K.A.E.PDE.....K....TT.D.A.VSALNSVKTV.......R. Tc  1689 ...R........NSYK.A.E.N.E.....R....T..D.A.VSAQNSVR.V.......S. Aa  1818 ...R.........L.KVA.E.PDE.E...K....TT.D.S..ANTNSVR.I.......P. Dm  1851 ...R........AM.K.A.E.PEE.....K.....T.D.AQVANLNSVR.I......... Hs  1720 ...R......IRHM.HVA.V.PED.Y..YR....T.QD..RVSALNSVHC.HV.....S. Gg  1697 ...R......IRHM.HVA.E.PDD.Y..YK....T.QD...VSALNSVHC.HV..N..S. TaC 1638 A..RL.V...I.AC.HVG.S.DQS.ER....I..TEQD.SRLSS.VIAHELKVPES..T. TaP 1693 ...R..I.D....C.RVG.S.DGS.ER..Q.I..TE.DHAR.SA.VIAHKMQLD-N..I. Zm  1708 ...R..I.D....C.RVG.S.EGS.ER..Q.I..TE.D.AR.SS.VIAHKLELD-S..I. Os  1650 A..RL.V...I.AC.NVG.S.DES.ER....I..TEQD.SRLSS.VIAHELKL.-S..T. At  1638 ...RL.V.....AC.KVG.S.EIS.EN..Q.I.....DHER.GS.VIAHEVKLS-S..T. Gm  1644 ...RL.V......C.RVG.SEESN.EN..Q.V..T..DNAR.GS.VIAHELKL.-S..T. Bn  1690 ...RL.V.....AC.KVG.S.EVS.EN..Q.I.....DHER.GS.VIAHEIKLP-S..T.   Tu  1719 YKILDIVGKEEGLGVENLKYAGLIAGETSRAYQEVITITMVTCRAIGIGSYLARLSQRIV Ph  1685 ...T..I..DD.......R...M......E..K.IV..S.............V..G..VI Tc  1749 ..LT..I..DD.......R...M.........D.IV..S..S..........V..G..VI Aa  1878 ...T..I..TD.......R...M.........ED.V..S.....T.......V..G..VI Dm  1911 ...T..I..DD.......R..........Q..E.IV..A.....T......VV..G..VI Hs  1780 ...T..I.....I.P...RGS.M....S.L..N.I...SL.........A..V..G..TI Gg  1757 ...T..I...D...I...RGS.M....S.L..ESI...NL.........A..V..G..TI TaC 1698 WVVDT.....D...C...HGS.A..SAY.K..R.TF.L.F..G......A.....GM.CI TaP 1752 WV.DSV....D......IHGSAA..SAY....E.TF.L.F..G.TV...A.....GI.CI Zm  1767 WI.DSV....D......IHGSAA..SAY....E.TF.L.F..G.TV...A.....GI.CI Os  1709 WVVDT.....D...C...HGS.A..SAY.K..K.TF.L.F..G..V...A.....GM.CI At  1697 WV.DT.....D.I.....TGS.A...AY.K..N.TF.L.F.SG.TV...A.....GM.CI Gm  1703 WV.DT.....D.......SGS.A...AY....K.TF.L.Y..G.TV...A.....GM.CI Bn  1749 WV.DT.....D.I.....TGS.A...AY..G.R.TF.L.F.SG.TV...A.....GM.CI 
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 Tu  1779 QLESSHIILTGHASLNKVLGTEVYSSNNQLGGTQIMFANGVSHAKAKDDLEAILVILDWL Ph  1745 .I.N.......YQA...L..R...A.......I...YN.....KTEPH..DG.YT..K.. Tc  1809 .I.N.......YSA...L..RQ..A.......I...YN.....KVEQG..DG.ATV.K.. Aa  1938 .IDN.......F.A...L..RK..A.......I...YN...T.KTEAL..DGVYT..Y.. Dm  1971 .IDN.......Y.A...L..RK..A............N...T.KTEAI..DGVYT..... Hs  1840 .V.N..L....AGA......R...T.......I...HN...T.CTVC..F.GVFTV.H.. Gg  1817 .V.N.......CGA......R...T.......I...HN...T.GTVC..F.GVYT..L.. TaC 1758 .RLDQP.....YSA...L..R.....QM....PK..AT...V.LTVS....GVSA..K.. TaP 1812 .RTDQP.....FSA...L..R.....HM....PK..AT...V.LTVS....GVSN..R.. Zm  1827 .RLDQP.....FSA...L..R.....HM....PK..AT...V.LTVP.V..GVSN..R.. Os  1769 .RLDQP.....FSA...L..R.....HM....PK..AT...V.LTVS....GVSA..K.. At  1757 .RLDQP.....FST...L..R.....HM....PK..GT...V.LTVS....GVSA..N.. Gm  1763 .RLDQP.....FSA...L..R.....HM....PK..AT...V.LTVS....GVSS..K.. Bn  1809 .RLDQP.....FST...L..R...T.HM....PK..G....V.LTVS....GVSA..N..   Tu  1839 SYAPKKREKATKLVNLTKIKPAPLPIMEPTDIIDRDVVYCPTSSPYDPRWILNGR--ESP Ph  1805 ..I..DKY-------------SIV..IKVS.P...EIS.M..KT......M.A..IINDG Tc  1869 ..V.RDKN-------------S...VIK.I.P.E.E.DFI..KA......M.E..ASPLD Aa  1998 ..I.DV.G-------------GL...VSAS.S.N.PIDFM..KA......M.A..VNP.N Dm  2031 ..I.AYIG-------------CD...VL.N.R.E.P.DFM..K.......M.G..VNPVN Hs  1900 ..M..SVH-------------SSV.LLNSK.P...IIEFV..KT......M.A..PHPTQ Gg  1877 ..M..SVY-------------S.V..LKVK.P...TIDFV..KT......M.A..PNP.Q TaC 1818 ..V.PYVGG-------------....VKSL.PPE.A.T.F.EN.-C.A.AAIC.IQ--DT TaP 1872 ..V.ANIGG-------------....TKSL.PP..P.A.I.ENT-C...AAIS.ID--DS Zm  1887 ..V.ANIGG-------------....TK.L.PP..P.A.I.ENT-C...AAIC.VD--DS Os  1829 ..V.PYVGG-------------.....K.L.PP..P.T.F.EN.-C.A.AAIC.VQ--DS At  1817 ..I.AYVGG-------------...VLA.L.PPE.I.E.V.EN.-C...AAIA.VK--DN Gm  1823 ..I.SHVGG-------------A...VK.L.PPE.P.E.F.EN.-C...AAIS.TL--DG Bn  1869 ..V.AHAGGP-----------L...LLS.L.PPE.T.E.V.EN.-C...AAIA.VN--DN   Tu  1897 QGVWEEGFFDKGSFHEIMAGWAKTVVVGRARLGGIPVGVISVEVRKTEVIIPADPANPTS Ph  1852 -TD..S....R..WD....P..Q...C.............A..T.TV.LNL......LE. Tc  1916 PKN..S....RD.WS...KP..Q...A.............A..T.TV.LNL......LD. Aa  2045 PSE..T....R.TWS.V.EP..........K.........A..T.TV.LT.......LD. Dm  2078 AND..N....RD.WS....S......T.......V.....A..T.TV..EM......LD. Hs  1947 K.Q.LS....Y...S...QP..Q................VA..T.TV.LS.......LD. Gg  1924 K.Q.QS....N...L...QP..Q................VA..T.TV.LS.......LD. TaC 1862 ..K.LS.M..RE..V.TLE......IT...K.......I.A..TETVMQV.....GQLD. TaP 1916 ..K.LG.M...D..V.TFE....S..T...K.........A..TQTMMQL.....GQLD. Zm  1931 ..K.LG.M...D..V.TFE.......T...K.........A..TQTMMQ......GQLD. Os  1873 ..K.MG.M..RE..V.TLE.......T...K.........A..TQTMMQV.....GQLD. At  1861 T.K.LG.I...N..I.TLE...R...T...K........VA..TQTVMQ......GQLD. Gm  1867 N.R.LG.I...D..V.TLE...R...T...K........VA..TQTVMQ......GQLD. Bn  1915 A.K.LG.I...N..M.TLE...R...T...K...V....VA..TQTVTQ......GQVD.   Tu  1957 ETKVQSQAGQVWFPDSAFKTAQAINDFNREGLPLMIFANWRGFSGGMKDMYDQILKFGAQ Ph  1911 .A.TV............Y......Q..SK.....F................E.VI....Y Tc  1976 .A.TV............Y....S.A..S..D...F................E..M....Y Aa  2105 .A.TFQ..........SY......K..G..E...I.L.........Q....E..V....Y Dm  2138 .A.TLQ......Y...SY......K..G..E...IV...............E..V....Y Hs  2007 .A.IIQ..............Y...K..........V.................V.....Y Gg  1984 .A.IIQ.............................V.................V.....Y TaC 1922 AER.VP...........A.....LL.....E...F.L.........QR.LFEG..QA.SM TaP 1976 HERSVPR..........T.....ML.........F.L.........QR.LFEG..QA.ST Zm  1991 HERSVPR..........T.....LL.........F.L.........QR.LFEG..QA.ST Os  1933 AER.VP...........T.....LL.....E...F.L.........QR.LFEG..QA.SN At  1921 HER.VP...........A.....LM.....E...F.L.........QR.LFEG..QA.ST Gm  1927 HER.VP...........T......L.....E...F.L.........QR.LFEG..QA.ST Bn  1975 HER.VP........G..A.....LM.........F.L.........QR.LFEG..QA.SA   Tu  2017 IVDALVAYNQPIIVYIPPYAELRGGAWAVVDTTINPRHMEMYADPDSRGGVIEPEGSVEI Ph  1971 ...G.RE.T....I.L..NG...........M.....Y.......E.....L..Q.I... Tc  2036 ...G.RQ.RK.V.I....NG...........P...S.Y.......E.....L....I... Aa  2165 ...G.RE.K..V.I.L..N..........L.P.....Y..T....E..A..L....I..V Dm  2198 ...G.RE.KK.VLI.L..N..........L.SL....Y..T....EA....L....I... Hs  2067 ...G.RECC..VL.....Q......S.V.I.SS...........RE...S.L....T... Gg  2044 ...G.RE.R..VLI....Q......S...I.P............RE....IL....T... TaC 1982 ..EN.RT.K..AF....KAG.......V...SK...E.I....ERTA..N.L.AP.LI.. TaP 2036 ..EN.RT....AF....KA........V.I.SK...DRI.F..ERTAK.N.L..Q.LI.. Zm  2051 ..EN.RT....AF....MAG.......V...SK...DRI.C..ERTAK.N.L..Q.LI.. Os  1993 ..EN.RT....AF....MGG.......V...SK...E.I....ERTAK.N.L....L... At  1981 ..EN.RT.R..VF....MMG.......V...SQ..SDYV.....ETA..N.L....TI.. Gm  1987 ..EN.RT.K...F....MMG.......V..VSR..SD.I.....RTDK.N.L....MI.. Bn  2035 ..EN.RT.G..VF....KMG.......V...SQ..SDYV.....ET...N.L....MI.. 
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 Tu  2077 RFRIKDQIKAMHRNDVICKKIIAEINKTTDPAVK--------KKLERQLNDREQQIKGAY Ph  2031 K..MR.LL.T...I.PVILS.KN.MMSKGEMLPE------QKAAY.KKIKA..TFLAPM. Tc  2096 KY.K..LL.T...I.PVLRELDEK.V.FNQTRPMGER--TSIVD..AKITE..NFLMPM. Aa  2225 K.KE..LV.SIQ.L.PVVLELKKKQAEAAGNKD-------ALAE..N.IKM.VNSLLHV. Dm  2258 KYKE..LV.TI..L.PTTIALKK.LDEANASGD.-----VRAAQVDEKIKA.IAVLMHV. Hs  2127 K..R..LV.T.R.V.PVYIHLAERLGTPELSTAE-------R.E..NK.KE..EFLIPI. Gg  2104 K..R..LV.T.R.V.PVYMRLAERLGTPELS.AD-------R.D..SK.KE..EFLIPI. TaC 2042 K.KPNELEES.L.L.PELISLN.KLL.E.SASPSPWETAAAAETIR.SMAA.RK.LMPI. TaP 2096 K..SEELQEC.G.L.PELINLK.KLLGAKHENGS----LSESES.QKSIEA.KK.LLPL. Zm  2111 K..SEELQDC.G.L.PELINLK.KLQDVNHGNGS----LPDIEGIRKSIEA.TK.LLPL. Os  2053 K..P.ELEEC.L.L.PELI.LSTRLREMKKENAG----LSEMDTTR.SIIA.MK.LMPI. At  2041 K..T.ELLEC.G.L.QKLISLK.KLQDAKQ-----SEAYANIEL.QQ.IKA..K.LLPV. Gm  2047 K..TRELLES.G.L.QQLITLK.PLQEAKS-----SRNIVAFVS.QQ.IKS..R.LLPV. Bn  2095 K..KREMLEC.G.L.QKLISLK.KLRDAKQ---------SEMELIKQ.IKA.KK.LLPL.   Tu  2129 HIVATYFADLHDKPYNMLMRKAIRGIIPWHRSRYYFYWRLRRLSVEEILKCDLESIDG-S Ph  2085 .Q..VQ......T.ER.QEKGC.LD.V..RN..KF.....K..VL.NEV.NK.LD.QP-D Tc  2154 .Q.SVH......T.ER..EKG..ND.V..RK..SIL.......LLQDKVVTA.LDAQP-M Aa  2278 .T..VH......T.ER..EKGC.SE.V..RS..SF....M...LL..HFIKQILDAQD-. Dm  2313 .T..VH......T.ER..EKEC.SE.V..RD..RWL.......LL.DAYIKKILRAQD-N Hs  2180 .Q..VQ......T.GR.QEKGV.SD.LD.KT..TF........LL.DLV.KKIHNANP-E Gg  2157 .Q..MQ......T.GR.QEKG..TD.LD.KT..TF........LL.DVV.KKIHDANP-E TaC 2102 TQ...R..E...TSAR.AAKGV.SKVVD.EE..AF..R..L.RLA.DS.AKQVREAA.EQ TaP 2152 TQI.VR..E...TSLR.AAKGV.KKVVD.ED..SF..K....RIS.DV.AKEIRGVS.KQ Zm  2167 TQI.IR..E...TSLR.AAKGV.KKVVD.EE..SF..K....RIA.DV.AKEIRQ.V.DK Os  2109 TQ...R..E...TSAR.AAKGV.GKVVD.EE..SF..R....RVT.DA.AKEIREAA.EQ At  2096 IQI..K..E...TSMR.AAKGV.KSVVE.SG..SF..KK.N.RIA.SS.VKNVREAS.DN Gm  2102 TQI..K..E...TSLR.AAKGV..EVLD.RN..SV..Q..H.RIG.QS.INSVRDAA.DQ Bn  2146 IQI..K......TSMR.AAKGV.KSVVE.SG..SF..KK.I.RIA.SS.VKNVIEAS.DN   Tu  2188 MTIEQINNLMEKWFYADQ-KNTQTQLWNDDKFVAEWLQMQLDDPASLVNENLKELRLNNF Ph  2144 L.VG.ASSMLRR..TEQE-GPAKVYM.DNNEE.I...ENPE-----TKMKLEENMEAVKR Tc  2213 LGVG.GEAMLRR..IE.K-GS.EGYK.DNNET.VH..ED..RK.P-SQSIINYN.HCVKK Aa  2337 LSVG.AKSMLRR..VE.K-GA.EAY..ENNEP.V...EN.KK----SDSTVSRNIYAVKK Dm  2372 LSVG.AKQMLRR.LVEEK-GA.EAY..DKNEEMVS.YEE.IN----AESIVSRNVNSVRR Hs  2239 L.DG..QAMLRR..VEVE-GTVKAYV.DNN.DL....EK..TEEDGVHSVIEENIKCISR Gg  2216 L.DG..QAMLRR..VEVE-GTVKAY..DSN.DLV...EK..MEEEGVRSVVDENIKYISR TaC 2162 QMPTHRAA.ECIKKWYLASQGGDGEK.S..EAFFA.KDDPDK-----YGKY.E..KAERA TaP 2212 FSHQSAIE.IQ..YL.SKGAE.GNTE.D..DAFVA.RENPEN-----YQ.YI....AQRV Zm  2227 F.HQLAME.IKE.YL.S.ATTG-STG.D..DAFVA.KDSPEN-----YKGHIQK..AQKV Os  2169 LSQKSALDYIK..YLSSNGSDGNSEK..N.EAFFA.KDDPTN-----YENQ.E..KAERV At  2156 LAYKSSMR.IQD..CNSDIAKGKEEA.T..QVFFT.KDNVSN-----YELK.S...AQKL Gm  2162 LSHASAM..LKE.YLNSDIAKGREDA.L..EAFFR.KDIPSN-----YENK.....VQKV Bn  2206 LSYKSAMG.IKD..CKSDVAKGKEEA.T..QVFFT.KENVGN-----YESE.S...AQKL   Tu  2247 SQVVESVCEQFLPKGLTSEDSLRVADCLRTLTDKLKTKVVFSNKHSDIEKEATNDGQSVE Ph  2198 NSI..QISHKVKECPQAAM...IGIFEILSPSQRVESHAHLESLLQKL.S.QHP------ Tc  2271 DA.INQINVALEDCPDVAL.AVVQIIQKLSDNQ.AEVIRTL.QLG.VENID--------- Aa  2392 DAIISQIQKALEECPEIAL.AVVGLCQALSPAHRGEVVKTL.QLEFTEKEH.KQHKYNPR Dm  2427 DAIISTISKMLEDCPDVAL.AVVGLCQGL.PVNRGVVVRTLAQMQLNE.TSNS.Q.---- Hs  2298 DY.LKQIRSLVQANPEVAM..IIHMTQHISP.QRAEVIRIL.TMD.PST----------- Gg  2275 DYILKQIRSLVQANPEVAM..IVHMTQHISP.QRAEIVRIL.TMD.PSST---------- TaC 2217 .TLLSNLA.-TSDAKALPNG-.SLLLSKMDPAKREQVMDGLRQLLG-------------- TaP 2267 ..LLSD.ADSSPDLEALPQG-.SMLLEKMDPSRRAQFVEEVKKVLK-------------- Zm  2281 .HSLSDLADSSSDLQAF.QG-.STLLDKMDPSQRA.FVQEVKKVLD-------------- Os  2224 .KWLSRLA.-SPDVKALPNG-.SIVLNKMNPSKREQVIDGLRQLLG-------------- At  2211 LNQLAEIGN-SSDLQALPQG-.ANLLNKVEPSKREELVAAIRKVLG-------------- Gm  2217 LLQLTNIGDSA.DLQALPQG-.AALLSKLEPLGRV.LTDELRKVLG-------------- Bn  2261 LKQLAEIGN-SSDLQALPQG-.ANILHKVEPLKREQLVDALRKVL.--------------   Tu  2307 STSNGVGNGSSK------------------------------------------------ Ph       ------------------------------------------------------------ Tc       ------------------------------------------------------------ Aa  2452 RAKRLAE.L.VDLRDLVKRCGFERYRVLAVVTVGDRNSQDFKSVLRFVWDAEKDGYVNVT Dm       ------------------------------------------------------------ Hs       ------------------------------------------------------------ Gg       ------------------------------------------------------------ TaC      ------------------------------------------------------------ TaP      ------------------------------------------------------------ Zm       ------------------------------------------------------------ Os       ------------------------------------------------------------ At       ------------------------------------------------------------ Gm       ------------------------------------------------------------ Bn       ------------------------------------------------------------ 
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 Tu       ------------------ Ph       ------------------ Tc       ------------------ Aa  2512 YETPTYFIVATVFAVYYE Dm       ------------------ Hs       ------------------ Gg       ------------------ TaC      ------------------ TaP      ------------------ Zm       ------------------ Os       ------------------ At       ------------------ Gm       ------------------ Bn       ------------------ 
 
Appendix 5 Sequence alignment of selected ACCase homologs from Tetranychus urticae (Tu), 
Pediculus humanus corporis (Phc, XP_002429216.1), Tribolium castaneum (Tc, XP_969851.2), 
Aedes aegypti (Aa, XP_001651879.1), Drosophila melanogaster ACCase isoform A (Dm, 
NP_610342.1), Homo sapiens ACCase1 (Hs, NP_942133.1), Gallus gallus (Gg, NP_990836.1), 
Triticum aestivum cytosolic ACCase (TaC, ACD46674), Triticum aestivum plastid ACCase (TaP, 
ACD46685), Zea mays (Zm, AAA80214), Oryza sativa (Os, AAM18728), Arabidopsis thaliana (At, 
AAC41645), Glycine max (Gm, AAA75528), Brassica napus (Bn, CAA54683). Protein sequences 
were aligned using the CLUSTALW alignment algorithm. Sequences were shaded using the 
BoxShade program. Structural motifs typical of this enzyme are shaded gray, the BC domain (31-528 
AA), the BCC domain (662- 728 AA) and the CT domain (1639- 2143 AA). 
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